#### Prospectus dated 23 March 2022

# Bayer Aktiengesellschaft

#### (incorporated in the Federal Republic of Germany)

## € 500,000,000
 Subordinated Resettable Fixed Rate Notes due 2082
 with a First Optional Redemption Date in 2027

**ISIN XS2451802768, Common Code 245180276, WKN A3MQSV, Issue price:99.429 per cent.**

## € 800,000,000
 Subordinated Resettable Fixed Rate Notes due 2082
 with a First Optional Redemption Date in 2030

**ISIN XS2451803063, Common Code 245180306, WKN A3MQSW, Issue price:99.204 per cent.**

Bayer Aktiengesellschaft (the "Issuer") will issue on 25 March 2022 (the "Issue Date") € 500,000,000 Subordinated Resettable Fixed Rate Notes due
2082 with a First Optional Redemption Date in 2027 (the "NC5.5 **Notes") and € 800,000,000 Subordinated Resettable Fixed Rate Notes due 2082**
with a First Optional Redemption Date 2030 (the "NC8.5 **Notes", and together with the NC5.5 Notes, the "Notes" and each a "Series"), each in the**
denomination of € 100,000 per Note.

The Notes will be governed by the laws of the Federal Republic of Germany ("Germany").

The NC5.5 Notes will bear interest from and including the Interest Commencement Date to but excluding 25 September 2027 (the "NC5.5 **Notes** **First**
**Reset Date") at a rate of 4.500 per cent. per annum. Thereafter, unless previously redeemed, the NC5.5 Notes will bear interest (i) from and including**
the NC5.5 Notes First Reset Date to but excluding 25 September 2032 (the "NC5.5 **Notes** **First Step-up Date") at a rate per annum equal to the**
applicable 5-year mid swap rate for the relevant Reset Period (each as defined in § 3 of the terms and conditions of the relevant Series of Notes (the
"Terms and Conditions")) plus 375.1 basis points per annum (no step-up), (ii) from and including the NC5.5 Notes First Step-up Date to but excluding
25 September 2047 (the "NC5.5 **Notes** **Second Step-up Date") at a rate per annum equal to the applicable 5-year mid swap rate for the relevant Reset**
Period plus 400.1 basis points per annum (including a step-up of 25 basis points) and (iii) from and including the NC5.5 Notes Second Step-up Date
to but excluding 25 March 2082 (the "NC5.5 **Notes** **Maturity Date") at a rate per annum equal to the applicable 5-year mid swap rate for the relevant**
Reset Period plus 475.1 basis points per annum (including a further step-up of 75 basis points).

Interest on the NC5.5 Notes is scheduled to be paid annually in arrear on 25 September in each year, commencing on 25 September 2022 (first short
coupon).

Unless previously redeemed or repurchased and cancelled, the NC5.5 Notes will be redeemed at par on the NC5.5 Notes Maturity Date.

The NC8.5 Notes will bear interest from and including the Interest Commencement Date to but excluding 25 September 2030 (the "NC8.5 **Notes** **First**
**Reset Date") at a rate of 5.375 per cent. per annum. Thereafter, unless previously redeemed, the NC8.5 Notes will bear interest (i) from and including**
the NC8.5 Notes First Reset Date to but excluding 25 September 2035 (the "NC8.5 **Notes** **First Step-up Date") at a rate per annum equal to the**
applicable 5-year mid swap rate for the relevant Reset Period plus 445.8 basis points per annum (no step-up), (ii) from and including the NC8.5 Notes
First Step-up Date to but excluding 25 September 2050 (the "NC8.5 **Notes** **Second Step-up Date") at a rate per annum equal to the applicable 5-year**
mid swap rate for the relevant Reset Period plus 470.8 basis points per annum (including a step-up of 25 basis points) and (iii) from and including the
NC8.5 Notes Second Step-up Date to but excluding 25 March 2082 (the "NC8.5 **Notes** **Maturity Date") at a rate per annum equal to the applicable**
5-year mid swap rate for the relevant Reset Period plus 545.8 basis points per annum (including a further step-up of 75 basis points).

Interest on the NC8.5 Notes is scheduled to be paid annually in arrear on 25 September in each year, commencing on 25 September 2022 (first short
coupon).

Unless previously redeemed or repurchased and cancelled, the NC8.5 Notes will be redeemed at par on the NC8.5 Notes Maturity Date.

The Issuer is entitled to defer interest payments on each Series of Notes under certain circumstances (as set out in § 4(1) of the Terms and Conditions)
(such payments the "Deferred Interest Payments").


-----

The Issuer may pay such Deferred Interest Payments at any time upon due notice (as set out in § 4(2) of the Terms and Conditions) and it shall pay
such Deferred Interest Payments (in whole, but not in part) under certain other circumstances (as set out in § 4(3) of the Terms and Conditions). Such
Deferred Interest Payments will not bear interest themselves.

The Issuer may, at its option, redeem each Series of Notes prior to its respective maturity date on the terms set forth in § 5 of the respective Terms and
Conditions.

Each Series of Notes will initially be represented by a temporary global note in bearer form (each a "Temporary Global Note"). Interests in each
Temporary Global Note will be exchangeable, in whole or in part, for interests in a corresponding permanent global note (each a "Permanent Global
**Note" and together with the Temporary Global Notes, the "Global Notes") not earlier than 40 days after the Issue Date (the "Exchange Date"), upon**
certification as to non-U.S. beneficial ownership.

This prospectus (the "Prospectus") constitutes a prospectus within the meaning of Article 6.3 of Regulation (EU) No 2017/1129 of the European
Parliament and of the Council of 14 June 2017 (as amended, the "Prospectus Regulation"). This Prospectus will be published in electronic form
together with all documents incorporated by reference on the website of the Luxembourg Stock Exchange (www.bourse.lu).

This Prospectus has been approved by the Commission de Surveillance du Secteur Financier, Luxembourg ("CSSF") in its capacity as competent
authority under the Prospectus Regulation. The CSSF only approves this Prospectus as meeting the standards of completeness, comprehensibility and
consistency imposed by the Prospectus Regulation. Such approval should neither be considered as an endorsement of the Issuer that is subject of this
Prospectus nor of the quality of the securities that are the subject of this Prospectus. The CSSF gives no undertaking as to the economic and financial
soundness of the transaction or the quality or solvency of the Issuer. Investors should make their own assessment as to the suitability of investing in
the Notes.

This Prospectus will be valid until 23 March 2023 and may in this period be used for admission of the Notes to trading on a regulated market. In case
of a significant new factor, material mistake or material inaccuracy relating to the information included in this Prospectus which may affect the
assessment of the Notes, the Issuer will prepare and publish a supplement to the Prospectus without undue delay in accordance with Article 23 of the
Prospectus Regulation. The obligation of the Issuer to supplement this Prospectus will cease to apply once the Notes have been admitted to trading on
the regulated market of the Luxembourg Stock Exchange and at the latest upon expiry of the validity period of this Prospectus.

Application has been made to the Luxembourg Stock Exchange for each Series of Notes to be listed on the official list of the Luxembourg Stock
Exchange (the "Official List") and to be admitted to trading on the Luxembourg Stock Exchange's regulated market. The Luxembourg Stock
Exchange's regulated market is a regulated market for the purposes of Directive 2014/65/EU of the European Parliament and of the Council of 15 May
2014 on markets in financial instruments (as amended, "MiFID II").

This Prospectus does not constitute an offer to sell, or the solicitation of an offer to buy, the Notes in any jurisdiction where such offer or solicitation
is unlawful.

**The Notes have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and subject to**
**certain exceptions, the Notes may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons.**

The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail
investor in the European Economic Area ("EEA"), the United Kingdom (the "UK") or anywhere else.

Prospective purchasers of the Notes should ensure that they understand the nature of the Notes and the extent of their exposure to risks and that they
consider the suitability of the Notes as an investment in the light of their own circumstances and financial condition. Investing in the Notes involves
certain risks. Please review the section entitled "Risk Factors" beginning on page 7 of this Prospectus.

_Joint Bookrunners and Co-ordinating Banks_

**BBVA** **J.P. Morgan**

**Morgan Stanley** **UniCredit**

_Joint Bookrunners_

**Barclays** **Deutsche Bank** **Mizuho Securities**

**SMBC Nikko** **Standard Chartered Bank AG**


-----

### RESPONSIBILITY STATEMENT

#### The Issuer with its registered office in Germany accepts responsibility for the information contained in this Prospectus and hereby declares that the information contained in this Prospectus is, to the best of its knowledge, in accordance with the facts and contains no omission likely to affect its import.

 The Issuer further confirms that (i) this Prospectus contains all relevant information with respect to the Issuer (also referred to as "Bayer AG" herein) and its consolidated subsidiaries taken as a whole ("Bayer", "we", "us", "our" or the "Bayer Group") and to the Notes which is material in the context of the issue and the offering of the Notes, including all relevant information which, according to the particular nature of the Issuer and of the Notes is necessary to enable investors and their investment advisers to make an informed assessment of the assets and liabilities, financial position, profits and losses, and prospects of the Issuer and the Bayer Group and of the rights attached to the Notes; (ii) the statements contained in this Prospectus relating to the Issuer, the Bayer Group and the Notes are in every material respect true and accurate and not misleading; (iii) there are no other facts in relation to the Issuer, the Bayer Group or the Notes the omission of which would, in the context of the issue and offering of the Notes, make any statement in the Prospectus misleading in any material respect; and (iv) reasonable enquiries have been made by the Issuer to ascertain such facts and to verify the accuracy of all such information and statements.

### NOTICE

#### No person is authorized to give any information or to make any representation other than those contained in this Prospectus and, if given or made, such information or representation must not be relied upon as having been authorized by or on behalf of the Issuer or Banco Bilbao Vizcaya Argentaria, S.A, J.P. Morgan SE, Morgan Stanley Europe SE, UniCredit Bank AG, Barclays Bank Ireland Plc, Deutsche Bank Aktiengesellschaft, Mizuho Securities Europe GmbH, SMBC Nikko Capital Markets Europe GmbH or Standard Chartered Bank AG (together, the "Joint Bookrunners").

 This Prospectus should be read and understood in conjunction with any supplement hereto and with all documents incorporated herein or therein by reference.

 The legally binding language of this Prospectus is English except for the Terms and Conditions in respect of which German is the legally binding language.

 In this Prospectus, all references to "€", "EUR" or "Euro" are to the currency introduced at the start of the third stage of the European economic and monetary union, and as defined in Article 2 of Council Regulation (EC) No. 974/98 of 3 May 1998 on the introduction of the Euro, as amended. References to "US$" are to United States dollars. References to "billions" are to thousands of millions.

 Each investor contemplating purchasing any Notes should make its own independent investigation of the financial condition and affairs, and its own appraisal of the creditworthiness, of the Issuer. This Prospectus does not constitute an offer of Notes or an invitation by or on behalf of the Issuer or the Joint Bookrunners to purchase any Notes. Neither this Prospectus nor any other information supplied in connection with the Notes should be considered as a recommendation by the Issuer or the Joint Bookrunners to a recipient hereof and thereof that such recipient should purchase any Notes.

 This Prospectus reflects the status as at its date. The offering, sale and delivery of the Notes and the distribution of the Prospectus may not be taken as an implication that the information contained herein is accurate and complete subsequent to the date hereof or that there has been no adverse change in the financial condition of the Issuer since the date hereof.

 To the extent permitted by the laws of any relevant jurisdiction, none of the Joint Bookrunners, any of its affiliates or any other person mentioned in the Prospectus, except for the Issuer, accepts responsibility for the accuracy and completeness of the information contained in this Prospectus or any other documents incorporated by reference and accordingly, and to the extent permitted by the laws of any relevant jurisdiction, none of these persons accept any responsibility for the accuracy and completeness of the information contained in any of these documents. The Joint Bookrunners have not independently verified any such information and accept no responsibility for the accuracy thereof.


-----

#### This Prospectus does not constitute, and may not be used for the purposes of, an offer or solicitation by anyone in any jurisdiction in which such offer or solicitation is not authorized or to any person to whom it is unlawful to make such offer or solicitation.

 The distribution of this Prospectus and the offering, sale and delivery of the Notes in certain jurisdictions may be restricted by law. Persons into whose possession this Prospectus comes are required to inform themselves about and to observe any such restrictions. For a description of the restrictions see the section "Subscription and Sale of the Notes – Selling Restrictions" below. In particular, the Notes have not been and will not be registered under the Securities Act and are subject to United States tax law requirements. Subject to certain exceptions, the Notes may not be offered, sold or delivered within the United States of America or to U.S. persons as defined in Regulation S under the Securities Act ("Regulation S").

 For the avoidance of doubt, the content of any website referred to in this Prospectus does not form part of this Prospectus and the information on such websites has not been scrutinized or approved by the CSSF as competent authority under the Prospectus Regulation.

### SINGAPORE SECURITIES AND FUTURES ACT PRODUCT CLASSIFICATION

#### In connection with Section 309B of the Securities and Futures Act 2001 of Singapore (the "SFA") and the Securities and Futures (Capital Markets Products) Regulations 2018 of Singapore (the "CMP Regulations 2018"), the Issuer has determined, and hereby notifies all relevant persons (as defined in Section 309A(1) of the SFA), that the Notes are 'prescribed capital markets products' (as defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on Recommendations on Investment Products).

 MIFID II PRODUCT GOVERNANCE / TARGET MARKET: PROFESSIONAL INVESTORS AND ECPS
 ONLY 

 Solely for the purposes of each manufacturer's product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is eligible counterparties and professional clients only, each as defined in MiFID II; and (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Notes (a "Distributor") should take into consideration the manufacturers' target market assessment; however, a Distributor subject to MiFID II is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturers' target market assessment) and determining appropriate distribution channels. 

 UK MiFIR PRODUCT GOVERNANCE / TARGET MARKET: PROFESSIONAL INVESTORS AND ECPS
 ONLY 

 Solely for the purposes of the manufacturer's product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is only eligible counterparties, as defined in the FCA Handbook Conduct of Business Sourcebook ("COBS"), and professional clients, as defined in Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("UK MiFIR"); and (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate. Any Distributor should take into consideration the manufacturers' target market assessment; however, a Distributor subject to the FCA Handbook Product Intervention and Product Governance Sourcebook (the "UK MiFIR Product Governance Rules") is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturers' target market assessment) and determining appropriate distribution channels.


-----

#### PRIIPS REGULATION / PROHIBITION OF SALES TO EEA AND UK RETAIL INVESTORS

 The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the EEA. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of MiFID II; or (ii) a customer within the meaning of Directive (EU) 2016/97 (as amended, the "Insurance Distribution Directive"), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently, no key information document required by Regulation (EU) No 1286/2014 (as amended, the "PRIIPs Regulation") for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation.

 The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the UK. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("EUWA"); or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the "FSMA") and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently, no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the "UK PRIIPs Regulation") for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.

 Where acting as agent on behalf of a disclosed or undisclosed client when purchasing, or making or accepting an offer to purchase, any Notes (or any beneficial interests therein) from the Issuer and/or the Joint Lead Managers the foregoing representations, warranties, agreements and undertakings will be given by and be binding upon both the agent and its underlying client. 

 BENCHMARK REGULATION: STATEMENT ON REGISTRATION OF BENCHMARK ADMINISTRATOR

 Following the respective first reset date, interest amounts payable under each Series of Notes are to be calculated by reference to the annual swap rate for swap transactions denominated in EUR with a term of 5 years, which appears on the Reuters Screen Page "ICESWAP2" under the heading "EURIBOR BASIS" as of 11.00 a.m. (Frankfurt time) on the relevant Interest Determination Date, and which is provided by ICE Benchmark Administration Limited ("IBA"). The annual swap rate for swap transactions denominated in Euro is calculated by reference to the Euro Interbank Offered Rate ("EURIBOR") which is provided by the European Money Market Institute ("EMMI"). As at the date of this Prospectus, EMMI appears on the register of administrators and benchmarks established and maintained by ESMA pursuant to Article 36 of the Benchmark Regulation, while IBA does not appear on the ESMA register.

 STABILISATION

 IN CONNECTION WITH THE ISSUE OF THE NOTES, MORGAN STANLEY EUROPE SE (THE "STABILISING MANAGER") (OR ANY PERSON ACTING ON BEHALF OF ANY STABILISING MANAGER) MAY OVER-ALLOT NOTES OR EFFECT TRANSACTIONS WITH A VIEW TO SUPPORTING THE MARKET PRICE OF THE NOTES AT A LEVEL HIGHER THAN THAT WHICH MIGHT OTHERWISE PREVAIL. HOWEVER, STABILISATION MAY NOT NECESSARILY OCCUR. ANY STABILISATION ACTION MAY BEGIN ON OR AFTER THE DATE ON WHICH ADEQUATE PUBLIC DISCLOSURE OF THE TERMS OF THE OFFER OF THE NOTES IS MADE AND, IF BEGUN, MAY CEASE AT ANY TIME, BUT IT MUST END NO LATER THAN THE EARLIER OF 30 DAYS AFTER THE ISSUE DATE OF THE NOTES AND 60 DAYS AFTER THE DATE OF THE ALLOTMENT OF THE NOTES. ANY STABILISATION ACTION OR OVER-ALLOTMENT MUST BE CONDUCTED BY THE STABILISING MANAGER (OR ANY PERSON ACTING ON BEHALF OF THE STABILISING MANAGER) IN ACCORDANCE WITH ALL APPLICABLE LAWS AND RULES.


-----

#### FORWARD-LOOKING STATEMENTS

 This Prospectus contains certain forward-looking statements, including statements using the words "believe", "anticipate", "intend", "expect", "will", "plans", "may" or other similar terms. This applies in particular to statements under the caption "Description of the Issuer and the Bayer Group" and statements elsewhere in this Prospectus relating to, among other things, the future financial performance, plans and expectations regarding developments in the business of the Issuer and Bayer Group. These forward-looking statements are subject to a number of risks, uncertainties, assumptions and other factors that may cause the actual results, including the financial position and profitability of the Issuer or the Bayer Group, to be materially different from or worse than those expressed or implied by these forward- looking statements. Neither the Issuer nor the Joint Bookrunners do assume any obligation to update such forward-looking statements and to adapt them to future events or developments.

 ALTERNATIVE PERFORMANCE MEASURES

 Certain terms used in this Prospectus and financial measures presented in the documents incorporated by reference are not recognized financial measures under International Financial Reporting Standards as adopted by the European Union ("IFRS") ("Alternative Performance Measures") and may therefore not be considered as an alternative to the financial measures defined in the accounting standards in accordance with generally accepted accounting principles. The Issuer has provided these Alternative Performance Measures because it believes they provide investors with additional information to assess the operating performance and financial results of Bayer Group's business activities. The definition of the Alternative Performance Measures may vary from the definition of identically named alternative performance measures used by other companies. The Alternative Performance Measures for Bayer Group presented by the Issuer should not be considered as an alternative to measures of operating performance or financial standing derived in accordance with IFRS. These Alternative Performance Measures have limitations as analytical tools and should not be considered in isolation or as substitutes for the analysis of the consolidated results or liabilities as reported under IFRS.

 For further information, please see "Description of the Issuer and the Bayer Group - Alternative Performance Measures".


-----

### TABLE OF CONTENTS

#### RISK FACTORS................................................................................................................................................................. 7

 TERMS AND CONDITIONS OF THE NC5.5 NOTES .................................................................................................. 17

 TERMS AND CONDITIONS OF THE NC8.5 NOTES .................................................................................................. 53

 USE OF PROCEEDS ....................................................................................................................................................... 89

 DESCRIPTION OF THE ISSUER AND THE BAYER GROUP .................................................................................... 90

 TAXATION .................................................................................................................................................................... 106

 SUBSCRIPTION AND SALE OF THE NOTES ........................................................................................................... 110

 GENERAL INFORMATION ......................................................................................................................................... 113

 DOCUMENTS INCORPORATED BY REFERENCE .................................................................................................. 115


-----

### RISK FACTORS

#### Before deciding to purchase the Notes, investors should carefully review and consider the following risk factors and the other information contained in this Prospectus. Should one or more of the risks described below materialize, this may have a material adverse effect on the business, prospects, shareholders' equity, assets, financial position and results of operations (Vermögens-, Finanz- und Ertragslage) or general affairs of the Issuer or the Bayer Group. Moreover, if any of these risks occur, the market value of the Notes and the likelihood that the Issuer will be in a position to fulfil its payment obligations under the Notes may decrease, in which case the holders of the Notes ("Noteholders") could lose all or part of their investments. Factors which the Issuer believes may be material for the purpose of assessing the market risks associated with the Notes are also described below.

 The Issuer believes that the factors described below represent the principal risks inherent in investing in the Notes, but the Issuer may be unable to pay interest, principal or other amounts on or in connection with the Notes for other unknown reasons than those described below. Additional risks of which the Issuer is not presently aware could also affect the business operations of the Bayer Group and have a material adverse effect on the business activities and financial condition and results of operations of the Bayer Group. Prospective investors should read the detailed information set out elsewhere in this Prospectus (including any documents incorporated by reference herein) and reach their own views prior to making any investment decision.

 Words and expressions defined in the Terms and Conditions shall have the same meanings in this section.

 The following risk factors are organized in categories depending on their respective nature.

 Potential investors should, among other things, consider the following:

 Risks relating to the Issuer and Bayer Group 

 Strategic Risks

 Social and Macroeconomic Trends including the COVID-19 pandemic

 A negative public perception of Bayer represents a risk. For example, modern agricultural methods, such as the application of certain classes of crop protection products and the use of genetic engineering, are often the subject of intense public debate and can adversely affect our reputation. The risk of an increasingly negative public debate that is not primarily based on science may, for example, lead to legislative and regulatory decisions that are unfavorable to Bayer Group, significantly limiting the use of our products or even resulting in voluntary or mandated product withdrawals. 

 In addition, the year 2021 was likewise marked by the COVID-19 pandemic, the impact of which gives rise to risks such as a prolonged, significant decline in global demand as well as unfavorable geopolitical and macroeconomic effects. Such developments could have consequences for Bayer Group, such as a decline in sales, supply chain disruptions and the inability to procure certain materials, an increase in input prices, or longer development times. Our profitability, working capital, cash flow and ability to achieve strategic objectives might continue to be negatively impacted.

 Moreover, negative developments of a macroeconomic nature, such as crises in important sales markets for Bayer Group, could weigh on our business and reduce our earnings. Our seed and crop protection business in particular is cyclical and is shaped by economic developments and factors including fluctuating weather conditions and pest pressure that may adversely impact our Crop Science business. Forecasts concerning climate change indicate that these risks may possibly increase in the long term.

 Geopolitical risks further arise in connection with the recent military intervention of Russia in Ukraine. Both, the direct influence of the military conflict as well as the influence due to applicable sanctions may negatively impact our business e.g., wheat prices, our (energy) costs, supply chain (disruptions), sales, earnings, and cash flows. Generally, the implications of the escalating political conflict are unpredictable and have the potential to significantly impact financial markets and economies, leading e.g., to high volatility of foreign exchange rates and to an economic slow-down. Thus, our market environment and consequently our business performance may be negatively impacted.


-----

#### Regulatory Changes

 Our business activity is subject to extensive regulations that are changing – and may become more stringent, including for reasons of a political nature. For example, further restrictions could be imposed on the sale and use of various crop protection products. In addition, approvals that have already been granted have already been and will probably continue to be challenged in court, especially by non-governmental organizations (NGOs), potentially resulting in temporary or permanent revocation of product registrations or approvals and financial loss from reduced sales of crop protection products as well as associated seed offerings. The issue of conserving biodiversity plays a role in this connection, as does the manufacture and use of certain chemical substances. In addition, the pricing of pharmaceutical products could become more strictly regulated – not only for products already exposed to generic competition, but also for innovative, patent- protected products. Residues of agrochemical products, pharmaceutical compounds or microplastics in the environment could also become subject to more stringent regulation. In addition, regulatory changes could affect agricultural imports from other parts of the world and therefore our business in those regions. Regulatory changes could also cause uncertainty over our products’ patent protection, potentially resulting in financial losses that may even include the repayment of license fees. Regulatory changes may also lead to higher product development costs and longer development times or even necessitate adjustments to our product portfolio, which in turn may negatively impact our reputation.

 Market Developments in the Seed and Crop Protection Industry

 In the Crop Science Division, we could face increased competition in the seed and crop protection industry. New competitors entering the market and aggressive marketing and pricing strategies – not only for generic products – could negatively impact our profitability. In addition, increasing digitalization in the agriculture sector could lead to the rise of new players and alter the market.

 Business Strategy

 Our business strategy is geared toward innovation, which is inherently associated with risks. In our Pharmaceuticals Division, we see challenges in setting up new therapy platforms, such as for cell and gene therapy, and in further developing established therapeutic areas through innovative solutions. Throughout Bayer Group, we need to ensure that the digital transformation we are targeting is accompanied by the corresponding IT support. In addition, we might encounter challenges in our endeavors to implement our voluntary sustainability commitments in a timely manner, which may also be due to external factors.

 Operational Risks

 Research and Development

 Technological advances in pharmaceutical product development may represent a risk for Bayer Group should we not be in a position to play a role in shaping such advances. Identifying a sufficient number of research candidates and ensuring their appropriate development represents a challenge. Targeting inlicensing and acquisitions as additional ways to strengthen Bayer Group involves the risk that we may be unable to identify suitable candidates on financially acceptable terms. Furthermore, we cannot ensure that all of the products we are currently developing or will develop in the future will obtain their planned approval/registration or achieve commercial success. These goals may not be reached if, for example, we are unable to satisfy technical or capacity requirements or meet time constraints in product development, fail to achieve study objectives or do not allocate financial resources optimally. Delays or cost overruns may occur during product registration or launch.

 Information Technology

 Our business and production processes and our internal and external communications are dependent on global IT systems. Ensuring the optimal alignment of our IT architecture, which also encompasses the use of cloud-based services and management of any service providers commissioned, therefore represents a challenge. System reliability and the confidentiality of internal and external data are matters of fundamental importance to Bayer Group. If our governance fails to address this challenging environment in an optimal manner, our operational stability could impact our business


-----

#### and our information security requirements may not be met adequately. If the risk of a breach of data confidentiality, integrity or authenticity, for example due to (cyber) attacks, were to materialize, it could lead to the manipulation and/or uncontrolled outflow of data and knowledge, and to reputational damage. Such attacks may also be carried out by in- house personnel. Our business and/or production processes could also be temporarily disrupted by (cyber) attacks.

 Supply of Products

 Despite all precautions, operations at our sites may be disrupted by fires, power outages, process changeovers – including those due to restrictions on the use of certain chemical substances – or plant breakdowns, for example. In addition, some of our production facilities are located in areas that may be affected by natural disasters such as flooding or earthquakes. These risks can lead to production disruptions or stoppages, result in personal injury and damage to our reputation, lead to declines in sales and/or margins, and necessitate the reconstruction of damaged infrastructure. If we are unable to meet product demand, sales may undergo a structural decline because patients then receive alternative treatments and may not switch back to our products. Disruptions in our upstream supply chain may also negatively impact our own supply capability. The substances we procure, and the companies that manufacture them, must meet all necessary regulatory requirements. These substances must also be suitable for fulfilling regulatory requirements further down the value chain. Certain materials, particularly in our Pharmaceuticals Division, are offered by only a small number of suppliers.

 Marketing, Sales and Distribution 

 New product launches present particular challenges for our marketing and distribution organization since assumptions about aspects such as the market and market circumstances may not materialize as anticipated. As a result, product launch concepts – including those related to clinical trials – and the planning or implementation of the distribution strategy could turn out to be inefficient or inadequate in terms of scheduling. In addition, if competitors’ marketing activities or advertised product characteristics surpass our own efforts in this regard, this may represent a risk for sales of our products.

 Human Resources

 Skilled and dedicated employees are essential for Bayer Group’s success. Difficulties in recruiting, hiring and retaining urgently needed specialized employees (on a regional level) – also in view of competition between employers – and in employee development could have significant adverse consequences for Bayer Group’s future development. Developments such as the growing relevance of disruptive technologies, the pandemic situation and new ways of working will require our employees to possess new, innovative skillsets. It is also possible that organizational changes may reduce employee engagement or increase staff turnover if they are not implemented transparently or do not fully deliver the anticipated benefits.

 Finance and Tax Risks

 We are exposed to financial risks in the form of liquidity, credit and market price risks, as well as risks resulting from pension obligations as well as tax risks. The following paragraphs provide additional details.

 Liquidity risks are defined as the possible inability of the Bayer Group to meet current or future payment obligations.

 Credit risks arise from the possibility that the value of receivables or other financial assets of the Bayer Group may be impaired because counterparties cannot meet their payment or other performance obligations. These risks may result in loss of financial assets.

 Foreign currency risks for the Bayer Group result from changes in exchange rates and the related changes in the value of financial instruments (including receivables and payables) and of anticipated payments and disbursements not in the functional currency. These risks may result in decreased financial receivables and increased financial payables and furthermore in diminished anticipated earnings.

 Interest rate risks arise for the Bayer Group from changes in capital market interest rates, which in turn could lead to changes in the fair value of fixed-rate financial instruments and changes in interest payments in the case of floating-rate instruments.


-----

#### Commodity price risks for the Bayer Group result from the volatility of raw material prices, which can lead to an increase in the prices we pay for seeds and energy.

 Financial risks associated with pension obligations arise as the Bayer Group has obligations to current and former employees related to pensions and other post-employment benefits. Changes in relevant measurement parameters such as interest rates, mortality and salary increase rates may raise the present value of our pension obligations. This may lead to increased costs for pension plans or diminish equity due to actuarial losses being recognized in other comprehensive income in the statement of comprehensive income. A large proportion of our pension and other post-employment benefit obligations is covered by plan assets including fixed-income securities, shares, real estate and other investments. Declining or even negative returns on these investments may adversely affect the future fair value of plan assets. Both of these effects may negatively impact the development of equity and / or earnings and / or may necessitate additional payments by Bayer Group.

 Tax risks arise as Bayer AG and its subsidiaries operate worldwide and are thus subject to many different national tax laws and regulations. The companies are regularly audited by the tax authorities in various countries. Amendments to tax laws and regulations, legal judgments and their interpretation by the tax authorities, and the findings of tax audits in these countries may result in higher tax expense and payments, thus also influencing the level of tax receivables, tax liabilities and deferred tax assets and liabilities. Significant acquisitions, divestments, restructuring programs and other reorganizational measures that we undertake could also have an impact.

 Safety, Quality and Compliance Risks

 Product Safety and Stewardship

 Despite extensive studies prior to approval or registration, products may be partially or completely withdrawn from the market due, for example, to the occurrence of unexpected side-effects or negative effects of our products. Such a withdrawal may be voluntary or result from legal or regulatory measures. In the agriculture business in particular, there is an additional risk that our customers could use our products incorrectly. Furthermore, the presence of traces of unwanted genetically modified organisms in agricultural products and/or foodstuffs may have wide-ranging negative repercussions.

 External Partner Compliance

 From the perspective of the Bayer Group as a whole, there is a risk that our partners, such as suppliers, do not pay due attention to our corporate values and requirements concerning ethics, compliance – including the observance of human rights – and sustainability.

 Health, Safety and Environment

 Misconduct or noncompliance with legal requirements or Bayer Group standards may result in personal injury, damage to property, reputation or the environment, loss of production, business interruptions and/or liability for compensation payments. This includes the risk of hazardous substances being released due to an incident in production.

 Intellectual Property

 Our portfolio largely consists of patent-protected products. Generic manufacturers, in particular, attempt to contest patents prior to their expiration. We are currently involved in legal proceedings to enforce patent protection for our products. On the other hand, legal action by third parties for alleged infringement of patent or other property rights by Bayer may impede or even halt the development or manufacturing of certain products. We may also be required to pay monetary damages or royalties to third parties.

 Quality and Regulatory Requirements

 In almost every country we operate, our business activity is subject to extensive regulations, standards, requirements and inspections that also apply to our local contract manufacturers. In the area of health, this pertains to clinical studies and production processes, for example. Acquisitions may at times also be subject to requirements, compliance with which must be ensured both during and after the integration process. Potential infringements of regulatory requirements may


-----

#### result in the imposition of civil or criminal penalties, including substantial monetary fines, restrictions on our freedom to operate, and/or other adverse financial consequences. They could also harm our reputation and lead to declining sales and/or margins.

 Security

 Potential criminal activities targeting our employees, property or business activities represent a risk for Bayer Group. These include intellectual property theft, vandalism and sabotage. In addition, counterfeit or adulterated versions of our products could be put into circulation. There is also the risk of crises such as a pandemic or a prolonged power outage that could lead to a breakdown of our information technology infrastructure and our production. These risks in addition to financial effects could negatively affect our reputation in some cases.

 Legal Risks

 Legal Proceedings

 We are exposed to risks from legal disputes or proceedings to which we are currently a party or which could arise in the future. The general risks to which we are potentially exposed include those in the areas of product liability, competition and antitrust law, anti-corruption law, patent law, tax law, data privacy and environmental protection, for example. Investigations of possible legal or regulatory violations may result in the imposition of civil or criminal penalties – including substantial monetary fines – and/or other adverse financial consequences. Payments may also need to be made under out-of-court settlements. These risks may harm our reputation and hamper our commercial success. 

 We may incur considerable financial disadvantages from the pending lawsuits and/or potential future cases if, for example, we are ordered to pay compensatory and possibly punitive damages or if we assume payment obligations under out-of- court settlements. We could be compelled to cover any such increased financial requirements by issuing additional external debt, increasing our equity capital or divesting assets – possibly on unfavorable terms – or through combinations of these measures. The terms on which we obtain external financing could become less favorable as a result of any increased financial requirements. These risks may also adversely affect our reputation.

 For further details concerning ongoing legal proceedings considered by us to be material please see "Description of the Issuer and the Bayer Group – Governmental, Legal, Tax and Arbitration Proceedings".

 Risks relating to the Notes 

 Risks associated with the Characteristics of the Notes

 Risk related to Subordination

 The obligations of the Issuer under each Series of Notes constitute unsecured obligations of the Issuer ranking pari passu among themselves and with any Parity Obligations (as defined in the Terms and Conditions), subordinated to all other present and future unsubordinated or subordinated obligations of the Issuer that are not Parity Obligations or Junior Obligation (as defined in the Terms and Conditions), and senior only to the rights and claims of holders of Junior Obligations (i.e. any rights and claims under any shares of the Issuer and other claims against the Issuer which rank or are expressed to rank pari passu therewith). 

 In a liquidation, dissolution, insolvency, composition or other proceeding for the avoidance of insolvency of, or against, the Issuer, it is very likely that Noteholders may recover significantly less than the holders of unsubordinated obligations of the Issuer or may recover nothing at all. Noteholders will have limited ability to influence the outcome of any insolvency proceedings or a restructuring outside insolvency. In particular, in insolvency proceedings over the assets of the Issuer, holders of subordinated debt, such as the Notes, will not have any right to vote in the assembly of creditors (Gläubigerversammlung) pursuant to the German Insolvency Code.

 Investors should take into consideration that unsubordinated liabilities may also arise out of events that are not reflected on the Issuer's balance sheet, including, without limitation, the issuance of guarantees or other payment undertakings.


-----

#### Claims of beneficiaries under such guarantees or other payment undertakings will, in winding-up or insolvency proceedings of the Issuer, become unsubordinated liabilities and will therefore be paid in full before payments are made to Noteholders.

 In case of insolvency plan proceedings (Insolvenzplanverfahren) the Noteholders generally would have no voting right on the adoption of an insolvency plan presented by the Issuer, the relevant insolvency administrator or custodian (Sections 237 and 246 of the German Insolvency Code). In addition, their claims would be waived after the adoption of the insolvency plan, unless the insolvency plan makes an exception to this general rule (Section 225 paragraph 1 of the German Insolvency Code).

 Risk related to the Nature of the Notes as Long-Term Securities and potential Early Redemption

 The Issuer will redeem the NC5.5 Notes and the NC8.5 Notes on 25 March 2082, unless the relevant Series of Notes has been previously redeemed or repurchased and cancelled. While, pursuant to the Terms and Conditions of the Notes, the Issuer may call and redeem each Series of Notes early at certain points in time or in certain circumstances, it is under no obligation to redeem any Series of Notes at any time before its respective maturity date. 

 The Issuer may, at its option, call and redeem the NC5.5 Notes at their principal amount on each Business Day during the period from and including 25 June 2027 (the "NC5.5 Notes First Optional Redemption Date") to but excluding the NC5.5 Notes First Reset Date, on the NC5.5 Notes First Reset Date and on each interest payment date of the NC5.5°Notes following the NC5.5 Notes First Reset Date. 

 The Issuer may, at its option, call and redeem the NC8.5 Notes at their principal amount on each Business Day during the period from and including 25 June 2030 (the "NC8.5 Notes First Optional Redemption Date") to but excluding the NC8.5 Notes First Reset Date, on the NC8.5 Notes First Reset Date and on each interest payment date of the NC8.5 Notes following the NC8.5 Notes First Reset Date. 

 In addition, the Issuer may, at its option, call and redeem each Series of Notes at the respective early redemption amount specified in the Terms and Conditions:

 (i) if by reason of any change in German law or published regulations becoming effective after the Interest Commencement Date, the Issuer would have to pay any additional amounts under the Notes (so called "Gross-up Event" as defined and described in the Terms and Conditions); or

 (ii) if any Rating Agency publishes a change in hybrid capital methodology or the interpretation thereof, as a result of which change, either (x) the Notes would no longer be eligible for the same or a higher category of "equity credit" attributed to the Notes at the date of issue of the Notes, or (y) the period of time the Notes are eligible for the same or a higher category of equity credit attributed to the Notes at the date of issue of the Notes is being shortened (so called "Rating Event" as defined and described in the Terms and Conditions); or

 (iii) if by reason of a change in German law or regulation, or any change in the official application or interpretation of such law, after the Interest Commencement Date, the tax regime is modified and such modification results in the interest expense of the Issuer in respect of the Notes being no longer fully deductible for corporate income tax purposes (so called "Tax Deductibility Event" as defined and described in the Terms and Conditions); or

 (iv) if 75% or more in principal amount of the relevant Series of Notes initially issued has been redeemed or purchased and cancelled. 

 In the event that the Issuer exercises the option to call and redeem any Series of Notes, the relevant Noteholders might suffer a lower than expected yield and might not be able to reinvest the funds on the same terms.

 The redemption at the option of the Issuer may affect the market value of the relevant Series of Notes. During any period when the Issuer may, or may be perceived to be able to, elect to call and redeem any Series of Notes, the market value of such Series of Notes generally will not rise substantially above the price at which they can be redeemed. Certain market expectations may exist among investors with regard to the Issuer making use of its option to call the Notes for redemption


-----

#### prior to their scheduled maturity. Should the Issuer's actions diverge from such expectations, the market value of the Notes may be adversely affected. 

 The Noteholders have no right to request the redemption of the Notes. The Noteholders should be aware that the Terms and Conditions of the Notes do not contain any event of default provisions.

 There is also no guarantee that an active public market in the Notes will develop or, if one does develop, that it will be maintained. In an illiquid market, an investor might not be able to sell his Notes at all or at any time at fair market prices.

 Prospective investors should be aware that they may be required to bear the financial risk of an investment in the Notes for a long period and may not recover their investment before the end of this period.

 Risks related to Interest Payments

 Risk resulting from the Issuer's Right to Defer Interest Payments 

 The Issuer may elect in its discretion to defer the payment of interest on any Series of Notes scheduled to be paid on any Interest Payment Date by giving not less than 10 Business Days' prior notice to the relevant Noteholders of such Series of Notes. Such interest will not be due and payable (fällig) to such extent on that Interest Payment Date.

 Noteholders will not receive any additional interest or compensation for the optional deferral of payment. In particular, the resulting Deferred Interest Payments will not bear interest. Any failure to pay interest as a result of an optional deferral will not constitute a default of the Issuer or any other breach of obligations under the Notes or for any other purpose. While the deferral of interest payments continues, the Issuer is not prohibited from making payments on any instrument ranking senior to the Notes.

 Any deferral of interest payments or the perception that the Issuer will need to exercise its optional deferral right will likely have an adverse effect on the market price of the Notes. In addition, as a result of the interest deferral provision of the Notes, the market price of the Notes may be more volatile than the market prices of other debt securities on which interest accrues that are not subject to such deferrals and may be more sensitive generally to adverse changes in the Issuer's financial condition.

 Risk related to Fixed Interest Rate Notes

 Each Series of Notes bears interest at a fixed rate to but excluding their respective first reset date.

 A holder of a fixed interest rate note is exposed to the risk that the price of such note may fall because of changes in the market interest rate. While the nominal interest rate of a fixed interest rate note is fixed during the life of such note or during a certain period of time, the current interest rate on the capital market (market interest rate) typically changes on a daily basis. As the market interest rate changes, the price of such note changes in the opposite direction. If the market interest rate increases, the price of such note typically falls, until the yield of such note is approximately equal to the market interest rate. If the market interest rate falls, the price of a fixed interest rate note typically increases, until the yield of such note is approximately equal to the market interest rate. Noteholders should be aware that movements of the market interest rate can adversely affect the market price of the Notes and can lead to losses for the Noteholders if they sell their Notes.

 Risk related to the Reset of the Interest Rate linked to the 5-year Mid Swap Rate

 From and including their respective first reset date to but excluding their respective maturity date, each Series of Notes bears interest at a rate which will be determined on the Interest Determination Date prior to the relevant reset date at the 5-year mid swap rate for the relevant Reset Period plus a margin. 

 Investors should be aware that the performance of the 5-year mid swap rate and the interest income on the Notes cannot be anticipated and neither the current nor the historical level of the 5-year mid swap rate is an indication of the future development of the 5-year mid swap rate. Due to varying interest income, investors are not able to determine a definite yield of the Notes at the time they purchase them, so that their return on investment cannot be compared with that of investments having longer fixed interest periods. In addition, after interest payment dates, investors are exposed to the


-----

#### reinvestment risk if market interest rates decline, as they may be able to reinvest the interest income paid to them only at the relevant lower interest rates then prevailing. 

 Furthermore, during each Reset Period, it cannot be ruled out that the price of the Notes may fall as a result of changes in the current interest rate on the capital market (market interest rate), as the market interest rate fluctuates. During each of these periods, the investor is exposed to the risk described in the section "Risk related to Fixed Interest Rate Notes".

 Risk related to the Reform of Interest Rate "Benchmarks" and possible Replacement of Benchmarks

 Following the respective first reset date, interest amounts payable under each Series of Notes are calculated by reference to the annual swap rate for swap transactions denominated in Euro with a term of 5 years, which appears on the Reuters Screen Page ICESWAP2.

 This swap-rate, the EURIBOR underlying the floating leg of this swap rate and other interest rates or other types of rates and indices which are deemed "benchmarks" (each a "Benchmark" and together, the "Benchmarks") have become the subject of regulatory scrutiny and recent national and international regulatory guidance and proposals for reform. Some of these reforms are already effective whilst others are still to be implemented. These reforms may cause such Benchmarks to perform differently than in the past, or to disappear entirely, or have other consequences which cannot be predicted. Any such consequence could have a material adverse effect on the Notes.

 International proposals for reform of Benchmarks include the Benchmark Regulation. 

 The Benchmark Regulation could have a material impact on the Notes, including in any of the following circumstances:

 • a rate or index which is a Benchmark may only be used if its administrator obtains authorization or is registered and in case of an administrator which is based in a non-EU jurisdiction, if the administrator's legal benchmark system is considered equivalent (Article 30 Benchmark Regulation), the administrator is recognized (Article 32 Benchmark Regulation) or the relevant Benchmark is endorsed (Article 33 Benchmark Regulation) (subject to applicable transitional provisions). If this is not the case, Notes linked to such Benchmarks could be impacted; and

 • the methodology or other terms of the Benchmark could be changed in order to comply with the terms of the Benchmark Regulation, and such changes could have the effect of reducing or increasing the rate or level or affecting the volatility of the published rate or level, and could have an impact on the Notes, including determination of the rate by the Issuer, the Calculation Agent or an independent adviser, as the case may be.

 In addition to the aforementioned Benchmark Regulation, there are numerous other proposals, initiatives and investigations which may impact Benchmarks.

 Following the implementation of any such potential reforms, the manner of administration of Benchmarks may change, with the result that they may perform differently than in the past, or Benchmarks could be eliminated entirely, or there could be other consequences which cannot be predicted. 

 Any changes to a Benchmark as a result of the Benchmark Regulation or other initiatives, could have a material adverse effect on the costs of administering or otherwise participating in the setting of a Benchmark and complying with any such regulations or requirements. Investors should be aware that any changes to a relevant Benchmark may have a material adverse effect on the value of the Notes.

 Under the Terms and Conditions of the Notes, certain benchmark replacement provisions will apply if a Benchmark (or any component part thereof) used as a reference for the calculation of interest amounts payable under the Notes were to be discontinued or otherwise became unavailable:

 If a Benchmark (or any component part thereof) used to calculate interest amounts payable under the Notes for any interest period has ceased to be calculated or administered or any other Benchmark Event (as defined and described in the Terms and Conditions) occurs, the Issuer shall endeavor to appoint an Independent Adviser, which must be an independent financial institution of international repute or other independent financial adviser experienced in the international capital


-----

#### markets. Such Independent Adviser will be tasked with determining whether an officially recognized successor rate to the discontinued Benchmark exists. If that is not the case, the Independent Adviser will attempt to find an alternative rate which, possibly after application of adjustments or spreads, can replace the discontinued Benchmark. Such adjustments or spreads are intended to be applied in order to produce an industry-accepted replacement benchmark rate, however the relevant adjustments or spreads may not be successful in doing so and the relevant Series of Notes may still perform differently than if the original Benchmark had continued to be used.

 Any adjustment in case of a Benchmark Event will be made only to the extent that no Loss in Equity Credit or Shortening in Equity Credit would occur as a result of such adjustment.

 If the Independent Adviser determines a successor rate or alternative rate (the "New Benchmark Rate"), such rate (after application of adjustments or spreads, if any) will replace the previous Benchmark for purposes of calculating the relevant rate of interest for such Series of Notes. Such determination will be binding for the Issuer, the Calculation Agent, the Paying Agents and the Noteholders of the relevant Series of Notes. Any amendments pursuant to these fall-back provisions will apply with effect from the respective effective date specified in the Terms and Conditions of the Notes.

 If, following a Benchmark Event, the Issuer does not appoint an independent adviser or if the adviser does not determine a New Benchmark Rate, any Adjustment Spread or Benchmark Amendments (if required) following a discontinuation of a relevant Benchmark, the reference rate applicable to the next Reset Period for such Series of Notes shall be the original benchmark rate on the relevant screen page on the last day preceding the relevant Interest Determination Date on which such original benchmark rate was displayed, provided, however, that, in case of the first reset period, the reference rate applicable to the first Reset Period shall be 0.874 per cent. per annum in case of the NC5.5 Notes and 1.042 per cent. per annum in case of the NC8.5 Notes.

 The replacement of a Benchmark could have adverse effects on the economic return of the Noteholder compared to the applicable original benchmark rate.

 Risks associated with the Solvency of the Issuer

 Risk of a Partial or Total Failure of the Issuer to make Interest and/or Redemption Payments

 The Notes are unsecured obligations of the Issuer.

 Any person who purchases the Notes is relying on the creditworthiness of the Issuer and has no rights against any other person. Noteholders are subject to the risk of a partial or total failure of the Issuer to make interest and/or redemption payments that the Issuer is obliged to make under the Notes. A materialization of the credit risk (for example, because of the materialization of any of the risks regarding the Issuer and/or the Bayer Group) may result in partial or total failure of the Issuer to make interest and/or redemption payments under the Notes.

 Risk of a potential Decrease in the Market Value of the Notes

 If the likelihood that the Issuer will be in a position to perform all obligations under the Notes in full when they fall due decreases, for example, because of the materialization of any of the risks regarding the Issuer and/or the Bayer Group described above, the market value of the Notes will suffer. In addition, even if the likelihood that the Issuer will be in a position to perform all obligations under the Notes when they fall due actually has not decreased, market participants could nevertheless have a different perception. If any of these risks occurs, third parties would only be willing to purchase Notes for a lower price than before the materialization of the mentioned risk. Under these circumstances, the market value of the Notes is likely to decrease.

 Other Risks related to the Notes

 Risks in connection with the Application of the German Act on Issues of Debt Securities (Gesetz über Schuldverschreibungen aus Gesamtemissionen, "SchVG")

 Since the Terms and Conditions of the Notes provide for meetings of Noteholders or the taking of votes without a meeting, the Terms and Conditions of each Series of Notes may be amended by majority resolution of the Noteholders of such


-----

#### Series of Notes and a Noteholder is subject to the risk of being outvoted by a majority resolution of the Noteholders. The rules pertaining to resolutions of Noteholders are set out in the SchVG and are largely mandatory. Pursuant to the SchVG the relevant majority for holders' resolutions is generally based on votes cast, rather than on the aggregate principal amount of the notes outstanding, therefore, any such resolution may effectively be passed with the consent of less than a majority of the aggregate principal amount of the Notes outstanding. As such majority resolution is binding on all Noteholders of the relevant Series of Notes, certain rights of a Noteholder against the Issuer under the Terms and Conditions of the relevant Series of Notes may be amended or reduced or even cancelled.

 Since the Terms and Conditions of the Notes provide that the Noteholders of each Series of Notes are entitled to appoint a holders' representative for the relevant Series of Notes by a majority resolution of such Noteholders, it is possible that a noteholder may be deprived of its individual right to pursue and enforce its rights under the Terms and Conditions of the Notes against the Issuer, such right passing to the holders' representative who is then exclusively responsible to claim and enforce the rights of all the noteholders of the relevant Series of Notes.

 Risks in respect of credit ratings

 Credit rating agencies are expected to assign credit ratings to the Notes. The credit ratings of the Notes may not reflect the potential impact of all risks related to the structure, market, additional risk factors discussed herein and other factors that may affect the value of the Notes. In general, European Union and UK regulated investors are restricted from using a rating for regulatory purposes if such rating is not issued by a credit rating agency established in the European Union or in the UK and registered under Regulation (EC) No 1060/2009 of the European Parliament and of the Council of 16 September 2009 on credit rating agencies, as amended (the "CRA Regulation") (as applicable in the UK by forming part of domestic law by virtue of the European Union (Withdrawal) Act 2018) unless the rating is provided by a credit rating agency operating in the European Union or in the UK before 7 June 2010 which has submitted an application for registration in accordance with the CRA Regulation and such registration has not been refused. If the status of the credit rating agency changes, European Union and UK regulated investors may no longer be able to use the rating for regulatory purposes and the Notes may have a different regulatory treatment. This may result in European Union and UK regulated investors selling the Notes which may impact the value of the Notes and any secondary market. A credit rating is not a recommendation to buy, sell or hold securities and may be revised, suspended or withdrawn by the credit rating agency at any time. No assurance can be given that a credit rating will remain constant for any given period of time or that a credit rating will not be reduced or withdrawn entirely by the credit rating agency if, in its judgment, circumstances so warrant. Rating agencies may also change their methodologies for rating securities in the future. Any change of the credit rating assigned or measures taken to the Notes by one or more of the credit rating agencies may adversely affect the cost and terms and conditions of the Bayer Group's financings and could adversely affect the value and trading of the Notes.


-----

### TERMS AND CONDITIONS OF THE NC5.5 NOTES

**Anleihebedingungen** **Terms and Conditions**


_Diese Anleihebedingungen sind in deutscher Sprache_

_abgefasst. Eine Übersetzung in die englische Sprache ist_

_beigefügt. Der deutsche Text ist bindend und maßgeblich._

_Die Übersetzung in die englische Sprache ist unverbindlich._

**§ 1**

**WÄHRUNG, STÜCKELUNG, FORM,**

**BEGRIFFSBESTIMMUNGEN**

(1) _Währung; Stückelung. Diese Emission von Schuld-_

verschreibungen (die "Schuldverschreibungen") der

Bayer Aktiengesellschaft (die "Emittentin") wird in

Euro (die "festgelegte **Währung")** im

Gesamtnennbetrag von Euro 500.000.000 (in Worten:

Euro fünfhundert Million) in Stückelungen von

Euro 100.000 (die "festgelegte Stückelung") begeben.

(2) _Form. Die Schuldverschreibungen lauten auf den_

Inhaber.


_These Terms and Conditions are written in the German_

_language and provided with an English language_

_translation. The German text shall be controlling and_

_binding. The English language translation is provided for_

_convenience only._

**§ 1**

**CURRENCY, DENOMINATION, FORM, CERTAIN**

**DEFINITIONS**

(1) _Currency; Denomination. This issue of notes (the_

"Notes") of Bayer Aktiengesellschaft (the "Issuer") is

being issued in Euro (the "Specified Currency") in

the aggregate principal amount of Euro 500,000,000

(in words: Euro fivehundred million) in

denominations of Euro 100,000 (the "Specified

**Denomination").**

(2) _Form. The Notes are being issued in bearer form._


(3) _Vorläufige Globalurkunde — Austausch._ (3) _Temporary Global Note — Exchange._


(a) Die Schuldverschreibungen sind anfänglich

durch eine vorläufige Globalurkunde (die

"vorläufige **Globalurkunde")** ohne

Zinsscheine verbrieft. Die vorläufige

Globalurkunde wird gegen

Schuldverschreibungen in den festgelegten

Stückelungen, die durch eine

Dauerglobalurkunde (die

"Dauerglobalurkunde" und zusammen mit der

vorläufigen Globalurkunde die

"Globalurkunden" und jede eine

"Globalurkunde") ohne Zinsscheine verbrieft

sind, ausgetauscht. Die vorläufige

Globalurkunde und die Dauerglobalurkunde

tragen jeweils die Unterschriften von zwei

ordnungsgemäß bevollmächtigten Vertretern

der Emittentin und sind jeweils von der

Hauptzahlstelle oder in deren Namen mit einer

Kontrollunterschrift versehen. Einzelurkunden

und Zinsscheine werden nicht ausgegeben.

(b) Die vorläufige Globalurkunde wird frühestens

an einem Tag (der "Austauschtag") gegen die

Dauerglobalurkunde austauschbar, der 40 Tage

nach dem Tag der Ausgabe der vorläufigen


(a) The Notes are initially represented by a

temporary global note (the "Temporary Global

**Note") without coupons. The Temporary Global**

Note will be exchangeable for Notes in

Specified Denominations represented by a

permanent global note (the "Permanent Global

**Note", and together with the Temporary Global**

Note, the "Global Notes" and each a "Global

**Note") without coupons. The Temporary Global**

Note and the Permanent Global Note shall each

be signed by two authorized signatories of the

Issuer and shall each be authenticated by or on

behalf of the Principal Paying Agent. Definitive

Notes and interest coupons will not be issued.

(b) The Temporary Global Note shall be

exchangeable for the Permanent Global Note

from a date (the "Exchange Date") 40 days after

the date of issue of the Temporary Global Note.


-----

Globalurkunde liegt. Ein solcher Austausch soll

nur nach Vorlage von Bescheinigungen gemäß

U.S. Steuerrecht erfolgen, wonach der oder die

wirtschaftlichen Eigentümer der durch die

vorläufige Globalurkunde verbrieften

Schuldverschreibungen keine U.S.-Personen

sind (ausgenommen bestimmte Finanzinstitute

oder bestimmte Personen, die

Schuldverschreibungen über solche

Finanzinstitute halten). Zinszahlungen auf durch

eine vorläufige Globalurkunde verbriefte

Schuldverschreibungen erfolgen erst nach

Vorlage solcher Bescheinigungen. Eine

gesonderte Bescheinigung ist hinsichtlich einer

jeden solchen Zinszahlung erforderlich. Jede

Bescheinigung, die am oder nach dem 40. Tag

nach dem Tag der Ausgabe der vorläufigen

Globalurkunde eingeht, wird als ein Ersuchen

behandelt, diese vorläufige Globalurkunde

gemäß diesem § 1(3)(b) auszutauschen.

Wertpapiere, die im Austausch für die

vorläufige Globalurkunde geliefert werden, sind

nur außerhalb der Vereinigten Staaten zu liefern

(wie in § 6(3) definiert).

(4) _Clearing System. Die die Schuldverschreibungen_

verbriefende Globalurkunde wird von einem oder im

Namen eines Clearing Systems verwahrt, bis sämtliche

Verbindlichkeiten der Emittentin aus den

Schuldverschreibungen erfüllt sind. "Clearing

**System" bedeutet jeweils folgendes: Clearstream**

Banking S.A., Luxemburg ("CBL") und Euroclear

Bank SA/NV Brüssel, als Betreiberin des Euroclear

Systems ("Euroclear") sowie jeder

Funktionsnachfolger.

Die Schuldverschreibungen werden in Form einer

Classical Global Note ausgegeben und von einer

gemeinsamen Verwahrstelle im Namen des Clearing

Systems verwahrt.

(5) _Gläubiger von Schuldverschreibungen._ "Gläubiger"

bezeichnet jeden Inhaber eines Miteigentumsanteils

oder anderen treugeberischen oder eigenen Rechts an

den Schuldverschreibungen.

**§ 2**

**STATUS**

(1) _Status. Die Schuldverschreibungen begründen nicht_

besicherte Verbindlichkeiten der Emittentin, die im


Such exchange shall only be made upon

delivery of certifications to the effect that the

beneficial owner or owners of the Notes

represented by the Temporary Global Note is

not a U.S. person (other than certain financial

institutions or certain persons holding Notes

through such financial institutions) as required

by U.S. tax law. Payment of interest on Notes

represented by a Temporary Global Note will be

made only after delivery of such certifications.

A separate certification shall be required in

respect of each such payment of interest. Any

such certification received on or after the 40th

day after the date of issue of the Temporary

Global Note will be treated as a request to

exchange such Temporary Global Note pursuant

to this § 1(3)(b). Any securities delivered in

exchange for the Temporary Global Note shall

be delivered only outside of the United States

(as defined in § 6(3)).

(4) _Clearing System. Each global note representing the_

Notes will be kept in custody by or on behalf of the

Clearing System until all obligations of the Issuer

under the Notes have been satisfied. "Clearing

**System" means each of the following: Clearstream**

Banking S.A., Luxembourg ("CBL") and Euroclear

Bank SA/NV Brussels as operator of the Euroclear

System ("Euroclear") and any successor in such

capacity.

The Notes are issued in classical global note form and

are kept in custody by a common depositary on behalf

of the Clearing System.

(5) _Holder of Notes._ "Holder" means any holder of a

proportionate co-ownership or other beneficial interest

or right in the Notes.

**§ 2**

**STATUS**

(1) _Status. The Issuer's obligations under the Notes_

constitute unsecured obligations of the Issuer and, in


-----

Fall der Abwicklung, Auflösung oder Liquidation der

Emittentin:

(i) nur Nachrangigen Verbindlichkeiten im Rang

vorgehen,

(ii) untereinander und mit Gleichrangigen

Verbindlichkeiten im Rang gleichstehen, und

(iii) allen anderen bestehenden und zukünftigen

nicht nachrangigen und nachrangigen

Verbindlichkeiten im Rang nachgehen, die nicht

Gleichrangige Verbindlichkeiten oder

Nachrangige Verbindlichkeiten sind.

Unter Beachtung dieser Nachrangregelung bleibt es

der Emittentin unbenommen, ihre Verbindlichkeiten

aus den Schuldverschreibungen auch aus dem

sonstigen freien Vermögen zu bedienen.


the event of the winding-up, dissolution or liquidation

of the Issuer rank:

(i) senior only to Junior Obligations,

(ii) _pari passu among themselves and with Parity_

Obligations, and

(iii) junior to all other present and future

unsubordinated or subordinated obligations of

the Issuer that are not Parity Obligations or

Junior Obligations.

Subject to this subordination provision, the Issuer may

satisfy its obligations under the Notes also from other

distributable assets (freies Vermögen) of the Issuer.


"Nachrangige Verbindlichkeiten" bezeichnet "Junior Obligations" means

(i) die Stammaktien der Emittentin, (i) the ordinary shares of the Issuer,


(ii) gegenwärtige oder zukünftige Aktien einer

anderen Gattung von Aktien der Emittentin, die

gleichrangig mit den Stammaktien der

Emittentin sind,

(iii) andere von der Emittentin begebene

gegenwärtige oder zukünftige Wertpapiere oder

andere Instrumente, bei denen die daraus

folgenden Verbindlichkeiten der Emittentin mit

den Stammaktien der Emittentin gleichrangig

sind oder für die ausdrücklich ein Gleichrang

festgelegt ist, und

(iv) jedes gegenwärtige oder zukünftige Wertpapier

oder jedes andere Instrument, das von einer

Tochtergesellschaft begeben und von der

Emittentin garantiert ist oder für das die

Emittentin die Haftung übernommen hat, und

bei dem die Verbindlichkeiten der Emittentin

aus der maßgeblichen Garantie oder

Haftungsübernahme mit den unter Ziffern (i)

und (ii) genannten Instrumenten gleichrangig

sind oder für die ausdrücklich ein Gleichrang

festgelegt ist.

"Gleichrangige **Verbindlichkeiten"** bezeichnet

bestehende und zukünftige Verbindlichkeiten der

Emittentin

(i) aus Wertpapieren oder anderen von der

Emittentin begebenen Instrumenten, die


(ii) any present or future shares of any other class of

shares of the Issuer ranking pari passu with the

ordinary shares of the Issuer,

(iii) any other present or future securities or other

instruments of the Issuer under which the

Issuer's obligations rank or are expressed to rank

_pari passu with the ordinary shares of the Issuer,_

and

(iv) any present or future security or other

instrument which is issued by a Subsidiary and

guaranteed by the Issuer or for which the Issuer

has otherwise assumed liability where the

Issuer's obligations under such guarantee or

other assumption of liability rank or are

expressed to rank _pari passu with the_

instruments described under clauses (i) and (ii).

"Parity Obligations" means any present or future

obligations of the Issuer

(i) under any securities or other instruments of the

Issuer which rank or are expressed to rank pari


-----

gleichrangig mit den Verbindlichkeiten der

Emittentin unter den Schuldverschreibungen

sind oder für die ausdrücklich ein Gleichrang

festgelegt ist, oder

(ii) aus einer Garantie oder anderen

Haftungsübernahmen der Emittentin für ein

gegenwärtiges oder zukünftiges Wertpapier

oder jedes andere Instrument, das von einer

Tochtergesellschaft begeben und von der

Emittentin garantiert ist oder für das die

Emittentin die Haftung übernommen hat, und

bei dem die Verbindlichkeiten der Emittentin

aus der maßgeblichen Garantie oder

Haftungsübernahme mit ihren

Verbindlichkeiten aus den

Schuldverschreibungen gleichrangig sind oder

ausdrücklich ein Gleichrang festgelegt ist,

soweit nicht zwingende gesetzliche Bestimmungen

solche anderen nachrangigen Verbindlichkeiten im

Rang besser stellen.

Gleichrangige Verbindlichkeiten sind, unter anderem,

die nicht besicherten nachrangigen

Schuldverschreibungen fällig in 2074, erstmals

kündbar in 2024, ISIN DE000A11QR73, die nicht

besicherten nachrangigen Schuldverschreibungen

fällig in 2075, erstmals kündbar in 2022,

ISIN DE000A14J611, die nicht besicherten

nachrangigen Schuldverschreibungen fällig in 2079,

erstmals kündbar in 2025, ISIN XS2077670003 und

die nicht besicherten nachrangigen

Schuldverschreibungen fällig in 2079, erstmals

kündbar in 2027, ISIN XS2077670342.

"Tochtergesellschaft" bezeichnet jede Gesellschaft,

Personengesellschaft und jedes sonstige Unternehmen

oder jede andere Person an der bzw. dem die

Emittentin direkt oder indirekt insgesamt mehr als

50 % des Kapitals oder der Stimmrechte hält.

(2) _Aufrechnungsverbot._ Die Gläubiger sind nicht

berechtigt, Forderungen aus den

Schuldverschreibungen gegen mögliche Forderungen

der Emittentin aufzurechnen. Die Emittentin ist nicht

berechtigt, Forderungen gegenüber Gläubigern gegen

Verpflichtungen aus den Schuldverschreibungen

aufzurechnen.


_passu with the Issuer's obligations under the_

Notes, or

(ii) under any guarantee or other assumption of

liability by the Issuer for any present or future

security or other instrument which is issued by

a Subsidiary and guaranteed by the Issuer or for

which the Issuer has otherwise assumed liability

where the Issuer's obligations under such

guarantee or other assumption of liability rank

or are expressed to rank _pari passu with its_

obligations under the Notes,

except for any subordinated obligations of the Issuer

required to be preferred by mandatory provisions of

law.

For the avoidance of doubt, Parity Obligations include

the unsecured subordinated notes due 2074 with a first

call date in 2024, ISIN DE000A11QR73, the unsecu
red subordinated notes due 2075 with a first call date

in 2022, ISIN DE000A14J611, the unsecured

subordinated notes due 2079 with a first call date in

2025, ISIN XS2077670003 and the unsecured

subordinated notes due 2079 with a first call date in

2027, ISIN XS2077670342.

"Subsidiary" means any corporation, partnership or

other enterprise in which the Issuer directly or

indirectly holds in the aggregate more than 50 per cent.

of the capital or the voting rights.

(2) _Prohibition of Set-Off. No Holder may set-off any_

claims arising under the Notes against any claims that

the Issuer may have against it. The Issuer may not set
off any claims it may have against the Holders against

any of its obligations under the Notes.


-----

**§ 3**

**ZINSEN**

(1) _Zinslauf. In dem Zeitraum ab dem 25. März 2022 (der_

"Zinslaufbeginn") (einschließlich) bis zum 25.

September 2027 (der "Erste **Reset-Termin")**

(ausschließlich) wird jede Schuldverschreibung

bezogen auf die festgelegte Stückelung mit 4,500 %

_per annum verzinst._

In dem Zeitraum ab dem Ersten Reset-Termin

(einschließlich) bis zum Endfälligkeitstag (wie in

§ 5(1) definiert) (ausschließlich) belaufen sich die

Zinsen jeder Schuldverschreibung auf den jeweiligen

Reset-Zinssatz.

Zinsen sind nachträglich am 25. September eines jeden

Jahres zur Zahlung vorgesehen, erstmals am

25. September 2022 (erste kurze Zinsperiode) (jeweils

ein "Zinszahlungstag"), und werden gemäß § 4 fällig.


**§ 3**

**INTEREST**

(1) _Interest Accrual. From and including 25 March 2022_

(the "Interest Commencement Date") to but

excluding 25 September 2027 (the "First Reset

**Date"), each Note bears interest on its Specified**

Denomination at a rate of 4.500 per cent. per annum.

From and including the First Reset Date to but

excluding the Maturity Date (as defined in § 5(1)),

each Note bears interest on its Specified Denomination

at the relevant Reset Rate of Interest.

Interest is scheduled to be paid annually in arrear on

25 September of each year, commencing on

25 September 2022 (short first coupon) (each an

"Interest Payment Date") and will fall due in

accordance with § 4.


Der "Reset-Zinssatz" entspricht The "Reset Rate of Interest" will be


(i) ab dem Ersten Reset-Termin (einschließlich) bis

zum 25. September 2032 (ausschließlich) (der

"Erste Step-up Termin") dem Ersten Reset
Zinssatz;

(ii) ab dem Ersten Step-up Termin (einschließlich)

bis zum 25. September 2047 (der "Zweite Step
**up Termin") (ausschließlich) dem Zweiten**

Reset-Zinssatz; und

(iii) ab dem Zweiten Step-up Termin (einschließlich)

bis zum Endfälligkeitstag (ausschließlich) dem

Dritten Reset-Zinssatz.

Der "Erste **Reset-Zinssatz" ist der Referenzsatz für**

den betreffenden Reset-Zeitraum zuzüglich 375,1

Basispunkte _per_ _annum,_ wie von der

Berechnungsstelle festgelegt.

Der "Zweite **Reset-Zinssatz" ist der Referenzsatz für**

den betreffenden Reset-Zeitraum zuzüglich 400,1

Basispunkte _per_ _annum,_ wie von der

Berechnungsstelle festgelegt.

Der "Dritte **Reset-Zinssatz" ist der Referenzsatz für**

den betreffenden Reset-Zeitraum zuzüglich 475,1

Basispunkte _per_ _annum,_ wie von der

Berechnungsstelle festgelegt.


(i) from and including the First Reset Date to but

excluding 25 September 2032 (the "First Step
**up Date") the First Reset Interest Rate;**

(ii) from and including the First Step-up Date to but

excluding 25 September 2047 (the "Second

**Step-up Date") the Second Reset Interest Rate;**

and

(iii) from and including the Second Step-up Date to

but excluding the Maturity Date the Third Reset

Interest Rate.

The "First Reset Interest Rate" will be the Reference

Rate for the relevant Reset Period plus 375.1 basis

points _per annum, as determined by the Calculation_

Agent.

The "Second Reset Interest Rate" will be the

Reference Rate for the relevant Reset Period plus

400.1 basis points _per annum, as determined by the_

Calculation Agent.

The "Third Reset Interest Rate" will be the

Reference Rate for the relevant Reset Period plus

475.1 basis points _per annum, as determined by the_

Calculation Agent.


-----

(2) _Feststellung des Referenzsatzes._ (2) _Determination of the Reference Rate._


Der "Referenzsatz" wird für einen Reset-Zeitraum

von der Berechnungsstelle an dem betreffenden

Zinsfestsetzungstag (wie nachstehend definiert) vor

dem Reset-Termin, an dem der betreffende Reset
Zeitraum beginnt, wie folgt festgelegt:

(a) Für jeden Reset-Zeitraum, der vor dem Eintritt

des etwaigen ersten Stichtags (wie in § 3(5)(g)

definiert) beginnt, gilt Folgendes:

Der Referenzsatz entspricht, vorbehaltlich

§ 3(2)(c), dem Ursprünglichen Benchmarksatz

an dem betreffenden Zinsfestsetzungstag.

Sofern der Ursprüngliche Benchmarksatz zu

dem betreffenden Zeitpunkt an dem

betreffenden Zinsfestsetzungstag nicht auf der

Bildschirmseite angezeigt wird, entspricht der

Referenzsatz, vorbehaltlich § 3(2)(c), dem

Referenzbankensatz an diesem

Zinsfestsetzungstag.

Sofern kein Referenzbankensatz gemäß der

Definition dieses Begriffs bestimmt werden

kann, weil keine 5-Jahres-Mid-Swapsatz
Quotierung (wie nachstehend definiert) zur

Verfügung gestellt wird, entspricht der

Referenzsatz, vorbehaltlich § 3(2)(c), dem

Ursprünglichen Benchmarksatz auf der

Bildschirmseite an dem letzten Tag vor dem

Zinsfestsetzungstag, an dem dieser

Ursprüngliche Benchmarksatz angezeigt wurde.

(b) Für den Reset-Zeitraum, der unmittelbar nach

dem jeweiligen Stichtag beginnt, und alle

folgenden Reset-Zeiträume wird der

Referenzsatz, vorbehaltlich § 3(2)(c), gemäß

§ 3(5) bestimmt.

(c) Für die Bestimmung des Referenzsatzes wird

jeder nicht auf jährlicher Basis ausgedrückte

Satz von der Berechnungsstelle auf eine

jährliche Basis umgerechnet.

"Ursprünglicher **Benchmarksatz"** an einem

TARGET-Geschäftstag bezeichnet den als Prozentsatz

ausgedrückten Euro-Mid-Swapsatz _per annum um_

11:00 Uhr (Frankfurter Zeit), wie er auf der

Bildschirmseite gegen 11:00 Uhr (Frankfurter Zeit)

(oder zu einer späteren Uhrzeit, zu welcher der Euro

The "Reference Rate" for a Reset Period will be

determined by the Calculation Agent on the relevant

Interest Determination Date (as defined below) prior

to the Reset Date on which the relevant Reset Period

commences as follows:

(a) For each Reset Period beginning prior to the

occurrence of the first Effective Date (as defined

in § 3(5)(g)), if any, the following applies:

The Reference Rate will be equal to the Original

Benchmark Rate on the relevant Interest

Determination Date, subject to § 3(2)(c).

If the Original Benchmark Rate does not appear

on the Screen Page as at such time on the

relevant Interest Determination Date, the

Reference Rate will be equal to the Reference

Bank Rate on that Interest Determination Date,

subject to § 3(2)(c).

If no Reference Bank Rate can be determined in

accordance with the definition of such term

because no 5-year Mid Swap Rate Quotation (as

defined below) is provided, the Reference Rate

shall be equal to the Original Benchmark Rate

on the Screen Page on the last day preceding the

Interest Determination Date on which such

Original Benchmark Rate was displayed, subject

to § 3(2)(c).

(b) For the Reset Period commencing immediately

after the relevant Effective Date and all

following Reset Periods, the Reference Rate will

be determined in accordance with § 3(5), subject

to § 3(2)(c).

(c) For purposes of the determination of the

Reference Rate, any rate which is not expressed

on an annual basis will be converted by the

Calculation Agent to an annual basis.

"Original Benchmark Rate" on a TARGET Business

Day means the annual Euro Mid Swap Rate (expressed

as a percentage per annum ) as at 11:00 a.m. (Frankfurt

time), as displayed on the Screen Page as at or around

11:00 a.m. (Frankfurt time) (or a later time at which the

Euro Mid Swap Rate becomes available on the Screen

Page) on such TARGET Business Day.


-----

Mid-Swapsatz auf der Bildschirmseite verfügbar wird)

an dem Zinsfestsetzungstag angezeigt wird.

Für diese Zwecke bezeichnet "Euro-Mid-Swapsatz"

das arithmetische Mittel der nachgefragten (bid) und

angebotenen (offered) Sätze für den jährlichen

Festzinszahlungsstrom einer fest- bis variablen (fixed
_for-floating) Zinsswap-Transaktion in Euro, (x) die_

eine 5-jährige Laufzeit hat, und (y) deren variabler

Zahlungsstrom auf dem 6-Monats-EURIBOR-Satz

(oder dem EURIBOR-Satz für eine andere Laufzeit,

die der Laufzeit gemäß dem dann vorherrschenden

Marktstandard für solche fest- bis variable (fixed-for
_floating) Zinsswap-Transaktionen in Euro entspricht)_

beruht.

Der "Referenzbankensatz" ist der Prozentsatz, der

von der Berechnungsstelle auf Grundlage der 5-Jahres
Mid-Swapsatz-Quotierungen an dem

Zinsfestsetzungstag festgestellt wird, die die

Emittentin von drei führenden, von ihr ausgewählten

Swap-Händlern im Interbankenhandel (jeweils eine

"Referenzbank") erfragt.

Wenn mindestens zwei 5-Jahres-Mid-Swapsatz
Quotierungen zur Verfügung gestellt werden, ist der

Referenzbankensatz das arithmetische Mittel der zur

Verfügung gestellten 5-Jahres-Mid-Swapsatz
Quotierungen.

Falls nur eine 5-Jahres-Mid-Swapsatz-Quotierung zur

Verfügung gestellt wird, entspricht der

Referenzbankensatz der zur Verfügung gestellten 5
Jahres-Mid-Swapsatz-Quotierung.

Für diese Zwecke bezeichnet "5-Jahres-Mid
**Swapsatz-Quotierung" einer Referenzbank an einem**

Tag das arithmetische Mittel der von der Referenzbank

der Emittentin und der Berechnungsstelle an diesem

Tag zur Verfügung gestellten nachgefragten (bid) und

angebotenen (offered) Sätze für den jährlichen

Festzinszahlungsstrom (berechnet auf einer Zinstage
Berechnungsbasis, die dem dann vorherrschenden

Marktstandard für solche fest- bis variable (fixed-for
_floating) Zinsswap-Transaktionen in Euro entspricht)_

einer fest- bis variablen (fixed-for-floating) Zinsswap
Transaktion in Euro, (x) die eine 5-jährige Laufzeit ab

dem betreffenden Reset-Termin (oder ab einem

anderen Tag, an dem eine solche fest- bis variable

(fixed-for-floating) Zinsswap-Transaktion in Euro

nach dem dann vorherrschenden regulären

Abrechnungszyklus unter der Annahme, dass dieser


For these purposes "Euro Mid Swap Rate" means the

arithmetic mean of the bid and offered rates for the

annual fixed leg of a fixed-for-floating interest rate

swap transaction in Euro which (x) has a term of 5

years and (y) has a floating leg based on the 6-month

EURIBOR rate (or the EURIBOR rate for such other

tenor as is the then prevailing market standard tenor for

such fixed-for-floating interest rate swap transactions

in Euro).

"Reference Bank Rate" means the percentage rate

determined by the Calculation Agent on the basis of the

5-year Mid Swap Rate Quotations on the Interest

Determination Date which the Issuer requests from

three leading swap dealers in the interbank market

selected by it (each, a "Reference Bank").

If at least two 5-year Mid Swap Rate Quotations are

provided, the Reference Bank Rate will be the

arithmetic mean of the 5-year Mid Swap Rate

Quotations so provided.

If only one 5-year Mid Swap Rate Quotation is

provided, the Reference Bank Rate will be such 5-year

Mid Swap Rate Quotation.

For this purpose, "5-year Mid Swap Rate Quotation"

in respect of any Reference Bank and on any date

means the arithmetic mean of the bid and offered rates

on such date provided by such Reference Bank to the

Issuer and the Calculation Agent for the annual fixed

rate leg (calculated on a day count basis consistent with

the then prevailing market standard for such fixed-for
floating interest rate swap transactions in Euro) of a

fixed-for-floating interest rate swap transaction in Euro

which transaction (x) has a term of 5 years

commencing on the relevant Reset Date (or, if

different, such other date on which such a fixed-for
floating interest rate swap transaction in Euro would

start based on the then prevailing regular settlement

cycle and assuming the trade date to be such date), (y)

is in an amount that is representative of a single

transaction in the relevant market at the relevant time,


-----

Tag das Transaktionsdatum (trade date) ist, zu laufen

beginnt) hat, (y) die auf einen Betrag lautet, der dem

einer repräsentativen einzelnen Transaktion in dem

relevanten Markt zur relevanten Zeit entspricht, und

(z) deren variabler Zahlungsstrom auf dem 6-Monats
EURIBOR (oder dem EURIBOR für eine andere

Laufzeit, die der Laufzeit gemäß dem dann

vorherrschenden Marktstandard für eine solche fest
bis variable (fixed-for-floating) Zinsswap-Transaktion

in Euro entspricht) (berechnet auf einer Zinstage
Berechnungsbasis, die dem dann vorherrschenden

Marktstandard für solche fest- bis variable (fixed-for
_floating) Zinsswap-Transaktionen in Euro entspricht)_

beruht.


and (z) has a floating leg based on the 6-month

EURIBOR (or the EURIBOR for such other tenor as is

the then prevailing market standard tenor for

EURIBOR for the purpose of fixed-for-floating

interest rate swap transactions) (calculated on a day

count basis consistent with the then prevailing market

standard for such fixed-for-floating interest rate swap

transactions in Euro).


Dabei gilt Folgendes: Where:


"Bildschirmseite" bezeichnet den Reuters Bildschirm

"ICESWAP2" unter der Überschrift "EURIBOR

BASIS" und dem Untertitel "11:00 AM Frankfurt

time" (auf dem solche Überschriften und Untertitel von

Zeit zur Zeit erscheinen) (die "Ursprüngliche

**Bildschirmseite").** Wenn die Ursprüngliche

Bildschirmseite dauerhaft eingestellt wird, oder wenn

darauf die Quotierung des Ursprünglichen

Benchmarksatzes dauerhaft eingestellt wird, jedoch

diese Quotierung auf einer anderen, von der Emittentin

nach billigem Ermessen ausgewählten Bildschirmseite

verfügbar ist (die "Ersatzbildschirmseite"), dann ist

"Bildschirmseite" die Ersatzbildschirmseite, und zwar

ab dem Tag, an dem die Emittentin die

Ersatzbildschirmseite auswählt.

"Geschäftstag" bezeichnet einen Tag (außer einem

Samstag oder Sonntag), an dem das Clearingsystem

sowie alle betroffenen Bereiche des Trans-European

Automated Real-time Gross Settlement Express

Transfer System (TARGET2) betriebsbereit sind, um

die betreffenden Zahlungen weiterzuleiten.

"Reset-Termin" bezeichnet den Ersten Reset-Termin

und danach jeden fünften Jahrestag des

vorausgegangenen Reset-Termins.

"Reset-Zeitraum" bezeichnet jeden Zeitraum ab dem

Ersten Reset-Termin (einschließlich) bis zu dem

nächstfolgenden Reset-Termin (ausschließlich) und

danach ab einem Reset-Termin (einschließlich) bis zu

dem nächstfolgenden Reset-Termin (ausschließlich).

"TARGET-Geschäftstag" bezeichnet einen Tag, an

dem das Trans-European Automated Real-time Gross


"Screen **Page"** means the Reuters screen

"ICESWAP2" under the heading "EURIBOR BASIS"

and the caption "11:00 AM Frankfurt time" (as such

headings and captions may appear from time to time)

(the "Original Screen Page"). If the Original Screen

Page permanently ceases to exist or permanently

ceases to quote the Original Benchmark Rate but such

quotation is available from another page selected by

the Issuer in its reasonable discretion (the

"Replacement Screen Page"), the "Screen Page" shall

be the Replacement Screen Page with effect from the

date on which the Replacement Screen Page is selected

by the Issuer.

"Business Day" means a day (other than a Saturday or

a Sunday) on which the Clearing System as well as all

relevant parts of the Trans-European Automated Real
time Gross settlement Express Transfer system

(TARGET2) are operational to forward the relevant

payments.

"Reset Date" means the First Reset Date and thereafter

each fifth anniversary of the preceding Reset Date.

"Reset Period" means each period from and including

the First Reset Date to but excluding the immediately

following Reset Date and thereafter from and including

a Reset Date to but excluding the immediately

following Reset Date.

"TARGET Business Day" means a day on which the

Trans-European Automated Real-time Gross


-----

settlement Express Transfer system 2 (TARGET)

betriebsbereit ist.

"Zinsfestsetzungstag" bezeichnet den zweiten

TARGET-Geschäftstag vor dem betreffenden Reset
Termin.

"Zinsperiode" bezeichnet den jeweiligen Zeitraum

von dem Verzinsungsbeginn (einschließlich) bis zum

ersten Zinszahlungstag (ausschließlich) bzw. von

jedem Zinszahlungstag (einschließlich) bis zum

nächstfolgenden Zinszahlungstag (ausschließlich).

(3) Unverzüglich nach Bestimmung des betreffenden

Referenzsatzes wird die Berechnungsstelle den Reset
Zinssatz für den betreffenden Reset-Zeitraum

berechnen.

(4) Die Berechnungsstelle wird veranlassen, dass der

Reset-Zinssatz der Emittentin, der Hauptzahlstelle,

und jeder Börse, an der die Schuldverschreibungen zu

diesem Zeitpunkt auf Veranlassung der Emittentin

notiert sind und deren Regeln eine Mitteilung an die

Börse verlangen, sowie den Gläubigern gemäß § 13

unverzüglich, aber keinesfalls später als am achten auf

dessen Feststellung folgenden Geschäftstag mitgeteilt

wird.

(5) _Benchmark-Ereignis. Wenn ein Benchmark-Ereignis_

(wie in § 3(5)(f) definiert) in Bezug auf den

Ursprünglichen Benchmarksatz eintritt, gilt für die

Bestimmung des Referenzsatzes und die Verzinsung

der Schuldverschreibungen gemäß § 3 Folgendes:

(a) _Unabhängiger Berater. Die Emittentin wird sich_

bemühen, sobald dies (nach Ansicht der

Emittentin) nach Eintritt des Benchmark
Ereignisses und vor dem nächsten

Zinsfestsetzungstag erforderlich ist, einen

Unabhängigen Berater (wie in § 3(5)(f)

definiert) zu benennen, der einen Neuen

Benchmarksatz (wie in § 3(5)(f) definiert), die

Anpassungsspanne (wie in § 3(5)(f) definiert)

und etwaige Benchmark-Änderungen (wie in

§ 3(5)(d) definiert) festlegt.

(b) _Ausweichsatz (fallback rate). Wenn vor dem 10._

Geschäftstag vor dem betreffenden

Zinsfestsetzungstag

(i) die Emittentin keinen Unabhängigen

Berater ernannt hat; oder


settlement Express Transfer system 2 (TARGET) is

operating.

"Interest Determination Date" means the second

TARGET Business Day prior to the relevant Reset

Date.

"Interest Period" means each period from and

including the Interest Commencement Date to but

excluding the first Interest Payment Date and from and

including each Interest Payment Date to but excluding

the immediately following Interest Payment Date.

(3) Promptly after the determination of the relevant

Reference Rate, the Calculation Agent shall determine

the Reset Rate of Interest for the relevant Reset Period.

(4) The Calculation Agent will cause the Reset Rate of

Interest to be notified to the Issuer, the Principal

Paying Agent and, if required by the rules of any stock

exchange on which the Notes are listed from time to

time at the request of the Issuer, to such stock

exchange, and to the Holders in accordance with § 13

without undue delay, but, in any case, not later than on

the eighth Business Day after its determination.

(5) _Benchmark Event. If a Benchmark Event (as defined in_

§ 3(5)(f)) occurs in relation to the Original Benchmark

Rate, the Reference Rate and the interest on the Notes

in accordance with § 3 will be determined as follows:

(a) _Independent Adviser. The Issuer shall, as soon_

as this is (in the Issuer's view) required

following the occurrence of the Benchmark

Event and prior to the next Interest

Determination Date, use its best efforts to

appoint an Independent Adviser (as defined in

§ 3(5)(f)), who will determine a New

Benchmark Rate (as defined in § 3(5)(f)), the

Adjustment Spread (as defined in § 3(5)(f)) and

any Benchmark Amendments (as defined in

§ 3(5)(d)).

(b) _Fallback rate. If, prior to the 10th Business Day_

prior to the relevant Interest Determination

Date,

(i) the Issuer has not appointed an

Independent Adviser; or


-----

(ii) der ernannte Unabhängige Berater keinen

Neuen Benchmarksatz, keine

Anpassungsspanne und/oder keine

Benchmark-Änderungen (sofern

erforderlich) gemäß diesem § 3(5)

festgelegt hat,

dann entspricht der Referenzsatz für den

nächsten Reset-Zeitraum dem Referenzsatz auf

der Bildschirmseite an dem letzten

Zinsfestsetzungstag an dem ein Referenzsatz

angezeigt wurde.

Sofern dieser § 3(5)(b) bereits an dem

Zinsfestsetzungstag für den Ersten Reset
Termin angewendet werden muss, entspricht der

Referenzsatz für den ersten Reset-Zeitraum

0,874 % per annum.

Sofern der gemäß diesem § 3(5)(b) bestimmte

Ausweichsatz (fallback rate) zur Anwendung

kommt, wird § 3(5) erneut angewendet, um den

Referenzsatz für den nächsten nachfolgenden

Reset-Zeitraum (und, sofern notwendig, weitere

nachfolgende Reset-Zeiträume) zu bestimmen.

(c) _Nachfolge-Benchmarksatz_ _oder_ _Alternativ-_

_Benchmarksatz. Falls der Unabhängige Berater_

nach billigem Ermessen feststellt,

(i) dass es einen Nachfolge-Benchmarksatz

gibt, dann ist dieser Nachfolge
Benchmarksatz der Neue Benchmarksatz;

oder

(ii) dass es keinen Nachfolge-Benchmarksatz

aber einen Alternativ-Benchmarksatz

gibt, dann ist dieser Alternativ
Benchmarksatz der Neue Benchmarksatz.

In beiden Fällen entspricht der Referenzsatz für

den unmittelbar nach dem Stichtag beginnenden

Reset-Zeitraum und (vorbehaltlich des Eintritts

eines weiteren Benchmark-Ereignisses) alle

folgenden Zinsanpassungszeiträume dann (x)

dem Neuen Benchmarksatz an dem betreffenden

Zinsfestsetzungstag zuzüglich (y) der

Anpassungsspanne.

(d) _Benchmark-Änderungen. Wenn ein Neuer_

Benchmarksatz und die entsprechende

Anpassungsspanne gemäß diesem § 3(5)

festgelegt werden, und wenn der Unabhängige


(ii) the appointed Independent Adviser has

not determined a New Benchmark Rate,

the Adjustment Spread and/or any

Benchmark Amendments (if required) in

accordance with this § 3(5),

then the Reference Rate applicable to the next

Reset Period shall be the Reference Rate on the

Screen Page on the last day preceding the

relevant Interest Determination Date on which

such Reference Rate was displayed.

If this § 3(5)(b) is to be applied on the Interest

Determination Date for the First Reset Date, the

Reference Rate applicable to the first Reset

Period shall be 0.874 per cent. per annum.

If the fallback rate determined in accordance

with this § 3(5)(b) is to be applied, § 3(5) will be

operated again to determine the Reference Rate

applicable to the next subsequent (and, if

required, further subsequent) Reset Period(s).

(c) _Successor Benchmark Rate or Alternative_

_Benchmark Rate. If the Independent Adviser_

determines in its reasonable discretion that:

(i) there is a Successor Benchmark Rate, then

that Successor Benchmark Rate shall

subsequently be the New Benchmark

Rate; or

(ii) there is no Successor Benchmark Rate but

that there is an Alternative Benchmark

Rate, then that Alternative Benchmark

Rate shall subsequently be the New

Benchmark Rate.

In either case the Reference Rate for the Reset

Period commencing immediately after the

Effective Date and (subject to the occurrence of

a further Benchmark Event) all following Reset

Periods will then be (x) the New Benchmark

Rate on the relevant Interest Determination Date

plus (y) the Adjustment Spread.

(d) _Benchmark Amendments. If any relevant New_

Benchmark Rate and the applicable Adjustment

Spread are determined in accordance with this

§ 3(5), and if the Independent Adviser


-----

Berater feststellt, dass resultierend aus den

vorgenannten Festlegungen Änderungen der

Bedingungen für die Feststellungen des

anwendbaren Reset-Zinssatzes notwendig sind,

um die ordnungsgemäße Anwendung des Neuen

Benchmarksatzes und der entsprechenden

Anpassungsspanne zu gewährleisten (diese

Änderungen, die "Benchmark-Änderungen"),

dann wird der Unabhängige Berater die

Benchmark-Änderungen feststellen.

Diese Benchmark-Änderungen können

insbesondere folgende Regelungen in diesen

Anleihebedingungen erfassen:

(i) den Referenzsatz einschließlich der

"Bildschirmseite" und/oder die Methode

zur Bestimmung des Ausweichsatzes

(sog. fallback rate) für den Referenzsatz

einschließlich des Referenzbankensatzes;

und/oder

(ii) die Definitionen der Begriffe

"Geschäftstag", "Reset-Termin", "Reset
Zeitraum", "Zinsfestsetzungstag",

"Zinsperiode", "Zinstagequotient"

und/oder

"Zinszahlungstag"(einschließlich der

Festlegung, ob der Referenzsatz

vorausschauend vor oder zu Beginn der

betreffenden Zinsperiode oder

zurückblickend vor oder zum Ablauf der

betreffenden Zinsperiode bestimmt wird);

und/oder

(iii) die Geschäftstagekonvention gemäß

§ 6(5).

(e) _Mitteilungen, etc. Die Emittentin wird einen_

Neuen Benchmarksatz, die Anpassungsspanne

und etwaige Benchmark-Änderungen gemäß

diesem § 3(5) bzw. den Ausweichsatz (sog.

_fallback_ _rate)_ gemäß § 3(5)(b) der

Hauptzahlstelle, etwaigen weiteren Zahlstellen,

der Berechnungsstelle sowie gemäß § 13 den

Gläubigern mitteilen, und zwar sobald eine

solche Mitteilung (nach Ansicht der Emittentin)

nach deren Feststellung erforderlich ist,

spätestens jedoch an dem 10. Geschäftstag vor

dem betreffenden Zinsfestsetzungstag. Eine

solche Mitteilung ist unwiderruflich und hat den

Stichtag zu benennen.


determines that, resulting from the

aforementioned determinations, amendments to

the conditions for the determinations of the

applicable Reset Rate of Interest are necessary

to ensure the proper operation of the New

Benchmark Rate and the applicable Adjustment

Spread (such amendments, the "Benchmark

**Amendments"), then the Independent Adviser**

will determine the Benchmark Amendments.

The Benchmark Amendments may include,

without limitation, the following provisions of

these Terms and Conditions:

(i) the Reference Rate including the "Screen

Page" and/or the method for determining

the fallback rate in relation to the

Reference Rate, including the Reference

Bank Rate; and/or

(ii) the definitions of the terms "Business

Day", "Reset Date", "Reset Period",

"Interest Determination Date", "Interest

Period", "Day Count Fraction" and/or

"Interest Payment Date" (including the

determination whether the Reference Rate

will be determined in advance on or prior

to the relevant Interest Period or in arrear

on or prior to the end of the relevant

Interest Period); and/or

(iii) the business day convention in

accordance with § 6(5).

(e) _Notices, etc. The Issuer will notify the Principal_

Paying Agent, any additional paying agents, the

Calculation Agent and, in accordance with § 13,

the Holders of a New Benchmark Rate, the

Adjustment Spread and the Benchmark

Amendments (if any) determined under this

§ 3(5) or the fallback rate in accordance with

§ 3(5)(b), as the case may be, as soon as such

notification is (in the Issuer's view) required

following the determination thereof, but in any

event not later than on the 10[th] Business Day

prior to the relevant Interest Determination

Date. Any such notice shall be irrevocable and

shall specify the Effective Date.


-----

Der Neue Benchmarksatz, die

Anpassungsspanne und etwaige Benchmark
Änderungen bzw. der Ausweichsatz (sog.

_fallback rate), die bzw. der jeweils in der_

Mitteilung benannt werden, sind (sofern nicht

ein offensichtlicher Irrtum vorliegt) für die

Emittentin, die Hauptzahlstelle, etwaige weitere

Zahlstellen, die Berechnungsstelle und die

Gläubiger bindend. Die Anleihebedingungen

gelten ab dem Stichtag als durch den Neuen

Benchmarksatz, die Anpassungsspanne und die

etwaigen Benchmark-Änderungen geändert.

An oder vor dem Tag dieser Mitteilung hat die

Emittentin der Zahlstelle und der

Berechnungsstelle eine durch zwei

Unterschriftsberechtigte der Emittentin

unterzeichnete Bescheinigung zu überlassen, die

(i) bestätigt, dass ein Benchmark-Ereignis

eingetreten ist;

(ii) den nach Maßgabe der Bestimmungen

dieses § 3(5) festgestellten Neuen

Benchmarksatz benennt;

(iii) die entsprechende Anpassungsspanne und

etwaige Benchmark-Änderungen

benennt, die jeweils nach Maßgabe der

Bestimmungen dieses § 3(5) festgestellt

wurden; und


The New Benchmark Rate, the Adjustment

Spread and the Benchmark Amendments (if

any) or the fallback rate, as the case may be, each

as specified in the notice, shall (in the absence

of manifest error) be binding on the Issuer, the

Principal Paying Agent, any additional paying

agents, the Calculation Agent and the Holders.

The Terms and Conditions shall be deemed to

have been amended by the New Benchmark

Rate, the Adjustment Spread and any

Benchmark Amendments with effect from the

Effective Date.

On or prior to the date of such notice, the Issuer

shall deliver to the Paying Agent and the

Calculation Agent a certificate signed by two

authorized signatories of the Issuer:

(i) confirming that a Benchmark Event has

occurred;

(ii) specifying the relevant New Benchmark

Rate determined in accordance with the

provisions of this § 3(5);

(iii) specifying the applicable Adjustment

Spread and the Benchmark Amendments

(if any), each determined in accordance

with the provisions of this § 3(5); and


(iv) den Stichtag benennt; und (iv) specifying the Effective Date; and


(v) bestätigt, dass die etwaigen Benchmark
Änderungen notwendig sind, um die

ordnungsgemäße Anwendung des Neuen

Benchmarksatzes und der entsprechenden

Anpassungsspanne zu gewährleisten.


(v) confirming that the Benchmark

Amendments, if any, are necessary to

ensure the proper operation of the New

Benchmark Rate and the applicable

Adjustment Spread.


(f) _Definitionen. Zur Verwendung in diesem § 3(5):_ (f) _Definitions. As used in this § 3(5):_


Die "Anpassungsspanne", die positiv, negativ

oder gleich Null sein kann, wird in Basispunkten

ausgedrückt und bezeichnet entweder (x) die

Spanne oder (y) das Ergebnis der Anwendung

der Formel oder Methode zur Berechnung der

Spanne, die

(i) im Fall eines Nachfolge
Benchmarksatzes formell im

Zusammenhang mit der Ersetzung des

Ursprünglichen Benchmarksatzes durch

den Nachfolge-Benchmarksatz von dem


The "Adjustment Spread", which may be

positive, negative or zero, will be expressed in

basis points and means either (x) the spread, or

(y) the result of the operation of the formula or

methodology for calculating the spread, which

(i) in the case of a Successor Benchmark

Rate, is formally recommended in relation

to the replacement of the Original

Benchmark Rate with the Successor


-----

Nominierungsgremium empfohlen wird;

oder

(ii) (sofern keine Empfehlung gemäß

Ziffer (i) abgegeben wurde oder im Fall

eines Alternativ-Benchmarksatzes)

üblicherweise an den internationalen

Anleihekapitalmärkten auf den Neuen

Benchmarksatz angewendet wird, um

einen industrieweit akzeptierten Ersatz
Benchmarksatz für den Ursprünglichen

Benchmarksatz zu erzeugen, wobei

sämtliche Feststellungen durch den

Unabhängigen Berater nach billigem

Ermessen vorgenommen werden; oder

(iii) (sofern der Unabhängige Berater nach

billigem Ermessen feststellt, dass keine

solche Spanne üblicherweise angewendet

wird, und dass das Folgende für die

Schuldverschreibungen angemessen ist)

als industrieweiter Standard für Over-the
Counter Derivatetransaktionen, die sich

auf den Ursprünglichen Benchmarksatz

beziehen, anerkannt oder bestätigt ist,

wenn der Ursprüngliche Benchmarksatz

durch den Neuen Benchmarksatz ersetzt

worden ist, wobei sämtliche

Feststellungen durch den Unabhängigen

Berater nach billigem Ermessen

vorgenommen werden.

"Alternativ-Benchmarksatz" bezeichnet eine

alternative Benchmark oder einen alternativen

Bildschirmsatz, die bzw. der üblicherweise an

den internationalen Anleihekapitalmärkten

(oder, hilfsweise, an den internationalen

Swapmärkten) zur Bestimmung eines Mid
Swap-Satzes mit 5-jähriger Laufzeit in Euro

angewendet wird, wobei sämtliche

Feststellungen durch den Unabhängigen Berater

vorgenommen werden.


Benchmark Rate by any Relevant

Nominating Body; or

(ii) (if no recommendation pursuant to

clause (i) has been made, or in the case of

an Alternative Benchmark Rate) is

customarily applied to the New

Benchmark Rate in the international debt

capital markets to produce an industry
accepted replacement benchmark rate for

the Original Benchmark Rate, provided

that all determinations will be made by the

Independent Adviser in its reasonable

discretion; or

(iii) (if the Independent Adviser in its

reasonable discretion determines that no

such spread is customarily applied and

that the following would be appropriate

for the Notes) is recognized or

acknowledged as being the industry

standard for over-the-counter derivative

transactions which reference the Original

Benchmark Rate, where the Original

Benchmark Rate has been replaced by the

New Benchmark Rate, provided that all

determinations will be made by the

Independent Adviser in its reasonable

discretion.

"Alternative Benchmark Rate" means an

alternative benchmark or an alternative screen

rate which is customarily applied in the

international debt capital markets (or,

alternatively, the international swap markets) for

the purpose of determining a mid swap rate with

a 5-year maturity in Euro, provided that all

determinations will be made by the Independent

Adviser.


Ein "Benchmark-Ereignis" tritt ein, wenn: A "Benchmark Event" occurs if:


(i) eine öffentliche Erklärung oder eine

Veröffentlichung von Informationen

durch die für den Administrator des

Ursprünglichen Benchmarksatzes

zuständige Aufsichtsbehörde oder in

deren Namen vorgenommen wird, aus der

hervorgeht, dass dieser Administrator die


(i) a public statement or publication of

information by or on behalf of the

regulatory supervisor of the Original

Benchmark Rate administrator is made,

stating that said administrator has ceased

or will cease to provide the Original

Benchmark Rate permanently or


-----

Bereitstellung des Ursprünglichen

Benchmarksatzes dauerhaft oder auf

unbestimmte Zeit eingestellt hat oder

einstellen wird, es sei denn, es gibt einen

Nachfolgeadministrator, der den

Ursprünglichen Benchmarksatz weiterhin

bereitstellt; oder

(ii) eine öffentliche Erklärung oder eine

Veröffentlichung von Informationen

durch den Administrator des

Ursprünglichen Benchmarksatzes oder in

dessen Namen vorgenommen wird, die

besagt, dass der Administrator die

Bereitstellung des Ursprünglichen

Benchmarksatzes dauerhaft oder auf

unbestimmte Zeit eingestellt hat oder

einstellen wird, es sei denn, es gibt einen

Nachfolgeadministrator, der den

Ursprünglichen Benchmarksatz weiterhin

bereitstellt; oder

(iii) eine öffentliche Erklärung der

Aufsichtsbehörde des Administrators des

Ursprünglichen Benchmarksatzes

veröffentlicht wird, wonach der

Ursprüngliche Benchmarksatz ihrer

Ansicht nach nicht mehr repräsentativ für

den zugrunde liegenden Markt, den er zu

messen vorgibt, ist oder sein wird, und

keine von der Aufsichtsbehörde des

Administrators des Ursprünglichen

Benchmarksatzes geforderten

Maßnahmen zur Behebung einer solchen

Situation ergriffen worden sind oder zu

erwarten sind; oder

(iv) die Verwendung des Ursprünglichen

Benchmarksatzes aus irgendeinem Grund

nach einem Gesetz oder einer

Verordnung, die in Bezug auf die

Zahlstellen, die Berechnungsstelle, die

Emittentin oder jeden Dritten anwendbar

sind, rechtswidrig geworden ist; oder

(v) der Ursprüngliche Benchmarksatz ohne

vorherige offizielle Ankündigung durch

die zuständige Behörde oder den

Administrator dauerhaft nicht mehr

veröffentlicht wird; oder


indefinitely, unless there is a successor

administrator that will continue to provide

the Original Benchmark Rate; or

(ii) a public statement or publication of

information by or on behalf of the Original

Benchmark Rate administrator is made,

stating that said administrator has ceased

or will cease to provide the Original

Benchmark Rate permanently or

indefinitely, unless there is a successor

administrator that will continue to provide

the Original Benchmark Rate; or

(iii) a public statement by the regulatory

supervisor of the Original Benchmark

Rate administrator is made that, in its

view, the Original Benchmark Rate is no

longer, or will no longer be, representative

of the underlying market it purports to

measure and no action to remediate such a

situation is taken or expected to be taken

as required by the supervisor of the

Original Benchmark Rate administrator;

or

(iv) it has become, for any reason, unlawful

under any law or regulation applicable to

any Paying Agent, the Calculation Agent,

the Issuer or any other party to use the

Original Benchmark Rate; or

(v) the Original Benchmark Rate is

permanently no longer published without

a previous official announcement by the

competent authority or the administrator;

or


-----

(vi) die Methode für die Feststellung des

Ursprünglichen Benchmarksatzes (oder

einer Teilkomponente davon) ändert sich

wesentlich gegenüber der Methode, die

der Administrator des Ursprünglichen

Benchmarksatzes bei Verzinsungsbeginn

anwendet.

"Nachfolge-Benchmarksatz" bezeichnet einen

Nachfolger oder Ersatz des Ursprünglichen

Benchmarksatzes, der formell durch das

Nominierungsgremium empfohlen wurde.

"Neuer **Benchmarksatz"** bezeichnet den

jeweils gemäß diesem § 3(5) bestimmten

Nachfolge-Benchmarksatz bzw. Alternativ
Benchmarksatz.

"Nominierungsgremium" bezeichnet in Bezug

auf die Ersetzung des Ursprünglichen

Benchmarksatzes:

(i) die Zentralbank für die Währung, in der

die Benchmark oder der Bildschirmsatz

dargestellt wird oder eine Zentralbank

oder andere Aufsichtsbehörde, die für die

Aufsicht des Administrators der

Benchmark oder des Bildschirmsatzes

zuständig ist; oder

(ii) jede Arbeitsgruppe oder jeden Ausschuss

gefördert durch, geführt oder mitgeführt

von oder gebildet von (1) der Zentralbank

für die Währung in der die Benchmark

oder der Bildschirmsatz dargestellt wird,

(2) einer Zentralbank oder anderen

Aufsichtsbehörde, die für die Aufsicht des

Administrators der Benchmark oder des

Bildschirmsatzes zuständig ist, (3) einer

Gruppe der zuvor genannten

Zentralbanken oder anderer

Aufsichtsbehörden oder (4) dem

Finanzstabilitätsrat (Financial Stability

_Board) oder Teilen davon._

"Unabhängiger Berater" bezeichnet ein von

der Emittentin ernanntes unabhängiges

Finanzinstitut mit internationalem Ansehen oder

einen anderen unabhängigen Finanzberater mit

Erfahrung in den internationalen


(vi) the methodology for the determination of

the Original Benchmark Rate (or any

component part thereof) is materially

altered compared to the methodology as

used by the administrator of the Original

Benchmark Rate at the Interest

Commencement Date.

"Successor **Benchmark** **Rate"** means a

successor to or replacement of the Original

Benchmark Rate which is formally

recommended by any Relevant Nominating

Body.

"New Benchmark Rate" means the Successor

Benchmark Rate or, as the case may be, the

Alternative Benchmark Rate determined in

accordance with this § 3(5).

"Relevant Nominating Body" means, in respect

of the replacement of the Original Benchmark

Rate:

(i) the central bank for the currency to which

the benchmark or screen rate (as

applicable) relates, or any central bank or

other supervisory authority which is

responsible for supervising the

administrator of the benchmark or screen

rate (as applicable); or

(ii) any working group or committee

sponsored by, chaired or co-chaired by or

constituted at the request of (1) the central

bank for the currency to which the

benchmark or screen rate (as applicable)

relates, (2) any central bank or other

supervisory authority which is responsible

for supervising the administrator of the

benchmark or screen rate (as applicable),

(3) a group of the aforementioned central

banks or other supervisory authorities or

(4) the Financial Stability Board or any

part thereof.

"Independent Adviser" means an independent

financial institution of international repute or

other independent financial adviser experienced

in the international debt capital markets, in each

case appointed by the Issuer, and which may be

the Calculation Agent.


-----

Anleihekapitalmärkten, und der die

Berechnungsstelle sein kann.

(g) Der Stichtag für die Anwendung des Neuen

Benchmarksatzes, der Anpassungsspanne und

der etwaigen Benchmark-Änderungen gemäß

diesem § 3(5) (der "Stichtag") ist der

Zinsfestsetzungstag, der auf den frühesten der

folgenden Tage fällt oder diesem nachfolgt:

(i) den Tag, an dem die Veröffentlichung des

Ursprünglichen Benchmarksatzes

eingestellt wird, an dem der

Ursprüngliche Benchmarksatz eingestellt

wird bzw. ab dem der Ursprüngliche

Benchmarksatz nicht mehr repräsentativ

ist oder sein wird, wenn das Benchmark
Ereignis aufgrund der Ziffern (i), (ii) oder

(iii) der Definition des Begriffs

"Benchmark-Ereignis" eingetreten ist;

oder

(ii) den Tag, ab dem der Ursprüngliche

Benchmarksatz nicht mehr verwendet

werden darf, wenn das Benchmark
Ereignis aufgrund der Ziffer (iv) der

Definition des Begriffs "Benchmark
Ereignis" eingetreten ist; oder

(iii) den Tag des Eintritts des Benchmark
Ereignisses, wenn das Benchmark
Ereignis aufgrund der Ziffern (v) oder (vi)

der Definition des Begriffs "Benchmark
Ereignis" eingetreten ist

(h) Eine Anpassung des Ursprünglichen

Benchmarksatzes im Falle eines Benchmark
Ereignisses darf nur insoweit durchgeführt

werden, als dass durch diese Anpassung kein

Verlust der Eigenkapitalanrechnung oder keine

Verkürzung der Eigenkapitalanrechnung

eintritt.

(i) Wenn ein Benchmark-Ereignis in Bezug auf

einen Neuen Benchmarksatz eintritt, gilt dieser

§ 3(5) entsprechend für die Ersetzung des Neuen

Benchmarksatzes durch einen neuen Nachfolge
Benchmarksatz bzw. Alternativ
Benchmarksatz. In diesem Fall gilt jede

Bezugnahme in diesem § 3 auf den Begriff

Ursprünglicher Benchmarksatz als Bezugnahme


(g) The effective date for the application of the New

Benchmark Rate, the Adjustment Spread and the

Benchmark Amendments (if any) determined

under this § 3(5) (the "Effective Date") will be

the Interest Determination Date falling on or

after the earliest of the following dates:

(i) if the Benchmark Event has occurred as a

result of clauses (i), (ii) or (iii) of the

definition of the term "Benchmark Event",

the date of cessation of publication of the

Original Benchmark Rate, the date of the

discontinuation of the Original

Benchmark Rate or the date as from which

the Original Benchmark Rate is no longer,

or will no longer be, representative, as the

case may be; or

(ii) if the Benchmark Event has occurred as a

result of clause (iv) of the definition of the

term "Benchmark Event", the date from

which the prohibition applies; or

(iii) if the Benchmark Event has occurred as a

result of clauses (v) or (vi) of the

definition of the term "Benchmark Event",

the date of the occurrence of the

Benchmark Event.

(h) Any adjustment to the Original Benchmark Rate

in case of a Benchmark Event will be made only

to the extent that no Loss in Equity Credit or

Shortening in Equity Credit would occur as a

result of such adjustment.

(i) If a Benchmark Event occurs in relation to any

New Benchmark Rate, § 3(5) shall apply mutatis

_mutandis to the replacement of such New_

Benchmark Rate by any new Successor

Benchmark Rate or Alternative Benchmark

Rate, as the case may be. In this case, all

references in this § 3 to the term Original

Benchmark Rate shall be deemed to be a


-----

auf den zuletzt verwendeten Neuen

Benchmarksatz.

(j) In diesem § 3(5) schließt jede Bezugnahme auf

den Begriff Ursprünglicher Benchmarksatz

gegebenenfalls auch eine Bezugnahme auf eine

etwaige Teilkomponente des Ursprünglichen

Benchmarksatzes ein, wenn in Bezug auf diese

Teilkomponente ein Benchmark-Ereignis

eingetreten ist.

(6) Die Zinsen für einen beliebigen Zeitraum werden auf

der Grundlage des Zinstagequotienten berechnet.

"Zinstagequotient" bezeichnet bei der Berechnung

des Zinsbetrages für eine Schuldverschreibung für

einen beliebigen Zeitraum (der

"Zinsberechnungszeitraum"):

(a) wenn der Zinsberechnungszeitraum der

Feststellungsperiode entspricht, in die er fällt,

oder kürzer als diese ist, die Anzahl von Tagen

in dem Zinsberechnungszeitraum dividiert

durch die Anzahl von Tagen in der betreffenden

Feststellungsperiode; und

(b) wenn der Zinsberechnungszeitraum länger als

eine Feststellungsperiode ist, die Summe aus

(i) der Anzahl der Tage in dem betreffenden

Zinsberechnungszeitraum, die in die

Feststellungsperiode fallen, in der der

Zinsberechnungszeitraum beginnt,

dividiert durch die Anzahl der Tage in der

betreffenden Feststellungsperiode; und

(ii) die Anzahl der Tage in dem betreffenden

Zinsberechnungszeitraum, die in die

nachfolgende Feststellungsperiode fallen,

dividiert durch die Anzahl der Tage in der

betreffenden Feststellungsperiode.


reference to the New Benchmark Rate last

applied.

(j) Any reference in this § 3(5) to the term Original

Benchmark Rate shall be deemed to include a

reference to any component part thereof, as

applicable, if a Benchmark Event has occurred

in respect of that component part.

(6) Interest for any period of time will be calculated on the

basis of the Day Count Fraction.

"Day Count Fraction" means, in respect of the

calculation of an amount of interest on any Note for

any period of time (the "Calculation Period"):

(a) if the Calculation Period is equal to or shorter

than the Determination Period in which it falls,

the number of days in the Calculation Period

divided by the number of days in such

Determination Period; and

(b) if the Calculation Period is longer than one

Determination Period, the sum of:

(i) the number of days in such Calculation

Period falling in the Determination Period

in which the Calculation Period begins

divided by the number of days in such

Determination Period; and

(ii) the number of days in such Calculation

Period falling in the next Determination

Period divided by the number of days in

such Determination Period.


Dabei gilt Folgendes: Where:


"Feststellungsperiode" bezeichnet jede Periode

ab einem Feststellungstermin (einschließlich),

der in ein beliebiges Jahr fällt, bis zum nächsten

Feststellungstermin (ausschließlich).

"Feststellungstermin" bezeichnet jeden

25. September.

(7) _Zinslaufende._ Die Verzinsung der

Schuldverschreibungen endet mit Beginn des Tages,

an dem ihr Nennbetrag zur Rückzahlung fällig wird.


"Determination Period" means each period

from and including a Determination Date in any

year to but excluding the next Determination

Date.

"Determination **Date"** means each

25 September.

(7) _Cessation of interest accrual. The Notes will cease to_

bear interest from the beginning of the day their

principal amount is due for repayment. If the Issuer


-----

Sollte die Emittentin eine Zahlung von Kapital auf die

Schuldverschreibungen bei Fälligkeit nicht leisten,

endet die Verzinsung der Schuldverschreibungen mit

Beginn des Tages der tatsächlichen Zahlung. Der in

einem solchen Fall jeweils anzuwendende Zinssatz

wird gemäß diesem § 3 bestimmt.

**§ 4**

**FÄLLIGKEIT VON ZINSZAHLUNGEN; AUFSCHUB**

**VON ZINSZAHLUNGEN; ZAHLUNG**

**AUFGESCHOBENER ZINSZAHLUNGEN**

(1) _Fälligkeit_ _von_ _Zinszahlungen;_ _wahlweiser_

_Zinsaufschub. Zinsen, die während einer Zinsperiode_

auflaufen, werden an dem betreffenden

Zinszahlungstag fällig, sofern sich die Emittentin nicht

durch eine Bekanntmachung an die Gläubiger gemäß

§ 13 innerhalb einer Frist von nicht weniger als 10

Geschäftstagen vor dem betreffenden Zinszahlungstag

dazu entscheidet, die betreffende Zinszahlung

(insgesamt, jedoch nicht teilweise) auszusetzen.

Wenn sich die Emittentin an einem Zinszahlungstag

zur Nichtzahlung aufgelaufener Zinsen entscheidet,

dann ist sie nicht verpflichtet, an dem betreffenden

Zinszahlungstag Zinsen zu zahlen. Diese sind

Aufgeschobene Zinszahlungen (wie nachstehend

definiert). Eine Nichtzahlung von Zinsen aus diesem

Grunde begründet keinen Verzug der Emittentin und

keine anderweitige Verletzung ihrer Verpflichtungen

aufgrund der Schuldverschreibungen oder für sonstige

Zwecke.

Nach Maßgabe dieses § 4(1) nicht fällig gewordene

Zinsen sind aufgeschobene Zinszahlungen

("Aufgeschobene Zinszahlungen").


fails to make any payment of principal under the Notes

when due, the Notes will cease to bear interest from the

beginning of the day on which such payment is made.

In such case the applicable rate of interest will be

determined pursuant to this § 3.

**§ 4**

**DUE DATE FOR INTEREST PAYMENTS,**

**DEFERRAL OF INTEREST PAYMENTS, PAYMENT**

**OF ARREARS OF INTEREST**

(1) _Due Date for Interest Payments; Optional Interest_

_Deferral. Interest which accrues during an Interest_

Period will be due and payable (fällig) on the relevant

Interest Payment Date, unless the Issuer elects, by

giving notice to the Holders not less than 10 Business

Days prior to the relevant Interest Payment Date in

accordance with § 13, to defer the relevant payment of

interest (in whole but not in part).

If the Issuer elects not to pay accrued interest on an

Interest Payment Date, then it will not have any

obligation to pay such interest on such Interest

Payment Date and will constitute Arrears of Interest

(as defined below). Any such non-payment of interest

will not constitute a default of the Issuer or any other

breach of its obligations under the Notes or for any

other purpose.

Interest not due and payable in accordance with this

§ 4(1) will constitute arrears of interest ("Arrears of

**Interest").**


Aufgeschobene Zinszahlungen werden nicht verzinst. Arrears of Interest will not bear interest.


(2) _Freiwillige_ _Zahlung_ _von_ _Aufgeschobenen_

_Zinszahlungen._ Die Emittentin ist berechtigt,

ausstehende Aufgeschobene Zinszahlungen jederzeit

insgesamt, jedoch nicht teilweise, nach

Bekanntmachung an die Gläubiger unter Einhaltung

einer Frist von nicht weniger als 10 Geschäftstagen vor

einer solchen freiwilligen Zinszahlung zu zahlen,

wobei eine solche Bekanntmachung (i) den Betrag an

Aufgeschobenen Zinszahlungen, der gezahlt werden

soll, und (ii) den für diese Zahlung festgelegten Termin

enthalten muss.


(2) _Optional Settlement of Arrears of Interest. The Issuer_

will be entitled to pay outstanding Arrears of Interest

in whole but not in part at any time by giving notice to

the Holders not less than 10 Business Days before such

voluntary payment and specifying (i) the amount of

Arrears of Interest to be paid and (ii) the date fixed for

such payment.


-----

(3) _Pflicht_ _zur_ _Zahlung_ _von_ _Aufgeschobenen_

_Zinszahlungen._ Die Emittentin ist verpflichtet,

Aufgeschobene Zinszahlungen insgesamt und nicht

nur teilweise am nächsten Pflichtnachzahlungstag zu

zahlen.

"Pflichtnachzahlungstag" bezeichnet den frühesten

der folgenden Tage:

(i) den Tag, der fünf Geschäftstage nach dem Tag

liegt, an dem ein Obligatorisches

Nachzahlungsereignis eingetreten ist;

(ii) den Tag, an dem die Emittentin Zinsen auf die

Schuldverschreibungen zahlt;

(iii) den Tag, an dem die Emittentin oder eine

Tochtergesellschaft eine Dividende, sonstige

Ausschüttung oder sonstige Zahlung auf eine

Gleichrangige Verbindlichkeit leistet;

(iv) den Tag, an dem die Emittentin oder eine

Tochtergesellschaft eine Gleichrangige

Verbindlichkeit oder eine Schuldverschreibung

zurückzahlt, zurückkauft oder anderweitig

erwirbt (jeweils direkt oder indirekt);

(v) den Tag der Rückzahlung der

Schuldverschreibungen gemäß diesen

Anleihebedingungen; und

(vi) den Tag, an dem eine Entscheidung hinsichtlich

der Auseinandersetzung, Liquidation oder

Auflösung der Emittentin ergeht (sofern dies

nicht für die Zwecke oder als Folge eines

Zusammenschlusses, einer Umstrukturierung

oder Sanierung geschieht, bei dem bzw. bei der

die Emittentin noch zahlungsfähig ist und bei

dem bzw. bei der die fortführende Gesellschaft

im Wesentlichen alle Vermögenswerte und

Verpflichtungen der Emittentin übernimmt),


(3) _Mandatory Payment of Arrears of Interest. The Issuer_

must pay Arrears of Interest (in whole but not in part)

on the next Mandatory Settlement Date.

"Mandatory Settlement Date" means the earliest of:

(i) the date falling five Business Days after the date

on which a Compulsory Settlement Event has

occurred;

(ii) the date on which the Issuer pays interest on the

Notes;

(iii) the date on which the Issuer or any Subsidiary

pays any dividend, other distribution or other

payment in respect of any Parity Obligation;

(iv) the date on which the Issuer or any Subsidiary

redeems, repurchases or otherwise acquires (in

each case directly or indirectly) any Parity

Obligations or any Notes;

(v) the date of redemption of the Notes in

accordance with these Terms and Conditions;

and

(vi) the date on which an order is made for the

winding up, liquidation or dissolution of the

Issuer (other than for the purposes of or pursuant

to an amalgamation, reorganization or

restructuring whilst solvent, where the

continuing entity assumes substantially all of the

assets and obligations of the Issuer),


mit der Maßgabe, dass provided that


(x) in den vorgenannten Fällen (iii) und (iv) kein

Pflichtnachzahlungstag vorliegt, wenn die

Emittentin oder die betreffende

Tochtergesellschaft nach Maßgabe der

Anleihebedingungen der betreffenden

Gleichrangigen Verbindlichkeit zu der Zahlung,

zu der Rückzahlung, zu dem Rückkauf oder zu

dem anderweitigen Erwerb verpflichtet ist;

(y) in dem vorgenannten Fall (iv) kein

Pflichtnachzahlungstag vorliegt, wenn die


(x) in the cases (iii) and (iv) above no Mandatory

Settlement Date occurs if the Issuer or the

relevant Subsidiary is obliged under the terms

and conditions of such Parity Obligation to make

such payment, such redemption, such

repurchase or such other acquisition;

(y) in the case (iv) above no Mandatory Settlement

Date occurs if the Issuer or the relevant


-----

Emittentin oder die betreffende

Tochtergesellschaft (jeweils direkt oder

indirekt) Gleichrangige Verbindlichkeiten oder

Schuldverschreibungen (insgesamt oder

teilweise) nach einem öffentlichen

Rückkaufangebot oder öffentlichen

Umtauschangebot mit einer unter dem

Nennwert liegenden Gegenleistung je

Gleichrangiger Verbindlichkeit bzw. je

Schuldverschreibung zurückkauft oder

anderweitig erwirbt; und

(z) in den vorgenannten Fällen (iii) und (iv) kein

Pflichtnachzahlungstag vorliegt, wenn die

betreffenden Zahlungen auf oder in Bezug auf

Gleichrangige Wertpapiere Konzerninterne

Zahlungen sind.

Ein "Obligatorisches **Nachzahlungsereignis"**

bezeichnet vorbehaltlich des nachstehenden Satzes 2

jedes der folgenden Ereignisse:

(i) die ordentliche Hauptversammlung der

Emittentin beschließt, eine Dividende, sonstige

Ausschüttung oder sonstige Zahlung auf eine

Aktie einer beliebigen Gattung der Emittentin zu

leisten (mit Ausnahme einer Dividende,

Ausschüttung oder Zahlung in Form von

Stammaktien der Emittentin);

(ii) die Emittentin oder eine Tochtergesellschaft

zahlt eine Dividende, sonstige Ausschüttung

oder sonstige Zahlung auf eine Nachrangige

Verbindlichkeit (mit Ausnahme einer

Dividende, Ausschüttung oder Zahlung in Form

von Stammaktien der Emittentin); oder

(iii) die Emittentin oder eine Tochtergesellschaft

(jeweils direkt oder indirekt) zahlt oder kauft

eine Nachrangige Verbindlichkeit zurück oder

erwirbt sie anderweitig.

In den vorgenannten Fällen (ii) und (iii) tritt jedoch

kein Obligatorisches Nachzahlungsereignis ein, wenn

(x) die Emittentin oder die betreffende

Tochtergesellschaft nach Maßgabe der

Anleihebedingungen der betreffenden

Nachrangigen Verbindlichkeit zu der Zahlung,

zu der Rückzahlung, zu dem Rückkauf oder zu

dem anderweitigen Erwerb verpflichtet ist;

(y) die Emittentin oder die betreffende

Tochtergesellschaft Aktien einer beliebigen


Subsidiary repurchases or otherwise acquires (in

each case directly or indirectly) any Parity

Obligations or any Notes in whole or in part in a

public tender offer or public exchange offer at a

consideration per Parity Obligation or Note

below its par value; and

(z) in the cases (iii) and (iv) above no Mandatory

Settlement Date occurs if the relevant payments

on, or in respect of, any Parity Securities are

Intra-Group Payments.

"Compulsory Settlement Event" means any of the

following events, subject to the proviso in sentence 2

below:

(i) the ordinary general meeting of shareholders

(ordentliche Hauptversammlung) of the Issuer

resolves on the payment of any dividend, other

distribution or other payment on any share of

any class of the Issuer (other than a dividend,

distribution or payment which is made in the

form of ordinary shares of the Issuer);

(ii) the Issuer or any Subsidiary pays any dividend,

other distribution or other payment in respect of

any Junior Obligation (other than a dividend,

distribution or payment which is made in the

form of ordinary shares of the Issuer); or

(iii) the Issuer or any Subsidiary redeems,

repurchases or otherwise acquires (in each case

directly or indirectly) any Junior Obligation.

The cases (ii) and (iii) above are subject to the proviso

that no Compulsory Settlement Event occurs if

(x) the Issuer or the relevant Subsidiary is obliged

under the terms and conditions of such Junior

Obligation to make such payment, such

redemption, such repurchase or such other

acquisition;

(y) the Issuer or the relevant Subsidiary repurchases

or otherwise acquires (in each case directly or


-----

Gattung der Emittentin oder eine Nachrangige

Verbindlichkeit nach Maßgabe eines

bestehenden oder zukünftigen Aktienoptions
oder Aktienbeteiligungsprogramms oder

ähnlichen Programms für Mitglieder des

Vorstands oder des Aufsichtsrats (oder, im Falle

verbundener Unternehmen, ähnlicher Gremien)

oder Mitarbeiter der Emittentin oder mit ihr

verbundener Unternehmen (jeweils direkt oder

indirekt) zurückkauft oder anderweitig erwirbt;

oder

(z) die betreffenden Zahlungen auf oder in Bezug

auf Nachrangige Verbindlichkeiten

Konzerninterne Zahlungen sind.

"Konzerninterne Zahlungen" sind Zahlungen, die

ausschließlich von einer Tochtergesellschaft an die

Emittentin und/oder von einer Tochtergesellschaft an

andere Tochtergesellschaften erfolgen.

**§ 5**

**RÜCKZAHLUNG**

(1) _Rückzahlung bei Endfälligkeit. Soweit nicht vorzeitig_

zurückgezahlt oder angekauft und entwertet, werden

die Schuldverschreibungen am 25. März 2082 (der

"Endfälligkeitstag") zu ihrer festgelegten Stückelung

zuzüglich Aufgeschobener Zinszahlungen

zurückgezahlt.


indirectly) any share of any class of the Issuer or

any Junior Obligation pursuant to the

obligations of the Issuer under any existing or

future stock option or stock ownership

programme or similar programme for any

members of the board of management or

supervisory board (or, in the case of affiliates,

comparable boards) or employees of the Issuer

or any of its affiliates; or

(z) the relevant payments on, or in respect of, any

Junior Obligation are Intra-Group Payments.

"Intra-Group Payments" means payments made by a

Subsidiary to the Issuer and/or by one Subsidiary to

another.

**§ 5**

**REDEMPTION**

(1) _Redemption at Maturity. Unless redeemed or_

purchased and cancelled earlier, the Notes will be

redeemed on 25 March 2082 (the "Maturity Date") at

their Specified Denomination plus any Arrears of

Interest.


(2) _Vorzeitige Rückzahlung nach Wahl der Emittentin._ (2) _Early Redemption at the Option of the Issuer._


(a) Die Emittentin kann die Schuldverschreibungen

(insgesamt, jedoch nicht teilweise) mit Wirkung

(i) zu jedem Tag während des Zeitraums ab dem

25. Juni 2027 (der "Erste **Optionale**

**Rückzahlungstag") bis zum Ersten Reset-**

Termin (jeweils einschließlich) und (ii) zu

jedem danach folgenden Zinszahlungstag nach

unwiderruflicher Kündigungsmitteilung an die

Gläubiger gemäß § 13 unter Einhaltung einer

Frist von mindestens 10 und nicht mehr als 40

Geschäftstagen kündigen.

(b) Eine solche Kündigungsmitteilung verpflichtet

die Emittentin, jede ausstehende

Schuldverschreibung an dem in der

Bekanntmachung festgelegten Rückzahlungstag

zu ihrer festgelegten Stückelung zuzüglich bis

dem in der Bekanntmachung festgelegten

Rückzahlungstag (ausschließlich) aufgelaufener


(a) The Issuer may call and redeem the Notes (in

whole but not in part) with effect (i) as of any

day during the period from and including

25 June 2027 (the "First Optional Redemption

**Date") to and including the First Reset Date and**

(ii) on any Interest Payment Date thereafter upon

giving not less than 10 nor more than 40

Business Days' irrevocable notice of redemption

to the Holders in accordance with § 13.

(b) Such notice of redemption shall oblige the Issuer

to redeem each outstanding Note on the

redemption date specified in the notice at their

Specified Denomination plus interest accrued to

but excluding the redemption date specified in

the notice and any outstanding Arrears of

Interest.


-----

Zinsen sowie Aufgeschobener Zinszahlungen

zurückzuzahlen.

(3) _Andere_ _vorzeitige_ _Rückzahlungsereignisse._ Die

Emittentin ist berechtigt, durch Bekanntmachung

gemäß § 13 unter Einhaltung einer Frist von nicht

weniger als 10 und nicht mehr als 60 Tagen, die

Schuldverschreibungen (insgesamt und nicht nur

teilweise) jederzeit zu kündigen, falls eines der

folgenden vorzeitigen Rückzahlungsereignisse ein
getreten ist. Im Falle einer solchen Kündigung ist die

Emittentin verpflichtet, jede ausstehende

Schuldverschreibung an dem in der Bekanntmachung

festgelegten Rückzahlungstag zu ihrem Vorzeitigen

Rückzahlungsbetrag zuzüglich bis zu dem in der

Bekanntmachung festgelegten Rückzahlungstag

(ausschließlich) aufgelaufener Zinsen sowie

Aufgeschobener Zinszahlungen zurückzuzahlen. Die

Bekanntmachung hat die zugrundeliegenden

Tatsachen des Rechts der Emittentin auf vorzeitige

Rückzahlung und den Rückzahlungstag anzugeben.


(3) _Other Early Redemption Events. The Issuer may, upon_

giving not less than 10 nor more than 60 days' notice

pursuant to § 13, call the Notes for redemption (in

whole but not in part) at any time, if any of the early

redemption events as set forth below has occurred. In

this case the Issuer shall redeem each outstanding Note

on the redemption date specified in the notice at its

Early Redemption Amount plus interest accrued to but

excluding the redemption date specified in the notice

and any Arrears of Interest. The notice shall set forth

the underlying facts of the Issuer's right to early

redemption and specify the redemption date.


(a) Ein "Ratingereignis" tritt ein, wenn entweder: (a) A "Rating Event" shall occur if either:


(i) eine Ratingagentur eine Veränderung in

der Methodologie für Hybridkapital oder

der Interpretation dieser Methodologie

veröffentlicht, wodurch entweder (x) die

Schuldverschreibungen nicht mehr länger

in derselben oder einer höheren

Eigenkapitalanrechnung (oder eine

vergleichbare Beschreibung, die von der

Ratingagentur in Zukunft genutzt wird,

um zu beschreiben in wieweit die

Bedingungen eines Instruments die

vorrangigen Verbindlichkeiten der

Emittentin unterstützen) (die

"Eigenkapitalanrechnung") wie an dem

Tag der Begebung der

Schuldverschreibungen einzuordnen sind

oder, wenn keine Eigenkapitalanrechnung

am Tag der Begebung der

Schuldverschreibungen von der

Ratingagentur bestimmt wurde, an dem

Tag, an dem erstmals die

Eigenkapitalanrechnung von der

Ratingagentur bestimmt wird (ein

"Verlust **der**

**Eigenkapitalanrechnung")** (dies gilt

auch für den Fall, dass die

Schuldverschreibungen nach deren Tag


(i) any Rating Agency publishes a change in

hybrid capital methodology or the

interpretation thereof, as a result of which

change, either, (x) the Notes would no

longer be eligible for the same or a higher

category of "equity credit" or such similar

nomenclature as may be used by that

Rating Agency from time to time to

describe the degree to which the terms of

an instrument are supportive of the

Issuer's senior obligations (the "equity

**credit"), attributed to the Notes at the date**

of issue of the Notes, or if "equity credit"

is not assigned on the date of issue of the

Notes by such Rating Agency, at the date

when the equity credit is assigned for the

first time by such Rating Agency (a "Loss

**in Equity Credit") (this also applies if the**

Notes have been partially or fully re
financed since the date of issue of the

Notes (or the date when the equity credit

is assigned for the first time by such

Rating Agency, as the case may be) and a

Loss in Equity Credit would have also

been occurred as a result of such change

had the Notes not been re-financed), or

(y) the period of time the Notes are


-----

der Begebung (bzw. dem Tag, an dem

erstmals die Eigenkapitalanrechnung von

der Ratingagentur bestimmt wird)

teilweise oder insgesamt refinanziert

wurden und der Verlust der

Eigenkapitalanrechnung aufgrund der

Veränderung auch eingetreten wäre, wenn

die Refinanzierung nicht zuvor erfolgt

wäre), oder (y) der Zeitraum, für die die

Schuldverschreibungen in derselben oder

einer höheren Eigenkapitalanrechnung

wie an dem Tag der Begebung der

Schuldverschreibungen (bzw. dem Tag,

an dem erstmals die

Eigenkapitalanrechnung von der

Ratingagentur bestimmt wird)

einzuordnen sind, verkürzt wird (eine

"Verkürzung **der**

**Eigenkapitalanrechnung"), oder**

(ii) die Emittentin eine schriftliche

Bestätigung von einer Ratingagentur

erhalten und diese an die Hauptzahlstelle

in Kopie weitergegeben hat, oder die

Ratingagentur eine Veröffentlichung

veranlasst hat, welche besagt, dass

aufgrund einer Änderung der

Methodologie für Hybridkapital oder der

Interpretation dieser Methodologie, ein

Verlust der Eigenkapitalanrechnung oder

eine Verkürzung der

Eigenkapitalanrechnung erfolgt ist,

und die Emittentin die Gläubiger über das

Ratingereignis gemäß § 13 informiert hat bevor

die Mitteilung der Rückzahlung (wie oben

beschrieben) bekanntgemacht wurde.

"Ratingagentur" bezeichnet jeweils Moody's,

S&P und Fitch, wobei "Moody's" die Moody's

Investors Service Ltd oder eine ihrer

Nachfolgegesellschaften bezeichnet, "S&P" die

S&P Global Ratings Europe Limited bezeichnet

und "Fitch" die Fitch Ratings Limited oder eine

ihrer Nachfolgegesellschaften bezeichnet, oder

eine andere durch die Emittentin bezeichnete

Ratingagentur mit gleichwertiger internationaler

Anerkennung sowie jeweils ihre Tochter- oder

Nachfolgegesellschaften.

(b) Ein "Steuerereignis" tritt ein, wenn die

Emittentin ein Gutachten einer international


eligible for the same or a higher category

of equity credit attributed to the Notes at

the date of issue of the Notes (or the date

when the equity credit is assigned for the

first time by such Rating Agency, as the

case may be) is being shortened (a

"Shortening in Equity Credit"), or

(ii) the Issuer has received, and has provided

the Principal Paying Agent with a copy of,

a written confirmation from any Rating

Agency or an official publication by such

Rating Agency that due to a change in

hybrid capital methodology or the

interpretation thereof, a Loss in Equity

Credit or a Shortening in Equity Credit

occurred,

and the Issuer has given notice to the Holders in

accordance with § 13 of such Rating Event prior

to giving the notice of redemption referred to

above.

"Rating Agency" means each of Moody's, S&P

and Fitch, where "Moody's" means Moody's

Investors Service Ltd or any of its successors,

"S&P" means S&P Global Ratings Europe

Limited and "Fitch" means Fitch Ratings

Limited or any of its successors, or any other

rating agency of equivalent international

standing specified from time to time by the

Issuer and, in each case their respective

subsidiaries or successors.

(b) A "Tax Deductibility Event" shall occur if an

opinion of a recognized law firm of international


-----

anerkannten Rechtsanwaltskanzlei erhalten hat,

aus dem hervorgeht, dass nach dem

Zinslaufbeginn als Folge einer Änderung von

deutschem Recht oder dessen offizieller

Auslegung oder Anwendung die steuerliche

Behandlung dergestalt geändert wurde, dass der

Zinsaufwand der Emittentin in Bezug auf die

Schuldverschreibungen für Zwecke der

Körperschaftsteuer nicht mehr vollständig

abzugsfähig ist, und die Emittentin dieses Risiko

nicht durch das Ergreifen zumutbarer

Maßnahmen vermeiden kann. Klarstellend sei

erwähnt, dass als eine Änderung auch eine

offizielle Auslegung oder Anwendung gilt, die

zum ersten Mal öffentlich bekannt geworden ist.

(c) Ein "Gross-up-Ereignis" tritt ein, wenn die

Emittentin als Folge einer Änderung von

deutschen Gesetzen oder veröffentlichten

Vorschriften nach dem Zinslaufbeginn

verpflichtet ist, sämtliche gemäß § 8 zahlbaren

zusätzlichen Beträge zu zahlen, allerdings nur

soweit die Emittentin die Zahlungsverpflichtung

nicht durch das Ergreifen zumutbarer

Maßnahmen vermeiden kann, die sie nach Treu

und Glauben für angemessen hält.

(d) Der "Vorzeitige **Rückzahlungsbetrag"**

bezeichnet (i) im Falle eines Ratingereignisses

oder eines Steuerereignisses, an dem der

maßgebliche für die Rückzahlung festgelegte

Tag vor dem Ersten Optionalen

Rückzahlungstag fällt, 101% der festgelegten

Stückelung, und (ii) im Falle eines

Ratingereignisses oder eines Steuerereignisses,

an dem der maßgebliche für die Rückzahlung

festgelegte Tag auf den oder nach dem Ersten

Optionalen Rückzahlungstag fällt und im Falle

eines Gross-up-Ereignisses, 100% der

festgelegten Stückelung.

(4) _Vorzeitige_ _Rückzahlung bei geringem ausstehendem_

_Gesamtnennbetrag._ Die Emittentin ist berechtigt,

durch Bekanntmachung gemäß § 13 unter Einhaltung

einer Frist von nicht weniger als 10 und nicht mehr als

60 Tagen, die Schuldverschreibungen (insgesamt und

nicht nur teilweise) jederzeit zu kündigen, falls

mindestens 75 % des ursprünglich begebenen

Gesamtnennbetrages der Schuldverschreibungen

(einschließlich Schuldverschreibungen, die gemäß

§ 12(1) zusätzlich begeben worden sind)


standing has been delivered to the Issuer, stating

that by reason of a change in German law or

regulation, or any change in the official

application or interpretation of such law, after

the Interest Commencement Date, the tax

regime is modified and such modification results

in the interest expense of the Issuer in respect of

the Notes being no longer fully deductible for

corporate income tax purposes, and such risk

cannot be avoided by the Issuer taking

reasonable measures available to it. For the

avoidance of doubt, a change shall also be

deemed to be an official interpretation or

application that has become publicly known for

the first time.

(c) A "Gross-up Event" shall occur if, by reason of

any change in German law or published

regulations becoming effective after the Interest

Commencement Date, the Issuer would have to

pay any additional amounts which may be

payable under § 8, provided that the payment

obligation cannot be avoided by the Issuer

taking such reasonable measures it (acting in

good faith) deems appropriate.

(d) The "Early Redemption Amount" shall be (i)

in case of a Rating Event or a Tax Deductibility

Event where the relevant date fixed for

redemption falls prior to the First Optional

Redemption Date, equal to 101 per cent. of the

Specified Denomination, and (ii) in the case of a

Rating Event or a Tax Deductibility Event where

the relevant date fixed for redemption falls on or

after the First Optional Redemption Date or in

case of a Gross-Up Event, equal to 100 per cent.

of the Specified Denomination.

(4) _Early Redemption in Case of Minimum Outstanding_

_Aggregate Principal Amount. The Issuer may, upon_

giving not less than 10 nor more than 60 days' notice

pursuant to § 13, call the Notes for redemption (in

whole but not in part) at any time if at least 75 per cent.

of the originally issued aggregate principal amount of

the Notes (including any Notes additionally issued in

accordance with § 12(1)) have been redeemed or

purchased and cancelled. In this case the Issuer shall

redeem each outstanding Note on the redemption date


-----

zurückgezahlt oder erworben und eingezogen worden

sind. Im Falle einer solchen Kündigung ist die

Emittentin verpflichtet, jede ausstehende

Schuldverschreibung an dem in der Bekanntmachung

festgelegten Rückzahlungstag zu ihrer festgelegten

Stückelung zuzüglich bis zu dem in der

Bekanntmachung festgelegten Rückzahlungstag

(ausschließlich) aufgelaufener Zinsen sowie

Aufgeschobener Zinszahlungen zurückzuzahlen.

**§ 6**

**ZAHLUNGEN**

(1) (a) _Zahlungen auf Kapital. Zahlungen auf Kapital in_

Bezug auf die Schuldverschreibungen erfolgen

nach Maßgabe von § 6(2) an das Clearing

System oder gegebenenfalls dessen Order zur

Gutschrift auf den Konten der jeweiligen

Kontoinhaber des Clearing Systems.

(b) _Zahlung von Zinsen. Die Zahlung von Zinsen_

auf Schuldverschreibungen erfolgt nach

Maßgabe von § 6(2) an das Clearing System

oder gegebenenfalls dessen Order zur Gutschrift

auf den Konten der jeweiligen Kontoinhaber des

Clearing Systems.

Die Zahlung von Zinsen auf Schuldverschreibungen,

die durch die vorläufige Globalurkunde verbrieft sind,

erfolgt nach Maßgabe von § 6(2) an das Clearing

System oder gegebenenfalls dessen Order zur

Gutschrift auf den Konten der jeweiligen

Kontoinhaber des Clearing Systems, und zwar nach

ordnungsgemäßer Bescheinigung gemäß § 1(3)(b).

(2) _Zahlungsweise. Vorbehaltlich geltender steuerlicher_

und sonstiger gesetzlicher Regelungen und

Vorschriften erfolgen zu leistende Zahlungen auf die

Schuldverschreibungen in der festgelegten Währung.

(3) _Vereinigte Staaten. Für die Zwecke des § 1(3) und_

§ 6(1) bezeichnet "Vereinigte **Staaten"** die

Vereinigten Staaten von Amerika (einschließlich deren

Bundesstaaten und des District of Columbia) sowie

deren Territorien (einschließlich Puerto Rico, der U.S.

Virgin Islands, Guam, American Samoa, Wake Island

und Northern Mariana Islands).

(4) _Erfüllung._ Die Emittentin wird durch Leistung der

Zahlung an das Clearing System oder dessen Order

von ihrer Zahlungspflicht befreit.


specified in the notice at its Specified Denomination

plus interest accrued to but excluding the redemption

date specified in the notice and any Arrears of Interest.

**§ 6**

**PAYMENTS**

(1) (a) _Payment of Principal. Payment of principal in_

respect of Notes shall be made, subject to § 6(2),

to the Clearing System or (if applicable) to its

order for credit to the accounts of the relevant

account holders of the Clearing System.

(b) _Payment of Interest. Payment of interest on_

Notes shall be made, subject to § 6(2), to the

Clearing System or (if applicable) to its order for

credit to the relevant account holders of the

Clearing System.

Payment of interest on Notes represented by the

Temporary Global Note shall be made, subject to

§ 6(2), to the Clearing System or (if applicable) to its

order for credit to the relevant account holders of the

Clearing System, upon due certification as provided in

§ 1(3)(b).

(2) _Manner of Payment. Subject to applicable fiscal and_

other laws and regulations, payments of amounts due

in respect of the Notes shall be made in the Specified

Currency.

(3) _United States. For purposes of § 1(3) and § 6(1),_

"United States" means the United States of America

(including the States thereof and the District of

Columbia) and its possessions (including Puerto Rico,

the U.S. Virgin Islands, Guam, American Samoa,

Wake Island and Northern Mariana Islands).

(4) _Discharge. The Issuer shall be discharged by payment_

to, or to the order of, the Clearing System.


-----

(5) _Zahltag._ Fällt der Fälligkeitstag einer Zahlung in

Bezug auf eine Schuldverschreibung auf einen Tag,

der kein Geschäftstag ist, dann hat der Gläubiger

keinen Anspruch auf Zahlung vor dem nächsten

Geschäftstag. Der Gläubiger ist nicht berechtigt,

weitere Zinsen oder sonstige Zahlungen aufgrund

dieser Verspätung zu verlangen.

(6) _Bezugnahmen auf Kapital und Zinsen. Bezugnahmen_

in diesen Anleihebedingungen auf einen Kapitalbetrag

der Schuldverschreibungen schließen, soweit

anwendbar, die folgenden Beträge ein: die festgelegte

Stückelung der Schuldverschreibungen, den

Vorzeitigen Rückzahlungsbetrag sowie sonstige auf

oder in Bezug auf die Schuldverschreibungen

zahlbaren Beträge. Bezugnahmen in diesen

Anleihebedingungen auf Zinsen auf die

Schuldverschreibungen sollen, soweit anwendbar,

sämtliche gemäß § 8 zahlbaren zusätzlichen Beträge

einschließen.

(7) _Hinterlegung von Kapital und Zinsen. Die Emittentin_

ist berechtigt, beim Amtsgericht Frankfurt am Main

Zins- oder Kapitalbeträge zu hinterlegen, die von den

Gläubigern nicht innerhalb von zwölf Monaten nach

dem jeweiligen Fälligkeitstag beansprucht worden

sind, auch wenn die Gläubiger sich nicht in

Annahmeverzug befinden. Soweit eine solche

Hinterlegung erfolgt, und auf das Recht der

Rücknahme verzichtet wird, erlöschen die Ansprüche

der Gläubiger gegen die Emittentin.

**§ 7**

**VERWALTUNGSSTELLEN**

(1) _Bestellung;_ _bezeichnete_ _Geschäftsstelle._ Die

anfänglich bestellte Hauptzahlstelle und die anfänglich

bestellte Berechnungsstelle und ihre bezeichneten

Geschäftsstellen lauten wie folgt:


(5) _Payment Business Day. If the date for payment of any_

amount in respect of any Note is not a Business Day

then the Holder shall not be entitled to payment until

the next day that is a Business Day and shall not be

entitled to further interest or other payment in respect

of such delay.

(6) _References to Principal and Interest. Reference in_

these Terms and Conditions to principal in respect of

the Notes shall be deemed to include, as applicable: the

Specified Denomination of the Notes, the Early

Redemption Amount and any other amounts which

may be payable under or in respect of the Notes.

Reference in these Terms and Conditions to interest in

respect of the Notes shall be deemed to include, as

applicable, any additional amounts which may be

payable under § 8.

(7) _Deposit of Principal and Interest. The Issuer may_

deposit with the _Amtsgericht in Frankfurt am Main_

principal or interest not claimed by Holders within

twelve months after the relevant due date, even though

such Holders may not be in default of acceptance of

payment. If and to the extent that the deposit is effected

and the right of withdrawal is waived, the respective

claims of such Holders against the Issuer shall cease.

**§ 7**

**AGENTS**

(1) _Appointment; Specified Offices. The initial Principal_

Paying Agent and the initial Calculation Agent and

their respective initial specified offices are:


Hauptzahlstelle: Principal Paying Agent:


**Deutsche Bank Aktiengesellschaft**

Taunusanlage 12

60325 Frankfurt am Main

Deutschland


**Deutsche Bank Aktiengesellschaft**

Taunusanlage 12

60325 Frankfurt am Main

Germany


Berechnungsstelle: Calculation Agent:


**Deutsche Bank Aktiengesellschaft**

Taunusanlage 12

60325 Frankfurt am Main

Deutschland


**Deutsche Bank Aktiengesellschaft**

Taunusanlage 12

60325 Frankfurt am Main

Germany


-----

Die Hauptzahlstelle und die Berechnungsstelle

behalten sich das Recht vor, jederzeit ihre

bezeichneten Geschäftsstellen durch eine andere

bezeichnete Geschäftsstelle in derselben Stadt zu

ersetzen.

(2) _Änderung der Bestellung oder Abberufung. Die_

Emittentin behält sich das Recht vor, jederzeit die

Bestellung der Hauptzahlstelle oder der

Berechnungsstelle zu ändern oder zu beenden und eine

andere Hauptzahlstelle, zusätzliche Zahlstellen oder

eine andere Berechnungsstelle zu bestellen. Die

Emittentin wird zu jedem Zeitpunkt (i) eine

Hauptzahlstelle unterhalten und (ii) eine

Berechnungsstelle unterhalten. Eine Änderung,

Abberufung, Bestellung oder ein sonstiger Wechsel

wird nur wirksam (außer im Insolvenzfall, in dem eine

solche Änderung sofort wirksam wird), sofern die

Gläubiger hierüber gemäß § 13 vorab unter Einhaltung

einer Frist von mindestens 30 und nicht mehr als 45

Tagen informiert wurden.

(3) _Beauftragte der Emittentin. Die Hauptzahlstelle und_

die Berechnungsstelle handeln ausschließlich als

Beauftragte der Emittentin und übernehmen keinerlei

Verpflichtungen gegenüber den Gläubigern und es

wird kein Auftrags- oder Treuhandverhältnis zwischen

ihnen und den Gläubigern begründet.

(4) Wenn die Emittentin gemäß § 3(5) einen

Unabhängigen Berater bestellt, dann ist § 7(3)

entsprechend auf den Unabhängigen Berater

anzuwenden.

**§ 8**

**STEUERN**

Sämtliche auf die Schuldverschreibungen zu zahlenden

Beträge sind an der Quelle ohne Einbehalt oder Abzug von

oder aufgrund von gegenwärtig oder zukünftig bestehenden

Steuern oder sonstigen Abgaben gleich welcher Art zu

leisten, die von oder in der Bundesrepublik Deutschland oder

für deren Rechnung oder von oder für Rechnung einer mit

dem Recht zur Steuererhebung versehenen politischen

Untergliederung oder Behörde der Vorgenannten auferlegt

oder erhoben werden (zusammen "Quellensteuer"), es sei

denn, dieser Einbehalt oder Abzug ist gesetzlich

vorgeschrieben. Wenn die Emittentin gesetzlich zu einem

Einbehalt oder Abzug von Quellensteuern verpflichtet ist,

wird die Emittentin diejenigen zusätzlichen Beträge zahlen,

die erforderlich sind, damit die den Gläubigern zufließenden

Nettobeträge nach diesem Einbehalt oder Abzug jeweils den


The Principal Paying Agent and the Calculation Agent

reserve the right at any time to change their respective

specified offices to some other specified offices in the

same city.

(2) _Variation or Termination of Appointment. The Issuer_

reserves the right at any time to vary or terminate the

appointment of the Principal Paying Agent or the

Calculation Agent and to appoint another Principal

Paying Agent, additional paying agents or another

Calculation Agent. The Issuer shall at all times

maintain (i) a Principal Paying Agent and (ii) a

Calculation Agent. Any variation, termination,

appointment or change shall only take effect (other

than in the case of insolvency, when it shall be of

immediate effect) after not less than 30 nor more than

45 days' prior notice thereof shall have been given to

the Holders in accordance with § 13.

(3) _Agents of the Issuer. The Principal Paying Agent and_

the Calculation Agent act solely as agents of the Issuer

and do not have any obligations towards or relationship

of agency or trust to any Holder.

(4) If the Issuer appoints an Independent Advisor in

accordance with § 3(5), § 7(3) shall apply mutatis

mutandis to the Independent Advisor.

**§ 8**

**TAXATION**

Principal and interest shall be payable without deduction or

withholding for or on account of any present or future taxes,

duties or governmental charges of any nature whatsoever

imposed, levied or collected by or on behalf of Germany or

by or on behalf of any political subdivision or authority

thereof having power to tax (together "Withholding

**Taxes"), unless such deduction or withholding is required by**

law. If the Issuer is required by law to make a deduction or

withholding of Withholding Taxes, the Issuer shall pay such

additional amounts as may be necessary in order that the net

amounts received by the Holders after such deduction or

withholding shall equal the respective amounts of principal

and interest which would have been receivable had no such

deduction or withholding been required. No such additional


-----

Beträgen an Kapital und Zinsen entsprechen, die ohne einen

solchen Abzug oder Einbehalt von den Gläubigern

empfangen worden wären. Die Verpflichtung zur Zahlung

solcher zusätzlicher Beträge besteht jedoch nicht im Hinblick

auf Steuern und Abgaben, die:

(a) anders als durch Einbehalt oder Abzug von Zahlungen

zu entrichten sind, die die Emittentin an den Gläubiger

leistet; oder

(b) von einer als Depotbank oder Inkassobeauftragter des

Gläubigers handelnden Person abgezogen oder

einbehalten werden oder sonst auf andere Weise zu

entrichten sind als dadurch, dass die Emittentin aus den

von ihr zu leistenden Zahlungen von Kapital oder

Zinsen einen Abzug oder Einbehalt vornimmt; oder

(c) von der Hauptzahlstelle oder einer zusätzlich bestellten

Zahlstelle abgezogen oder einbehalten werden, wenn

eine andere Zahlstelle die Zahlung ohne einen solchen

Abzug oder Einbehalt hätte leisten können; oder

(d) aufgrund (i) einer Richtlinie oder Verordnung der

Europäischen Union betreffend die Besteuerung von

Zinserträgen oder (ii) einer zwischenstaatlichen

Vereinbarung über deren Besteuerung, an der die

Bundesrepublik Deutschland oder die Europäische

Union beteiligt ist/sind, oder (iii) einer gesetzlichen

Vorschrift, die diese Richtlinie, Verordnung oder

Vereinbarung umsetzt oder befolgt, abzuziehen oder

einzubehalten sind; oder

(e) aufgrund einer Rechtsänderung zu zahlen sind, welche

später als 30 Tage nach Fälligkeit der betreffenden

Zahlung von Kapital oder Zinsen oder, wenn dies

später erfolgt, ordnungsgemäßer Bereitstellung aller

fälligen Beträge wirksam wird; oder

(f) wegen einer gegenwärtigen oder früheren persönlichen

oder geschäftlichen Beziehung des Gläubigers zu der

Bundesrepublik Deutschland oder weil der Gläubiger

in der Bundesrepublik Deutschland wohnhaft ist bzw.

für Zwecke der Besteuerung so behandelt wird oder

weil der Gläubiger gewünscht hat, so behandelt zu

werden oder weil der Gläubiger einen dauerhaften

Wohnsitz in der Bundesrepublik Deutschland (oder so

behandelt wird) oder in einem anderen Mitgliedstaat

der Europäischen Union hat zu zahlen sind. Dies gilt

jedoch nicht allein deshalb, weil Zahlungen auf die

Schuldverschreibungen aus Quellen in der

Bundesrepublik Deutschland stammen (oder für


amounts shall, however, be payable on account of any taxes,

duties or governmental charges which:

(a) are payable otherwise than by withholding or

deduction from payments made by the Issuer to the

Holder, or

(b) are deducted or withheld by any person acting as

custodian bank or collecting agent on behalf of a

Holder, or otherwise payable in any manner which

does not constitute a deduction or withholding by the

Issuer from payments of principal or interest made by

it; or

(c) are deducted or withheld by the Principal Paying Agent

or an additional paying agent from a payment if the

payment could have been made by another paying

agent without such deduction or withholding; or

(d) are deducted or withheld pursuant to (i) any European

Union Directive or Regulation concerning the taxation

of savings, or (ii) any international treaty or

understanding relating to such taxation and to which

Germany or the European Union is a party/are parties

or (iii) any provision of law implementing, or

complying with, or introduced to conform with, such

Directive, Regulation, treaty or understanding; or

(e) are payable by reason of a change in law that becomes

effective more than 30 days after the relevant payment

becomes due, or is duly provided for, whichever occurs

later; or

(f) are payable by reason of the Holder having, or having

had, some personal or business connection with

Germany or being a (deemed) resident of Germany or

is treated for tax purposes as a resident of Germany or

has elected to be taxed as a resident of Germany or the

Holder having a (deemed) permanent establishment in

Germany or another member state of the European

Union and not merely by reason of the fact that

payments in respect of the Notes are, or for purposes

of taxation are deemed to be, derived from sources in,

or are secured in, Germany.


-----

Zwecke der Besteuerung so behandelt werden) oder

dort besichert sind.

Ungeachtet sonstiger hierin enthaltener Bestimmungen, darf

die Emittentin Beträge, die gemäß einer beschriebenen

Vereinbarung in Section 1471 (b) des U.S. Revenue Code

von 1986 (der "Code") erforderlich sind oder die anderweitig

aufgrund der Sections 1471 bis 1474 des Codes (oder jeder

geänderten oder Nachfolgeregelung), der Regelungen oder

Verträge darunter, der offiziellen Auslegungen davon oder

jeglicher rechtsausführender und zwischenstaatlicher

Zusammenarbeit dazu beruhen, einbehalten oder abziehen

("FATCA Quellensteuer"). Die Emittentin ist aufgrund

einer durch die Emittentin, die Hauptzahlstelle, eine

zusätzlich bestellte Zahlstelle oder eine andere Partei

abgezogenen oder einbehaltenen FATCA Quellensteuer

nicht zur Zahlung zusätzlicher Beträge oder anderweitig zur

Entschädigung der Gläubiger verpflichtet.

**§ 9**

**VORLEGUNGSFRIST**

Die in § 801 Absatz 1 Satz 1 BGB bestimmte

Vorlegungsfrist wird für Ansprüche aus den

Schuldverschreibungen auf zehn Jahre verkürzt.

**§ 10**

**ERSETZUNG**

(1) _Ersetzung. Die Emittentin ist jederzeit berechtigt,_

sofern sie sich nicht mit einer Zahlung von Kapital

oder Zinsen auf die Schuldverschreibungen in Verzug

befindet, ohne Zustimmung der Gläubiger jede andere

Gesellschaft, deren stimmberechtigte Anteile zu mehr

als 90% direkt oder indirekt von der Emittentin

gehalten werden, an Stelle der Emittentin als

Hauptschuldnerin (die "Nachfolgeschuldnerin") für

alle Verpflichtungen aus und im Zusammenhang mit

dieser Emission einzusetzen, vorausgesetzt, dass:

(a) die Nachfolgeschuldnerin alle Verpflichtungen

der Emittentin in Bezug auf die

Schuldverschreibungen übernimmt;

(b) die Nachfolgeschuldnerin alle erforderlichen

Genehmigungen erhalten hat und berechtigt ist,

an die Hauptzahlstelle die zur Erfüllung der

Zahlungsverpflichtungen aus den

Schuldverschreibungen zahlbaren Beträge in

Euro zu zahlen, ohne verpflichtet zu sein,

jeweils in dem Land, in dem die

Nachfolgeschuldnerin ihren Sitz oder Steuersitz


Notwithstanding any other provisions contained herein, the

Issuer shall be permitted to withhold or deduct any amounts

required pursuant to an agreement described in Section 1471

(b) of the U.S. Internal Revenue Code of 1986 (the "Code")

or otherwise imposed pursuant to Sections 1471 through

1474 of the Code (or any amended or successor provisions),

any regulations or agreements thereunder, official

interpretations thereof, or any law implementing and

intergovernmental approach thereto ("FATCA

**withholding"). The Issuer will have no obligation to pay**

additional amounts or otherwise indemnify any Holder for

any such FATCA withholding deducted or withheld by the

Issuer, the Principal Paying Agent, an additional paying

agent or any other party.

**§ 9**

**PRESENTATION PERIOD**

The presentation period provided in § 801 paragraph 1,

sentence 1 BGB (German Civil Code) is reduced to ten years

for claims under the Notes.

**§ 10**

**SUBSTITUTION**

(1) _Substitution._ The Issuer may, without the consent of

the Holders, if no payment of principal of or interest

on any of the Notes is in default, at any time substitute

for the Issuer any other company more than 90 percent

of the voting share or other equity interests of which

are directly or indirectly owned by the Issuer as

principal debtor in respect of all obligations arising

from or in connection with the Notes (the "Substitute

**Debtor") provided that:**

(a) the Substitute Debtor assumes all obligations of

the Issuer in respect of the Notes;

(b) the Substitute Debtor has obtained all necessary

authorizations and may transfer to the Principal

Paying Agent in Euro and without being

obligated to deduct or withhold any taxes or

other duties of whatever nature levied by the

country in which the Substitute Debtor has its

domicile or tax residence, all amounts required


-----

hat, erhobene Steuern oder andere Abgaben

jeder Art abzuziehen oder einzubehalten;

(c) die Nachfolgeschuldnerin sich verpflichtet hat,

jeden Gläubiger hinsichtlich solcher

Quellensteuern, Abgaben oder behördlichen

Lasten freizustellen, die einem Gläubiger

bezüglich der Ersetzung auferlegt werden;

(d) die Emittentin unwiderruflich und unbedingt

gegenüber den Gläubigern die Zahlung aller von

der Nachfolgeschuldnerin auf die

Schuldverschreibungen zahlbaren Beträge auf

nachrangiger Basis garantiert; und

(e) der Hauptzahlstelle jeweils ein Rechtsgutachten

bezüglich der betroffenen Rechtsordnungen von

anerkannten Rechtsanwälten vorgelegt werden,

die bestätigen, dass die Bestimmungen in den

vorstehenden Unterabsätzen (a), (b), (c) und (d)

erfüllt wurden.

(2) _Bekanntmachung. Jede Ersetzung ist gemäß § 13_

bekanntzumachen.

(3) _Änderung von Bezugnahmen. Im Fall einer Ersetzung_

gilt jede Bezugnahme in diesen Anleihebedingungen

auf die Emittentin ab dem Zeitpunkt der Ersetzung als

Bezugnahme auf die Nachfolgeschuldnerin und jede

Bezugnahme auf das Land, in dem die Emittentin ihren

Sitz oder Steuersitz hat, gilt ab diesem Zeitpunkt als

Bezugnahme auf das Land, in dem die

Nachfolgeschuldnerin ihren Sitz oder Steuersitz hat.

Außerdem gilt im Falle der Ersetzung in § 8 und

§ 5(3)(b) und (c) eine alternative Bezugnahme auf die

Bundesrepublik Deutschland als aufgenommen

zusätzlich zu der Bezugnahme nach Maßgabe des

vorstehenden Satzes auf das Land, in dem die

Nachfolgeschuldnerin ihren Sitz oder Steuersitz hat.

Klarstellend sei erwähnt, dass dies nur gilt, soweit sich

nicht aus Sinn und Zweck der jeweiligen Bedingung

ergibt, dass die Bezugnahme entweder weiterhin nur

auf die Bayer AG erfolgen soll (also insbesondere im

Hinblick auf Ziffer (i) der Definition des Begriffs

Obligatorisches Nachzahlungsereignis und das

Ratingereignis), oder dass die Bezugnahme auf die

Nachfolgeschuldnerin und gleichzeitig auch auf die

Bayer AG, im Hinblick auf deren Verpflichtungen aus

der Garantie gemäß § 10(1)(d), erfolgen soll (Gross
up-Ereignis, Steuerereignis und § 8).


for the fulfilment of the payment obligations

arising under the Notes;

(c) the Substitute Debtor has agreed to indemnify

and hold harmless each Holder against any

withholding tax, duty, assessment or

governmental charge imposed on such Holder in

respect of such substitution;

(d) the Issuer irrevocably and unconditionally

guarantees on a subordinated basis in favour of

each Holder the payment of all sums payable by

the Substitute Debtor in respect of the Notes;

and

(e) there shall have been delivered to the Principal

Paying Agent an opinion or opinions of lawyers

of recognized standing to the effect that

subparagraphs (a), (b), (c) and (d) above have

been satisfied.

(2) _Notice. Notice of any such substitution shall be_

published in accordance with § 13.

(3) _Change of References._ In the event of any such

substitution, any reference in these Terms and

Conditions to the Issuer shall from then on be deemed

to refer to the Substitute Debtor and any reference to

the country in which the Issuer is domiciled or resident

for taxation purposes shall from then on be deemed to

refer to the country of domicile or residence for

taxation purposes of the Substitute Debtor.

Furthermore, in the event of such substitution, in § 8

and § 5(3)(b) and (c) an alternative reference to

Germany shall be deemed to have been included in

addition to the reference according to the preceding

sentence to the country of domicile or residence for

taxation purposes of the Substitute Debtor.

For the avoidance of doubt this will apply only to the

extent that the meaning and purpose of the relevant

condition requires that the relevant reference will

continue to be a reference only to Bayer AG (i.e. in

particular in relation to clause (i) of the definition of

the term Compulsory Settlement Event and the Rating

Event), or that the reference will be to the Substitute

Debtor and Bayer AG, in relation to Bayer AG's

obligations under the guarantee pursuant to § 10(1)(d),

at the same time (Gross-up Event, Tax Deductibility

Event and § 8).


-----

Die Emittentin ist berechtigt, die Globalurkunde und

die Anleihebedingungen ohne Zustimmung der

Gläubiger anzupassen, soweit dies erforderlich ist, um

die Wirkungen der Ersetzung nachzuvollziehen.

Entsprechend angepasste Globalurkunden oder

Anleihebedingungen werden bei dem oder für das

Clearing System hinterlegt.

**§ 11**

**ÄNDERUNG DER ANLEIHEBEDINGUNGEN,**

**GEMEINSAMER VERTRETER**

(1) _Änderung der Anleihebedingungen. Die Emittentin_

kann mit Zustimmung der Gläubiger entsprechend den

Bestimmungen des Gesetzes über Schuldverschrei
bungen aus Gesamtemissionen (Schuldverschrei
bungsgesetz – "SchVG") die Anleihebedingungen

hinsichtlich eines nach dem SchVG zugelassenen

Gegenstands ändern. Die Gläubiger entscheiden über

ihre Zustimmung durch einen Beschluss mit der in

§ 11(2) bestimmten Mehrheit. Die

Mehrheitsbeschlüsse der Gläubiger sind für alle

Gläubiger gleichermaßen verbindlich. Ein

Mehrheitsbeschluss der Gläubiger, der nicht gleiche

Bedingungen für alle Gläubiger vorsieht, ist

unwirksam, es sei denn, die benachteiligten Gläubiger

stimmen ihrer Benachteiligung ausdrücklich zu.

(2) _Mehrheitserfordernisse. Die Gläubiger entscheiden_

mit einer Mehrheit von 75 % der an der Abstimmung

teilnehmenden Stimmrechte. Beschlüsse, durch

welche der wesentliche Inhalt der Anleihebedingungen

nicht geändert wird, und die keinen Gegenstand des § 5

Absatz 3 Nr. 1 bis Nr. 8 und (soweit § 10 dieser

Anleihebedingungen keine andere Regelung vorsieht)

Nr. 9 des SchVG betreffen, bedürfen zu ihrer

Wirksamkeit einer einfachen Mehrheit der an der

Abstimmung teilnehmenden Stimmrechte.

(3) _Abstimmung ohne Versammlung. Alle Abstimmungen_

werden, vorbehaltlich des nächsten Satzes,

ausschließlich im Wege der Abstimmung ohne

Versammlung durchgeführt. Eine

Gläubigerversammlung und eine Übernahme der

Kosten für eine solche Versammlung durch die

Emittentin finden ausschließlich im Fall des § 18

Absatz 4 Satz 2 SchVG statt. Die Gegenstände und

Vorschläge zur Beschlussfassung sowie nähere

Angaben zu den Abstimmungsmodalitäten werden den

Gläubigern mit der Aufforderung zur Stimmabgabe

bekannt gemacht. Die Ausübung der Stimmrechte ist


The Issuer is authorized to adapt the global note and

the Terms and Conditions without the consent of the

Holders to the extent necessary to reflect the changes

resulting from the substitution. Appropriately adjusted

global notes or Terms and Conditions will be deposited

with or on behalf of the Clearing System.

**§ 11**

**AMENDMENT OF THE TERMS AND CONDITIONS,**

**HOLDERS' REPRESENTATIVE**

(1) _Amendment of the Terms and Conditions. In_

accordance with the Act on Debt Securities of 2009

(Gesetz _über_ _Schuldverschreibungen_ _aus_

_Gesamtemissionen_ _(Schuldverschreibungsgesetz_ –

"SchVG")) the Issuer may, with the consent of the

Holders, amend the Terms and Conditions with regard

to matters permitted by the SchVG. The Holders'

consent to such amendments is given by resolution

with the majority specified in § 11(2). Majority

resolutions shall be binding on all Holders.

Resolutions which do not provide for identical

conditions for all Holders are void, unless Holders who

are disadvantaged have expressly consented to their

being treated disadvantageously.

(2) _Majority. Resolutions shall be passed by a majority of_

not less than 75 per cent. of the votes cast. Resolutions

relating to amendments of the Terms and Conditions

which are not material and which do not relate to the

matters listed in § 5(3) No. 1 – 8 and (if § 10 of these

Terms and Conditions does not provide otherwise) No.

9 of the SchVG require a simple majority of the votes

cast.

(3) _Vote without a meeting. All votes will be taken, subject_

to the next sentence, exclusively by vote taken without

a meeting. A meeting of Holders and the assumption

of the fees by the Issuer for such a meeting will only

take place in the circumstances of § 18(4) sentence 2

of the SchVG. The subject matter of the vote as well as

the proposed resolutions and further information on

voting procedures shall be notified to the Holders

together with the request for voting. The exercise of

voting rights is subject to the Holders' registration. The

registration must be received at the address stated in

the request for voting no later than the third day


-----

von einer vorherigen Anmeldung der Gläubiger

abhängig. Die Anmeldung muss unter der in der

Aufforderung zur Stimmabgabe mitgeteilten Adresse

spätestens am dritten Tag vor Beginn des

Abstimmungszeitraums zugehen. Mit der Anmeldung

müssen die Gläubiger ihre Berechtigung zur

Teilnahme an der Abstimmung durch einen in

Textform erstellten besonderen Nachweis der

Depotbank gemäß § 14(3)(i)(a) und (b) und durch

Vorlage eines Sperrvermerks der Depotbank, aus dem

hervorgeht, dass die betreffenden

Schuldverschreibungen ab dem Tag der Absendung

der Anmeldung (einschließlich) bis zum letzten Tag

des Abstimmungszeitraums (einschließlich) nicht

übertragbar sind, nachweisen.

(4) _Zweite Versammlung. Wird für die Abstimmung ohne_

Versammlung gemäß § 11(3) die mangelnde

Beschlussfähigkeit festgestellt, kann der

Abstimmungsleiter eine zweite Versammlung im

Sinne von § 15 Absatz 3 Satz 3 SchVG einberufen. Die

Teilnahme an der zweiten Versammlung und die

Ausübung der Stimmrechte sind von einer vorherigen

Anmeldung der Gläubiger abhängig. Die Anmeldung

muss unter der in der Bekanntmachung der

Einberufung mitgeteilten Adresse spätestens am

dritten Tag vor der zweiten Versammlung zugehen.

Mit der Anmeldung müssen die Gläubiger ihre

Berechtigung zur Teilnahme an der Abstimmung

durch einen in Textform erstellten besonderen

Nachweis der Depotbank gemäß § 14(3)(i)(a) und (b)

und durch Vorlage eines Sperrvermerks der

Depotbank, aus dem hervorgeht, dass die betreffenden

Schuldverschreibungen ab dem Tag der Absendung

der Anmeldung (einschließlich) bis zum angegebenen

Ende der Versammlung (einschließlich) nicht

übertragbar sind, nachweisen.

(5) _Leitung der Abstimmung. Die Abstimmung wird von_

einem von der Emittentin beauftragten Notar oder,

falls der Gemeinsame Vertreter (wie in § 11(7)

definiert) zur Abstimmung aufgefordert hat, vom

Gemeinsamen Vertreter geleitet.

(6) _Stimmrecht. An Abstimmungen der Gläubiger nimmt_

jeder Gläubiger nach Maßgabe des Nennwerts oder des

rechnerischen Anteils seiner Berechtigung an den

ausstehenden Schuldverschreibungen teil.

(7) _Gemeinsamer Vertreter. Die Gläubiger können durch_

Mehrheitsbeschluss zur Wahrnehmung ihrer Rechte

einen gemeinsamen Vertreter für alle Gläubiger


preceding the beginning of the voting period. As part

of the registration, Holders must demonstrate their

eligibility to participate in the vote by means of a

special confirmation of the Custodian in accordance

with § 14(3)(i)(a) and (b) hereof in text form and by

submission of a blocking instruction by the Custodian

stating that the relevant Notes are not transferable from

and including the day such registration has been sent

until and including the day the voting period ends.

(4) _Second Meeting. If it is ascertained that no quorum_

exists for the vote without a meeting pursuant to

§ 11(3), the scrutineer (Abstimmungsleiter) may

convene a second meeting within the meaning of

section 15 paragraph 3 sentence 3 of the SchVG.

Attendance at the second meeting and exercise of

voting rights is subject to the Holders' registration. The

registration must be received at the address stated in

the convening notice no later than the third day

preceding the second meeting. As part of the

registration, Holders must demonstrate their eligibility

to participate in the vote by means of a special

confirmation of the Custodian in accordance with

§ 14(3)(i)(a) and (b) hereof in text form and by

submission of a blocking instruction by the Custodian

stating that the relevant Notes are not transferable from

and including the day such registration has been sent

until and including the stated end of the meeting.

(5) _Chair of the vote. The vote will be chaired by a notary_

appointed by the Issuer or, if the Holders'

Representative (as defined in § 11(7) below) has

convened the vote, by the Holders' Representative.

(6) _Voting rights. Each Holder participating in any vote_

shall cast votes in accordance with the nominal amount

or the notional share of its entitlement to the

outstanding Notes.

(7) _Holders' Representative. The Holders may by majority_

resolution appoint a common representative (the

"Holders' Representative") to exercise the Holders'


-----

bestellen (der "Gemeinsame Vertreter"). Der

Gemeinsame Vertreter hat die Aufgaben und

Befugnisse, welche ihm durch Gesetz oder von den

Gläubigern durch Mehrheitsbeschluss eingeräumt

wurden. Er hat die Weisungen der Gläubiger zu

befolgen. Soweit er zur Geltendmachung von Rechten

der Gläubiger ermächtigt ist, sind die einzelnen

Gläubiger zur selbständigen Geltendmachung dieser

Rechte nicht befugt, es sei denn, der

Mehrheitsbeschluss sieht dies ausdrücklich vor. Über

seine Tätigkeit hat der Gemeinsame Vertreter den

Gläubigern zu berichten. Für die Abberufung und die

sonstigen Rechte und Pflichten des Gemeinsamen

Vertreters gelten die Vorschriften des SchVG.

(8) _Garantie. Im Fall einer Schuldnerersetzung gemäß_

§ 10 gilt dieser § 11 entsprechend für Änderungen der

Garantie gemäß § 10(1)(d), und Änderungen der

Anleihebedingungen und der Garantie sind nur mit

Zustimmung der Nachfolgeschuldnerin und der Bayer

Aktiengesellschaft als Garantin zulässig.

**§ 12**

**BEGEBUNG WEITERER**

**SCHULDVERSCHREIBUNGEN,**

**ANKAUF UND ENTWERTUNG**

(1) _Begebung_ _weiterer_ _Schuldverschreibungen._ Die

Emittentin ist jederzeit berechtigt, ohne Zustimmung

der Gläubiger weitere Schuldverschreibungen mit den

gleichen Bedingungen (gegebenenfalls mit Ausnahme

des Tages der Begebung, des Zinslaufbeginns

und/oder des Ausgabepreises) in der Weise zu

begeben, dass sie mit den Schuldverschreibungen eine

einheitliche Emission bilden.

(2) _Ankauf. Die Emittentin ist berechtigt, jederzeit_

Schuldverschreibungen im Markt oder anderweitig zu

jedem beliebigen Preis zu kaufen. Die von der

Emittentin erworbenen Schuldverschreibungen

können nach Wahl der Emittentin von ihr gehalten,

weiterverkauft oder bei der Hauptzahlstelle zwecks

Entwertung eingereicht werden. Sofern diese Käufe

durch öffentliches Rückkaufangebot erfolgen, muss

dieses Angebot allen Gläubigern gleichermaßen

gemacht werden.

(3) _Entwertung. Sämtliche vollständig zurückgezahlten_

Schuldverschreibungen sind unverzüglich zu

entwerten und können nicht wiederbegeben oder

wiederverkauft werden.


rights on behalf of each Holder. The Holders'

Representative shall have the duties and powers

provided by law or granted by majority resolution of

the Holders. The Holders' Representative shall comply

with the instructions of the Holders. To the extent that

the Holders' Representative has been authorized to

assert certain rights of the Holders, the Holders shall

not be entitled to assert such rights themselves, unless

explicitly provided for in the relevant majority

resolution. The Holders' Representative shall provide

reports to the Holders on its activities. The regulations

of the SchVG apply with regard to the recall and the

other rights and obligations of the Holders'

Representative.

(8) _Guarantee._ In the event of a substitution pursuant to

§ 10, this § 11 shall apply _mutatis mutandis for any_

amendment of the guarantee pursuant to § 10(1)(d),

and the Terms and Conditions and such guarantee may

only be amended with the consent of the Substitute

Debtor and Bayer Aktiengesellschaft as guarantor.

**§ 12**

**FURTHER ISSUES, PURCHASES AND**

**CANCELLATION**

(1) _Further Issues._ The Issuer may from time to time,

without the consent of the Holders, issue further Notes

having the same terms and conditions as the Notes in

all respects (or in all respects except for the issue date,

interest commencement date and/or issue price) so as

to form a single issue with the Notes.

(2) _Purchases. The Issuer may at any time purchase Notes_

in the open market or otherwise and at any price. Notes

purchased by the Issuer may, at the option of the Issuer,

be held, resold or surrendered to the Principal Paying

Agent for cancellation. If purchases are made by public

tender, tenders for such Notes must be made available

to all Holders of such Notes alike.

(3) _Cancellation._ All Notes redeemed in full shall be

cancelled forthwith and may not be reissued or resold.


-----

**§ 13**

**MITTEILUNGEN**

(1) _Bekanntmachung. Alle die Schuldverschreibungen_

betreffenden Mitteilungen werden im Bundesanzeiger

veröffentlicht und erfolgen zusätzlich durch

elektronische Publikation auf der Website der

Luxemburger Börse (www.bourse.lu). Jede Mitteilung

gilt am dritten Tag nach dem Tag der Veröffentlichung

als wirksam erfolgt.

(2) _Mitteilungen an das Clearing System._ Solange

Schuldverschreibungen an der Offiziellen Liste der

Luxemburger Börse notiert sind, findet Absatz 1

Anwendung. Soweit die Regeln der Luxemburger

Börse dies sonst zulassen, kann die Emittentin eine

Veröffentlichung nach Absatz 1 durch eine Mitteilung

an das Clearing System zur Weiterleitung an die

Gläubiger ersetzen; jede derartige Mitteilung gilt am

siebten Tag nach dem Tag der Mitteilung an das

Clearing System als den Gläubigern mitgeteilt.

**§ 14**

**ANWENDBARES RECHT,**

**GERICHTSSTAND UND GERICHTLICHE**

**GELTENDMACHUNG**

(1) _Anwendbares_ _Recht._ Form und Inhalt der

Schuldverschreibungen sowie Pflichten der Emittentin

und Rechte der Gläubiger bestimmen sich in jeder

Hinsicht nach deutschem Recht.

(2) _Gerichtsstand._ Vorbehaltlich eines zwingend

vorgeschriebenen Gerichtsstands für bestimmte

Verfahren nach dem SchVG ist nicht ausschließlich

zuständig für sämtliche im Zusammenhang mit den

Schuldverschreibungen entstehenden Klagen oder

sonstige Verfahren ("Rechtsstreitigkeiten") das

Landgericht Frankfurt am Main.

(3) _Gerichtliche Geltendmachung. Jeder Gläubiger von_

Schuldverschreibungen ist berechtigt, in jedem

Rechtsstreit gegen die Emittentin oder in jedem

Rechtsstreit, in dem der Gläubiger und die Emittentin

Partei sind, seine Rechte aus diesen

Schuldverschreibungen im eigenen Namen auf der

folgenden Grundlage wahrzunehmen oder geltend zu

machen: (i) er bringt eine Bescheinigung der

Depotbank bei, bei der er für die

Schuldverschreibungen ein Wertpapierdepot unterhält,

welche (a) den vollständigen Namen und die


**§ 13**

**NOTICES**

(1) _Publication. All notices concerning the Notes shall be_

published in the Federal Gazette (Bundesanzeiger) and

in addition will be made by means of electronic

publication on the internet website of the Luxembourg

Stock Exchange (www.bourse.lu). Any notice so given

will be deemed to have been validly given on the third

day following the date of such publication.

(2) _Notification to Clearing System. So long as any Notes_

are listed on the Official List of the Luxembourg Stock

Exchange, subparagraph (1) shall apply. If the Rules of

the Luxembourg Stock Exchange otherwise so permit,

the Issuer may deliver the relevant notice to the

Clearing System for communication by the Clearing

System to the Holders, in lieu of publication as set

forth in subparagraph (1) above; any such notice shall

be deemed to have been validly given on the seventh

day after the day on which the said notice was given to

the Clearing System.

**§ 14**

**APPLICABLE LAW, PLACE OF JURISDICTION**

**AND ENFORCEMENT**

(1) _Applicable Law._ The Notes, as to form and content,

and all obligations of the Issuer and rights of the

Holders shall be governed by German law.

(2) _Submission to Jurisdiction. Subject to any mandatory_

jurisdiction for specific proceedings under the SchVG,

the District Court (Landgericht) in Frankfurt am Main

shall have non-exclusive jurisdiction for any action or

other legal proceedings ("Proceedings") arising out of

or in connection with the Notes.

(3) _Enforcement._ Any Holder of Notes may in any

proceeding against the Issuer, or to which such Holder

and the Issuer are parties, protect and enforce in its

own name its rights arising under such Notes on the

basis of (i) a statement issued by the Custodian (as

defined below) with whom such Holder maintains a

securities account in respect of the Notes (a) stating the

full name and address of the Holder, (b) specifying the

aggregate principal amount of Notes credited to such

securities account on the date of such statement and (c)

confirming that the Custodian has given written notice


-----

vollständige Adresse des Gläubigers enthält, (b) den

Gesamtnennbetrag der Schuldverschreibungen

bezeichnet, die unter dem Datum der Bestätigung auf

dem Wertpapierdepot verbucht sind und (c) bestätigt,

dass die Depotbank gegenüber dem Clearing System

eine schriftliche Erklärung abgegeben hat, die die

vorstehend unter (a) und (b) bezeichneten

Informationen enthält; und (ii) er legt eine Kopie der

die betreffenden Schuldverschreibungen

verbriefenden Globalurkunde vor, deren

Übereinstimmung mit dem Original eine

vertretungsberechtigte Person des Clearing Systems

oder des Verwahrers des Clearing Systems bestätigt

hat, ohne dass eine Vorlage der Originalbelege oder

der die Schuldverschreibungen verbriefenden

Globalurkunde in einem solchen Verfahren

erforderlich wäre. Für die Zwecke des Vorstehenden

bezeichnet "Depotbank" jede Bank oder ein sonstiges

anerkanntes Finanzinstitut, die bzw. das berechtigt ist,

das Wertpapierverwahrungsgeschäft zu betreiben und

bei der/dem der Gläubiger ein Wertpapierdepot für die

Schuldverschreibungen unterhält, einschließlich des

Clearing Systems. Unbeschadet des Vorstehenden

kann jeder Gläubiger seine Rechte aus den

Schuldverschreibungen auch auf jede andere Weise

schützen oder geltend machen, die im Land des

Rechtsstreits prozessual zulässig ist.

**§ 15**

**SPRACHE**

Diese Anleihebedingungen sind in deutscher Sprache

abgefasst. Eine Übersetzung in die englische Sprache ist

beigefügt. Der deutsche Text ist bindend und maßgeblich.

Die Übersetzung in die englische Sprache ist unverbindlich.


to the Clearing System containing the information

pursuant to (a) and (b); and (ii) a copy of the Note in

global form certified as being a true copy by a duly

authorized officer of the Clearing System or a

depository of the Clearing System, without the need

for production in such proceedings of the actual

records or the global note representing the Notes. For

purposes of the foregoing, "Custodian" means any

bank or other financial institution of recognized

standing authorized to engage in securities custody

business with which the Holder maintains a securities

account in respect of the Notes and includes the

Clearing System. Each Holder may, without prejudice

to the foregoing, protect and enforce its rights under

these Notes also in any other way which is admitted in

the country of the Proceedings.

**§ 15**

**LANGUAGE**

These Terms and Conditions are written in the German

language and provided with an English language translation.

The German text shall be controlling and binding. The

English language translation is provided for convenience

only.


-----

**Restrictions regarding the Redemption and Repurchase of the NC5.5 Notes**

The following paragraphs in italics do not form part of the Terms and Conditions of the NC5.5 Notes.

_The Issuer intends (without thereby assuming a legal or contractual obligation) at any time that it will redeem or repurchase the NC5.5_
_Notes only to the extent that the aggregate principal amount of NC5.5 Notes to be redeemed or repurchased does not exceed such part_
_of the net proceeds received by the Issuer or any Subsidiary of the Issuer on or prior to the date of such redemption or repurchase from_
_the sale or issuance by the Issuer or such Subsidiary to third parties of NC5.5 Notes which are assigned by S&P, at the time of sale or_
_issuance, an aggregate "equity credit" (or such similar nomenclature used by S&P from time to time) that is equal to or greater than_
_the "equity credit" assigned to the NC5.5 Notes to be redeemed or repurchased at the time of their issuance (but taking into account_
_any changes in hybrid capital methodology or another relevant methodology or the interpretation thereof since the issuance of the_
_NC5.5 Notes)._

_The following exceptions apply as to the Issuer's replacement intention. The NC5.5 Notes are not required to be replaced:_

_(i)_ _if the rating assigned by S&P to the Issuer is the same as or higher than the long-term corporate credit rating assigned to the_
_Issuer on the date when the most recent additional hybrid security was issued (excluding refinancings without net new issuance)_
_and the Issuer is comfortable that such rating would not fall below this level as a result of such redemption or repurchase, or_

_(ii)_ _in the case of repurchase or redemption of the NC5.5 Notes taken together with other repurchases or redemptions of hybrid_
_securities of the Issuer (as the case may be) which are less than (x) 10 per cent. of the aggregate principal amount of the Issuer's_
_outstanding hybrid securities in any period of 12 consecutive months or (y) 25 per cent. of the aggregate principal amount of_
_the Issuer's outstanding hybrid securities in any period of 10 consecutive years provided that in each case such repurchase or_
_redemption has no materially negative effect on the Issuer's credit profile, or_

_(iii) if the NC5.5 Notes are redeemed: (i) pursuant to a Rating Event, a Tax Deductibility Event, a Gross-Up Event, or (ii) in case of_

_a Minimum Outstanding Aggregate Principal Amount, or_

_(iv)_ _if the NC5.5 Notes are not assigned any category (not even minimal, except where minimal results due to effective remaining_
_maturity) of "equity credit" (or such similar nomenclature then used by S&P at the time of such redemption or repurchase), or_

_(v)_ _if such redemption or repurchase occurs on or after 25 September 2047._

_The replacement intention of the Issuer, including during the period of five years following the Interest Commencement Date, shall not_
_apply for repurchases of NC5.5 Notes with an aggregate amount up to the S&P Excess Amount. "S&P Excess Amount" means the_
_aggregate principal amount of outstanding hybrid capital of the Issuer exceeding the maximum aggregate principal amount of hybrid_
_capital for which S&P under its then prevailing methodology would recognize equity credit from time to time based on the Issuer's_
_adjusted total capitalization._


-----

### TERMS AND CONDITIONS OF THE NC8.5 NOTES

**Anleihebedingungen** **Terms and Conditions**


_Diese Anleihebedingungen sind in deutscher Sprache_

_abgefasst. Eine Übersetzung in die englische Sprache ist_

_beigefügt. Der deutsche Text ist bindend und maßgeblich._

_Die Übersetzung in die englische Sprache ist unverbindlich._

**§ 1**

**WÄHRUNG, STÜCKELUNG, FORM,**

**BEGRIFFSBESTIMMUNGEN**

(1) _Währung; Stückelung. Diese Emission von Schuld-_

verschreibungen (die "Schuldverschreibungen") der

Bayer Aktiengesellschaft (die "Emittentin") wird in

Euro (die "festgelegte **Währung")** im

Gesamtnennbetrag von Euro 800.000.000 (in Worten:

Euro achthundert Millionen) in Stückelungen von

Euro 100.000 (die "festgelegte Stückelung") begeben.

(2) _Form. Die Schuldverschreibungen lauten auf den_

Inhaber.


_These Terms and Conditions are written in the German_

_language and provided with an English language_

_translation. The German text shall be controlling and_

_binding. The English language translation is provided for_

_convenience only._

**§ 1**

**CURRENCY, DENOMINATION, FORM, CERTAIN**

**DEFINITIONS**

(1) _Currency; Denomination. This issue of notes (the_

"Notes") of Bayer Aktiengesellschaft (the "Issuer") is

being issued in Euro (the "Specified Currency") in

the aggregate principal amount of Euro 800,000,000

(in words: Euro eighthundred million) in

denominations of Euro 100,000 (the "Specified

**Denomination").**

(2) _Form. The Notes are being issued in bearer form._


(3) _Vorläufige Globalurkunde — Austausch._ (3) _Temporary Global Note — Exchange._


(a) Die Schuldverschreibungen sind anfänglich

durch eine vorläufige Globalurkunde (die

"vorläufige **Globalurkunde")** ohne

Zinsscheine verbrieft. Die vorläufige

Globalurkunde wird gegen

Schuldverschreibungen in den festgelegten

Stückelungen, die durch eine

Dauerglobalurkunde (die

"Dauerglobalurkunde" und zusammen mit der

vorläufigen Globalurkunde die

"Globalurkunden" und jede eine

"Globalurkunde") ohne Zinsscheine verbrieft

sind, ausgetauscht. Die vorläufige

Globalurkunde und die Dauerglobalurkunde

tragen jeweils die Unterschriften von zwei

ordnungsgemäß bevollmächtigten Vertretern

der Emittentin und sind jeweils von der

Hauptzahlstelle oder in deren Namen mit einer

Kontrollunterschrift versehen. Einzelurkunden

und Zinsscheine werden nicht ausgegeben.

(b) Die vorläufige Globalurkunde wird frühestens

an einem Tag (der "Austauschtag") gegen die

Dauerglobalurkunde austauschbar, der 40 Tage

nach dem Tag der Ausgabe der vorläufigen


(a) The Notes are initially represented by a

temporary global note (the "Temporary Global

**Note") without coupons. The Temporary Global**

Note will be exchangeable for Notes in

Specified Denominations represented by a

permanent global note (the "Permanent Global

**Note", and together with the Temporary Global**

Note, the "Global Notes" and each a "Global

**Note") without coupons. The Temporary Global**

Note and the Permanent Global Note shall each

be signed by two authorized signatories of the

Issuer and shall each be authenticated by or on

behalf of the Principal Paying Agent. Definitive

Notes and interest coupons will not be issued.

(b) The Temporary Global Note shall be

exchangeable for the Permanent Global Note

from a date (the "Exchange Date") 40 days after

the date of issue of the Temporary Global Note.


-----

Globalurkunde liegt. Ein solcher Austausch soll

nur nach Vorlage von Bescheinigungen gemäß

U.S. Steuerrecht erfolgen, wonach der oder die

wirtschaftlichen Eigentümer der durch die

vorläufige Globalurkunde verbrieften

Schuldverschreibungen keine U.S.-Personen

sind (ausgenommen bestimmte Finanzinstitute

oder bestimmte Personen, die

Schuldverschreibungen über solche

Finanzinstitute halten). Zinszahlungen auf durch

eine vorläufige Globalurkunde verbriefte

Schuldverschreibungen erfolgen erst nach

Vorlage solcher Bescheinigungen. Eine

gesonderte Bescheinigung ist hinsichtlich einer

jeden solchen Zinszahlung erforderlich. Jede

Bescheinigung, die am oder nach dem 40. Tag

nach dem Tag der Ausgabe der vorläufigen

Globalurkunde eingeht, wird als ein Ersuchen

behandelt, diese vorläufige Globalurkunde

gemäß diesem § 1(3)(b) auszutauschen.

Wertpapiere, die im Austausch für die

vorläufige Globalurkunde geliefert werden, sind

nur außerhalb der Vereinigten Staaten zu liefern

(wie in § 6(3) definiert).

(4) _Clearing System. Die die Schuldverschreibungen_

verbriefende Globalurkunde wird von einem oder im

Namen eines Clearing Systems verwahrt, bis sämtliche

Verbindlichkeiten der Emittentin aus den

Schuldverschreibungen erfüllt sind. "Clearing

**System" bedeutet jeweils folgendes: Clearstream**

Banking S.A., Luxemburg ("CBL") und Euroclear

Bank SA/NV Brüssel, als Betreiberin des Euroclear

Systems ("Euroclear") sowie jeder

Funktionsnachfolger.

Die Schuldverschreibungen werden in Form einer

Classical Global Note ausgegeben und von einer

gemeinsamen Verwahrstelle im Namen des Clearing

Systems verwahrt.

(5) _Gläubiger von Schuldverschreibungen._ "Gläubiger"

bezeichnet jeden Inhaber eines Miteigentumsanteils

oder anderen treugeberischen oder eigenen Rechts an

den Schuldverschreibungen.

**§ 2**

**STATUS**

(1) _Status. Die Schuldverschreibungen begründen nicht_

besicherte Verbindlichkeiten der Emittentin, die im


Such exchange shall only be made upon

delivery of certifications to the effect that the

beneficial owner or owners of the Notes

represented by the Temporary Global Note is

not a U.S. person (other than certain financial

institutions or certain persons holding Notes

through such financial institutions) as required

by U.S. tax law. Payment of interest on Notes

represented by a Temporary Global Note will be

made only after delivery of such certifications.

A separate certification shall be required in

respect of each such payment of interest. Any

such certification received on or after the 40th

day after the date of issue of the Temporary

Global Note will be treated as a request to

exchange such Temporary Global Note pursuant

to this § 1(3)(b). Any securities delivered in

exchange for the Temporary Global Note shall

be delivered only outside of the United States

(as defined in § 6(3)).

(4) _Clearing System. Each global note representing the_

Notes will be kept in custody by or on behalf of the

Clearing System until all obligations of the Issuer

under the Notes have been satisfied. "Clearing

**System" means each of the following: Clearstream**

Banking S.A., Luxembourg ("CBL") and Euroclear

Bank SA/NV Brussels as operator of the Euroclear

System ("Euroclear") and any successor in such

capacity.

The Notes are issued in classical global note form and

are kept in custody by a common depositary on behalf

of the Clearing System.

(5) _Holder of Notes._ "Holder" means any holder of a

proportionate co-ownership or other beneficial interest

or right in the Notes.

**§ 2**

**STATUS**

(1) _Status. The Issuer's obligations under the Notes_

constitute unsecured obligations of the Issuer and, in


-----

Fall der Abwicklung, Auflösung oder Liquidation der

Emittentin:

(i) nur Nachrangigen Verbindlichkeiten im Rang

vorgehen,

(ii) untereinander und mit Gleichrangigen

Verbindlichkeiten im Rang gleichstehen, und

(iii) allen anderen bestehenden und zukünftigen

nicht nachrangigen und nachrangigen

Verbindlichkeiten im Rang nachgehen, die nicht

Gleichrangige Verbindlichkeiten oder

Nachrangige Verbindlichkeiten sind.

Unter Beachtung dieser Nachrangregelung bleibt es

der Emittentin unbenommen, ihre Verbindlichkeiten

aus den Schuldverschreibungen auch aus dem

sonstigen freien Vermögen zu bedienen.


the event of the winding-up, dissolution or liquidation

of the Issuer rank:

(i) senior only to Junior Obligations,

(ii) _pari passu among themselves and with Parity_

Obligations, and

(iii) junior to all other present and future

unsubordinated or subordinated obligations of

the Issuer that are not Parity Obligations or

Junior Obligations.

Subject to this subordination provision, the Issuer may

satisfy its obligations under the Notes also from other

distributable assets (freies Vermögen) of the Issuer.


"Nachrangige Verbindlichkeiten" bezeichnet "Junior Obligations" means

(i) die Stammaktien der Emittentin, (i) the ordinary shares of the Issuer,


(ii) gegenwärtige oder zukünftige Aktien einer

anderen Gattung von Aktien der Emittentin, die

gleichrangig mit den Stammaktien der

Emittentin sind,

(iii) andere von der Emittentin begebene

gegenwärtige oder zukünftige Wertpapiere oder

andere Instrumente, bei denen die daraus

folgenden Verbindlichkeiten der Emittentin mit

den Stammaktien der Emittentin gleichrangig

sind oder für die ausdrücklich ein Gleichrang

festgelegt ist, und

(iv) jedes gegenwärtige oder zukünftige Wertpapier

oder jedes andere Instrument, das von einer

Tochtergesellschaft begeben und von der

Emittentin garantiert ist oder für das die

Emittentin die Haftung übernommen hat, und

bei dem die Verbindlichkeiten der Emittentin

aus der maßgeblichen Garantie oder

Haftungsübernahme mit den unter Ziffern (i)

und (ii) genannten Instrumenten gleichrangig

sind oder für die ausdrücklich ein Gleichrang

festgelegt ist.

"Gleichrangige **Verbindlichkeiten"** bezeichnet

bestehende und zukünftige Verbindlichkeiten der

Emittentin

(i) aus Wertpapieren oder anderen von der

Emittentin begebenen Instrumenten, die


(ii) any present or future shares of any other class of

shares of the Issuer ranking pari passu with the

ordinary shares of the Issuer,

(iii) any other present or future securities or other

instruments of the Issuer under which the

Issuer's obligations rank or are expressed to rank

_pari passu with the ordinary shares of the Issuer,_

and

(iv) any present or future security or other

instrument which is issued by a Subsidiary and

guaranteed by the Issuer or for which the Issuer

has otherwise assumed liability where the

Issuer's obligations under such guarantee or

other assumption of liability rank or are

expressed to rank _pari passu with the_

instruments described under clauses (i) and (ii).

"Parity Obligations" means any present or future

obligations of the Issuer

(i) under any securities or other instruments of the

Issuer which rank or are expressed to rank pari


-----

gleichrangig mit den Verbindlichkeiten der

Emittentin unter den Schuldverschreibungen

sind oder für die ausdrücklich ein Gleichrang

festgelegt ist, oder

(ii) aus einer Garantie oder anderen

Haftungsübernahmen der Emittentin für ein

gegenwärtiges oder zukünftiges Wertpapier

oder jedes andere Instrument, das von einer

Tochtergesellschaft begeben und von der

Emittentin garantiert ist oder für das die

Emittentin die Haftung übernommen hat, und

bei dem die Verbindlichkeiten der Emittentin

aus der maßgeblichen Garantie oder

Haftungsübernahme mit ihren

Verbindlichkeiten aus den

Schuldverschreibungen gleichrangig sind oder

ausdrücklich ein Gleichrang festgelegt ist,

soweit nicht zwingende gesetzliche Bestimmungen

solche anderen nachrangigen Verbindlichkeiten im

Rang besser stellen.

Gleichrangige Verbindlichkeiten sind, unter anderem,

die nicht besicherten nachrangigen

Schuldverschreibungen fällig in 2074, erstmals

kündbar in 2024, ISIN DE000A11QR73, die nicht

besicherten nachrangigen Schuldverschreibungen

fällig in 2075, erstmals kündbar in 2022,

ISIN DE000A14J611, die nicht besicherten

nachrangigen Schuldverschreibungen fällig in 2079,

erstmals kündbar in 2025, ISIN XS2077670003 und

die nicht besicherten nachrangigen

Schuldverschreibungen fällig in 2079, erstmals

kündbar in 2027, ISIN XS2077670342.

"Tochtergesellschaft" bezeichnet jede Gesellschaft,

Personengesellschaft und jedes sonstige Unternehmen

oder jede andere Person an der bzw. dem die

Emittentin direkt oder indirekt insgesamt mehr als

50 % des Kapitals oder der Stimmrechte hält.

(2) _Aufrechnungsverbot._ Die Gläubiger sind nicht

berechtigt, Forderungen aus den

Schuldverschreibungen gegen mögliche Forderungen

der Emittentin aufzurechnen. Die Emittentin ist nicht

berechtigt, Forderungen gegenüber Gläubigern gegen

Verpflichtungen aus den Schuldverschreibungen

aufzurechnen.


_passu with the Issuer's obligations under the_

Notes, or

(ii) under any guarantee or other assumption of

liability by the Issuer for any present or future

security or other instrument which is issued by

a Subsidiary and guaranteed by the Issuer or for

which the Issuer has otherwise assumed liability

where the Issuer's obligations under such

guarantee or other assumption of liability rank

or are expressed to rank _pari passu with its_

obligations under the Notes,

except for any subordinated obligations of the Issuer

required to be preferred by mandatory provisions of

law.

For the avoidance of doubt, Parity Obligations include

the unsecured subordinated notes due 2074 with a first

call date in 2024, ISIN DE000A11QR73, the unsecu
red subordinated notes due 2075 with a first call date

in 2022, ISIN DE000A14J611, the unsecured

subordinated notes due 2079 with a first call date in

2025, ISIN XS2077670003 and the unsecured

subordinated notes due 2079 with a first call date in

2027, ISIN XS2077670342.

"Subsidiary" means any corporation, partnership or

other enterprise in which the Issuer directly or

indirectly holds in the aggregate more than 50 per cent.

of the capital or the voting rights.

(2) _Prohibition of Set-Off. No Holder may set-off any_

claims arising under the Notes against any claims that

the Issuer may have against it. The Issuer may not set
off any claims it may have against the Holders against

any of its obligations under the Notes.


-----

**§ 3**

**ZINSEN**

(1) _Zinslauf. In dem Zeitraum ab dem 25. März 2022 (der_

"Zinslaufbeginn") (einschließlich) bis zum

25. September 2030 (der "Erste Reset-Termin")

(ausschließlich) wird jede Schuldverschreibung

bezogen auf die festgelegte Stückelung mit 5,375 %

_per annum verzinst._

In dem Zeitraum ab dem Ersten Reset-Termin

(einschließlich) bis zum Endfälligkeitstag (wie in

§ 5(1) definiert) (ausschließlich) belaufen sich die

Zinsen jeder Schuldverschreibung auf den jeweiligen

Reset-Zinssatz.

Zinsen sind nachträglich am 25. September eines jeden

Jahres zur Zahlung vorgesehen, erstmals am

25. September 2022 (erste kurze Zinsperiode) (jeweils

ein "Zinszahlungstag"), und werden gemäß § 4 fällig.


**§ 3**

**INTEREST**

(1) _Interest Accrual. From and including 25 March 2022_

(the "Interest Commencement Date") to but

excluding 25 September 2030 (the "First Reset

**Date"), each Note bears interest on its Specified**

Denomination at a rate of 5.375 per cent. per annum.

From and including the First Reset Date to but

excluding the Maturity Date (as defined in § 5(1)),

each Note bears interest on its Specified Denomination

at the relevant Reset Rate of Interest.

Interest is scheduled to be paid annually in arrear on

25 September of each year, commencing on

25 September 2022 (short first coupon) (each an

"Interest Payment Date") and will fall due in

accordance with § 4.


Der "Reset-Zinssatz" entspricht The "Reset Rate of Interest" will be


(i) ab dem Ersten Reset-Termin (einschließlich) bis

zum 25. September 2035 (ausschließlich) (der

"Erste Step-up Termin") dem Ersten Reset
Zinssatz;

(ii) ab dem Ersten Step-up Termin (einschließlich)

bis zum 25. September 2050 (der "Zweite Step
**up Termin") (ausschließlich) dem Zweiten**

Reset-Zinssatz; und

(iii) ab dem Zweiten Step-up Termin (einschließlich)

bis zum Endfälligkeitstag (ausschließlich) dem

Dritten Reset-Zinssatz.

Der "Erste **Reset-Zinssatz" ist der Referenzsatz für**

den betreffenden Reset-Zeitraum zuzüglich 445,8

Basispunkte _per_ _annum,_ wie von der

Berechnungsstelle festgelegt.

Der "Zweite **Reset-Zinssatz" ist der Referenzsatz für**

den betreffenden Reset-Zeitraum zuzüglich 470,8

Basispunkte _per_ _annum,_ wie von der

Berechnungsstelle festgelegt.

Der "Dritte **Reset-Zinssatz" ist der Referenzsatz für**

den betreffenden Reset-Zeitraum zuzüglich 545,8

Basispunkte _per_ _annum,_ wie von der

Berechnungsstelle festgelegt.


(i) from and including the First Reset Date to but

excluding 25 September 2035 (the "First Step
**up Date") the First Reset Interest Rate;**

(ii) from and including the First Step-up Date to but

excluding 25 September 2050 (the "Second

**Step-up Date") the Second Reset Interest Rate;**

and

(iii) from and including the Second Step-up Date to

but excluding the Maturity Date the Third Reset

Interest Rate.

The "First Reset Interest Rate" will be the Reference

Rate for the relevant Reset Period plus 445.8 basis

points _per annum, as determined by the Calculation_

Agent.

The "Second Reset Interest Rate" will be the

Reference Rate for the relevant Reset Period plus

470.8 basis points _per annum, as determined by the_

Calculation Agent.

The "Third Reset Interest Rate" will be the

Reference Rate for the relevant Reset Period plus

545.8 basis points _per annum, as determined by the_

Calculation Agent.


-----

(2) _Feststellung des Referenzsatzes._ (2) _Determination of the Reference Rate._


Der "Referenzsatz" wird für einen Reset-Zeitraum

von der Berechnungsstelle an dem betreffenden

Zinsfestsetzungstag (wie nachstehend definiert) vor

dem Reset-Termin, an dem der betreffende Reset
Zeitraum beginnt, wie folgt festgelegt:

(a) Für jeden Reset-Zeitraum, der vor dem Eintritt

des etwaigen ersten Stichtags (wie in § 3(5)(g)

definiert) beginnt, gilt Folgendes:

Der Referenzsatz entspricht, vorbehaltlich

§ 3(2)(c), dem Ursprünglichen Benchmarksatz

an dem betreffenden Zinsfestsetzungstag.

Sofern der Ursprüngliche Benchmarksatz zu

dem betreffenden Zeitpunkt an dem

betreffenden Zinsfestsetzungstag nicht auf der

Bildschirmseite angezeigt wird, entspricht der

Referenzsatz, vorbehaltlich § 3(2)(c), dem

Referenzbankensatz an diesem

Zinsfestsetzungstag.

Sofern kein Referenzbankensatz gemäß der

Definition dieses Begriffs bestimmt werden

kann, weil keine 5-Jahres-Mid-Swapsatz
Quotierung (wie nachstehend definiert) zur

Verfügung gestellt wird, entspricht der

Referenzsatz, vorbehaltlich § 3(2)(c), dem

Ursprünglichen Benchmarksatz auf der

Bildschirmseite an dem letzten Tag vor dem

Zinsfestsetzungstag, an dem dieser

Ursprüngliche Benchmarksatz angezeigt wurde.

(b) Für den Reset-Zeitraum, der unmittelbar nach

dem jeweiligen Stichtag beginnt, und alle

folgenden Reset-Zeiträume wird der

Referenzsatz, vorbehaltlich § 3(2)(c), gemäß

§ 3(5) bestimmt.

(c) Für die Bestimmung des Referenzsatzes wird

jeder nicht auf jährlicher Basis ausgedrückte

Satz von der Berechnungsstelle auf eine

jährliche Basis umgerechnet.

"Ursprünglicher **Benchmarksatz"** an einem

TARGET-Geschäftstag bezeichnet den als Prozentsatz

ausgedrückten Euro-Mid-Swapsatz _per annum um_

11:00 Uhr (Frankfurter Zeit), wie er auf der

Bildschirmseite gegen 11:00 Uhr (Frankfurter Zeit)

(oder zu einer späteren Uhrzeit, zu welcher der Euro

The "Reference Rate" for a Reset Period will be

determined by the Calculation Agent on the relevant

Interest Determination Date (as defined below) prior

to the Reset Date on which the relevant Reset Period

commences as follows:

(a) For each Reset Period beginning prior to the

occurrence of the first Effective Date (as defined

in § 3(5)(g)), if any, the following applies:

The Reference Rate will be equal to the Original

Benchmark Rate on the relevant Interest

Determination Date, subject to § 3(2)(c).

If the Original Benchmark Rate does not appear

on the Screen Page as at such time on the

relevant Interest Determination Date, the

Reference Rate will be equal to the Reference

Bank Rate on that Interest Determination Date,

subject to § 3(2)(c).

If no Reference Bank Rate can be determined in

accordance with the definition of such term

because no 5-year Mid Swap Rate Quotation (as

defined below) is provided, the Reference Rate

shall be equal to the Original Benchmark Rate

on the Screen Page on the last day preceding the

Interest Determination Date on which such

Original Benchmark Rate was displayed, subject

to § 3(2)(c).

(b) For the Reset Period commencing immediately

after the relevant Effective Date and all

following Reset Periods, the Reference Rate will

be determined in accordance with § 3(5), subject

to § 3(2)(c).

(c) For purposes of the determination of the

Reference Rate, any rate which is not expressed

on an annual basis will be converted by the

Calculation Agent to an annual basis.

"Original Benchmark Rate" on a TARGET Business

Day means the annual Euro Mid Swap Rate (expressed

as a percentage per annum ) as at 11:00 a.m. (Frankfurt

time), as displayed on the Screen Page as at or around

11:00 a.m. (Frankfurt time) (or a later time at which the

Euro Mid Swap Rate becomes available on the Screen

Page) on such TARGET Business Day.


-----

Mid-Swapsatz auf der Bildschirmseite verfügbar wird)

an dem Zinsfestsetzungstag angezeigt wird.

Für diese Zwecke bezeichnet "Euro-Mid-Swapsatz"

das arithmetische Mittel der nachgefragten (bid) und

angebotenen (offered) Sätze für den jährlichen

Festzinszahlungsstrom einer fest- bis variablen (fixed
_for-floating) Zinsswap-Transaktion in Euro, (x) die_

eine 5-jährige Laufzeit hat, und (y) deren variabler

Zahlungsstrom auf dem 6-Monats-EURIBOR-Satz

(oder dem EURIBOR-Satz für eine andere Laufzeit,

die der Laufzeit gemäß dem dann vorherrschenden

Marktstandard für solche fest- bis variable (fixed-for
_floating) Zinsswap-Transaktionen in Euro entspricht)_

beruht.

Der "Referenzbankensatz" ist der Prozentsatz, der

von der Berechnungsstelle auf Grundlage der 5-Jahres
Mid-Swapsatz-Quotierungen an dem

Zinsfestsetzungstag festgestellt wird, die die

Emittentin von drei führenden, von ihr ausgewählten

Swap-Händlern im Interbankenhandel (jeweils eine

"Referenzbank") erfragt.

Wenn mindestens zwei 5-Jahres-Mid-Swapsatz
Quotierungen zur Verfügung gestellt werden, ist der

Referenzbankensatz das arithmetische Mittel der zur

Verfügung gestellten 5-Jahres-Mid-Swapsatz
Quotierungen.

Falls nur eine 5-Jahres-Mid-Swapsatz-Quotierung zur

Verfügung gestellt wird, entspricht der

Referenzbankensatz der zur Verfügung gestellten 5
Jahres-Mid-Swapsatz-Quotierung.

Für diese Zwecke bezeichnet "5-Jahres-Mid
**Swapsatz-Quotierung" einer Referenzbank an einem**

Tag das arithmetische Mittel der von der Referenzbank

der Emittentin und der Berechnungsstelle an diesem

Tag zur Verfügung gestellten nachgefragten (bid) und

angebotenen (offered) Sätze für den jährlichen

Festzinszahlungsstrom (berechnet auf einer Zinstage
Berechnungsbasis, die dem dann vorherrschenden

Marktstandard für solche fest- bis variable (fixed-for
_floating) Zinsswap-Transaktionen in Euro entspricht)_

einer fest- bis variablen (fixed-for-floating) Zinsswap
Transaktion in Euro, (x) die eine 5-jährige Laufzeit ab

dem betreffenden Reset-Termin (oder ab einem

anderen Tag, an dem eine solche fest- bis variable

(fixed-for-floating) Zinsswap-Transaktion in Euro

nach dem dann vorherrschenden regulären

Abrechnungszyklus unter der Annahme, dass dieser


For these purposes "Euro Mid Swap Rate" means the

arithmetic mean of the bid and offered rates for the

annual fixed leg of a fixed-for-floating interest rate

swap transaction in Euro which (x) has a term of 5

years and (y) has a floating leg based on the 6-month

EURIBOR rate (or the EURIBOR rate for such other

tenor as is the then prevailing market standard tenor for

such fixed-for-floating interest rate swap transactions

in Euro).

"Reference Bank Rate" means the percentage rate

determined by the Calculation Agent on the basis of the

5-year Mid Swap Rate Quotations on the Interest

Determination Date which the Issuer requests from

three leading swap dealers in the interbank market

selected by it (each, a "Reference Bank").

If at least two 5-year Mid Swap Rate Quotations are

provided, the Reference Bank Rate will be the

arithmetic mean of the 5-year Mid Swap Rate

Quotations so provided.

If only one 5-year Mid Swap Rate Quotation is

provided, the Reference Bank Rate will be such 5-year

Mid Swap Rate Quotation.

For this purpose, "5-year Mid Swap Rate Quotation"

in respect of any Reference Bank and on any date

means the arithmetic mean of the bid and offered rates

on such date provided by such Reference Bank to the

Issuer and the Calculation Agent for the annual fixed

rate leg (calculated on a day count basis consistent with

the then prevailing market standard for such fixed-for
floating interest rate swap transactions in Euro) of a

fixed-for-floating interest rate swap transaction in Euro

which transaction (x) has a term of 5 years

commencing on the relevant Reset Date (or, if

different, such other date on which such a fixed-for
floating interest rate swap transaction in Euro would

start based on the then prevailing regular settlement

cycle and assuming the trade date to be such date), (y)

is in an amount that is representative of a single

transaction in the relevant market at the relevant time,


-----

Tag das Transaktionsdatum (trade date) ist, zu laufen

beginnt) hat, (y) die auf einen Betrag lautet, der dem

einer repräsentativen einzelnen Transaktion in dem

relevanten Markt zur relevanten Zeit entspricht, und

(z) deren variabler Zahlungsstrom auf dem 6-Monats
EURIBOR (oder dem EURIBOR für eine andere

Laufzeit, die der Laufzeit gemäß dem dann

vorherrschenden Marktstandard für eine solche fest
bis variable (fixed-for-floating) Zinsswap-Transaktion

in Euro entspricht) (berechnet auf einer Zinstage
Berechnungsbasis, die dem dann vorherrschenden

Marktstandard für solche fest- bis variable (fixed-for
_floating) Zinsswap-Transaktionen in Euro entspricht)_

beruht.


and (z) has a floating leg based on the 6-month

EURIBOR (or the EURIBOR for such other tenor as is

the then prevailing market standard tenor for

EURIBOR for the purpose of fixed-for-floating

interest rate swap transactions) (calculated on a day

count basis consistent with the then prevailing market

standard for such fixed-for-floating interest rate swap

transactions in Euro).


Dabei gilt Folgendes: Where:


"Bildschirmseite" bezeichnet den Reuters Bildschirm

"ICESWAP2" unter der Überschrift "EURIBOR

BASIS" und dem Untertitel "11:00 AM Frankfurt

time" (auf dem solche Überschriften und Untertitel von

Zeit zur Zeit erscheinen) (die "Ursprüngliche

**Bildschirmseite").** Wenn die Ursprüngliche

Bildschirmseite dauerhaft eingestellt wird, oder wenn

darauf die Quotierung des Ursprünglichen

Benchmarksatzes dauerhaft eingestellt wird, jedoch

diese Quotierung auf einer anderen, von der Emittentin

nach billigem Ermessen ausgewählten Bildschirmseite

verfügbar ist (die "Ersatzbildschirmseite"), dann ist

"Bildschirmseite" die Ersatzbildschirmseite, und zwar

ab dem Tag, an dem die Emittentin die

Ersatzbildschirmseite auswählt.

"Geschäftstag" bezeichnet einen Tag (außer einem

Samstag oder Sonntag), an dem das Clearingsystem

sowie alle betroffenen Bereiche des Trans-European

Automated Real-time Gross Settlement Express

Transfer System (TARGET2) betriebsbereit sind, um

die betreffenden Zahlungen weiterzuleiten.

"Reset-Termin" bezeichnet den Ersten Reset-Termin

und danach jeden fünften Jahrestag des

vorausgegangenen Reset-Termins.

"Reset-Zeitraum" bezeichnet jeden Zeitraum ab dem

Ersten Reset-Termin (einschließlich) bis zu dem

nächstfolgenden Reset-Termin (ausschließlich) und

danach ab einem Reset-Termin (einschließlich) bis zu

dem nächstfolgenden Reset-Termin (ausschließlich).

"TARGET-Geschäftstag" bezeichnet einen Tag, an

dem das Trans-European Automated Real-time Gross


"Screen **Page"** means the Reuters screen

"ICESWAP2" under the heading "EURIBOR BASIS"

and the caption "11:00 AM Frankfurt time" (as such

headings and captions may appear from time to time)

(the "Original Screen Page"). If the Original Screen

Page permanently ceases to exist or permanently

ceases to quote the Original Benchmark Rate but such

quotation is available from another page selected by

the Issuer in its reasonable discretion (the

"Replacement Screen Page"), the "Screen Page" shall

be the Replacement Screen Page with effect from the

date on which the Replacement Screen Page is selected

by the Issuer.

"Business Day" means a day (other than a Saturday or

a Sunday) on which the Clearing System as well as all

relevant parts of the Trans-European Automated Real
time Gross settlement Express Transfer system

(TARGET2) are operational to forward the relevant

payments.

"Reset Date" means the First Reset Date and thereafter

each fifth anniversary of the preceding Reset Date.

"Reset Period" means each period from and including

the First Reset Date to but excluding the immediately

following Reset Date and thereafter from and including

a Reset Date to but excluding the immediately

following Reset Date.

"TARGET Business Day" means a day on which the

Trans-European Automated Real-time Gross


-----

settlement Express Transfer system 2 (TARGET)

betriebsbereit ist.

"Zinsfestsetzungstag" bezeichnet den zweiten

TARGET-Geschäftstag vor dem betreffenden Reset
Termin.

"Zinsperiode" bezeichnet den jeweiligen Zeitraum

von dem Verzinsungsbeginn (einschließlich) bis zum

ersten Zinszahlungstag (ausschließlich) bzw. von

jedem Zinszahlungstag (einschließlich) bis zum

nächstfolgenden Zinszahlungstag (ausschließlich).

(3) Unverzüglich nach Bestimmung des betreffenden

Referenzsatzes wird die Berechnungsstelle den Reset
Zinssatz für den betreffenden Reset-Zeitraum

berechnen.

(4) Die Berechnungsstelle wird veranlassen, dass der

Reset-Zinssatz der Emittentin, der Hauptzahlstelle,

und jeder Börse, an der die Schuldverschreibungen zu

diesem Zeitpunkt auf Veranlassung der Emittentin

notiert sind und deren Regeln eine Mitteilung an die

Börse verlangen, sowie den Gläubigern gemäß § 13

unverzüglich, aber keinesfalls später als am achten auf

dessen Feststellung folgenden Geschäftstag mitgeteilt

wird.

(5) _Benchmark-Ereignis. Wenn ein Benchmark-Ereignis_

(wie in § 3(5)(f) definiert) in Bezug auf den

Ursprünglichen Benchmarksatz eintritt, gilt für die

Bestimmung des Referenzsatzes und die Verzinsung

der Schuldverschreibungen gemäß § 3 Folgendes:

(a) _Unabhängiger Berater. Die Emittentin wird sich_

bemühen, sobald dies (nach Ansicht der

Emittentin) nach Eintritt des Benchmark
Ereignisses und vor dem nächsten

Zinsfestsetzungstag erforderlich ist, einen

Unabhängigen Berater (wie in § 3(5)(f)

definiert) zu benennen, der einen Neuen

Benchmarksatz (wie in § 3(5)(f) definiert), die

Anpassungsspanne (wie in § 3(5)(f) definiert)

und etwaige Benchmark-Änderungen (wie in

§ 3(5)(d) definiert) festlegt.

(b) _Ausweichsatz (fallback rate). Wenn vor dem 10._

Geschäftstag vor dem betreffenden

Zinsfestsetzungstag

(i) die Emittentin keinen Unabhängigen

Berater ernannt hat; oder


settlement Express Transfer system 2 (TARGET) is

operating.

"Interest Determination Date" means the second

TARGET Business Day prior to the relevant Reset

Date.

"Interest Period" means each period from and

including the Interest Commencement Date to but

excluding the first Interest Payment Date and from and

including each Interest Payment Date to but excluding

the immediately following Interest Payment Date.

(3) Promptly after the determination of the relevant

Reference Rate, the Calculation Agent shall determine

the Reset Rate of Interest for the relevant Reset Period.

(4) The Calculation Agent will cause the Reset Rate of

Interest to be notified to the Issuer, the Principal

Paying Agent and, if required by the rules of any stock

exchange on which the Notes are listed from time to

time at the request of the Issuer, to such stock

exchange, and to the Holders in accordance with § 13

without undue delay, but, in any case, not later than on

the eighth Business Day after its determination.

(5) _Benchmark Event. If a Benchmark Event (as defined in_

§ 3(5)(f)) occurs in relation to the Original Benchmark

Rate, the Reference Rate and the interest on the Notes

in accordance with § 3 will be determined as follows:

(a) _Independent Adviser. The Issuer shall, as soon_

as this is (in the Issuer's view) required

following the occurrence of the Benchmark

Event and prior to the next Interest

Determination Date, use its best efforts to

appoint an Independent Adviser (as defined in

§ 3(5)(f)), who will determine a New

Benchmark Rate (as defined in § 3(5)(f)), the

Adjustment Spread (as defined in § 3(5)(f)) and

any Benchmark Amendments (as defined in

§ 3(5)(d)).

(b) _Fallback rate. If, prior to the 10th Business Day_

prior to the relevant Interest Determination

Date,

(i) the Issuer has not appointed an

Independent Adviser; or


-----

(ii) der ernannte Unabhängige Berater keinen

Neuen Benchmarksatz, keine

Anpassungsspanne und/oder keine

Benchmark-Änderungen (sofern

erforderlich) gemäß diesem § 3(5)

festgelegt hat,

dann entspricht der Referenzsatz für den

nächsten Reset-Zeitraum dem Referenzsatz auf

der Bildschirmseite an dem letzten

Zinsfestsetzungstag an dem ein Referenzsatz

angezeigt wurde.

Sofern dieser § 3(5)(b) bereits an dem

Zinsfestsetzungstag für den Ersten Reset
Termin angewendet werden muss, entspricht der

Referenzsatz für den ersten Reset-Zeitraum

1,042 % per annum.

Sofern der gemäß diesem § 3(5)(b) bestimmte

Ausweichsatz (fallback rate) zur Anwendung

kommt, wird § 3(5) erneut angewendet, um den

Referenzsatz für den nächsten nachfolgenden

Reset-Zeitraum (und, sofern notwendig, weitere

nachfolgende Reset-Zeiträume) zu bestimmen.

(c) _Nachfolge-Benchmarksatz_ _oder_ _Alternativ-_

_Benchmarksatz. Falls der Unabhängige Berater_

nach billigem Ermessen feststellt,

(i) dass es einen Nachfolge-Benchmarksatz

gibt, dann ist dieser Nachfolge
Benchmarksatz der Neue Benchmarksatz;

oder

(ii) dass es keinen Nachfolge-Benchmarksatz

aber einen Alternativ-Benchmarksatz

gibt, dann ist dieser Alternativ
Benchmarksatz der Neue Benchmarksatz.

In beiden Fällen entspricht der Referenzsatz für

den unmittelbar nach dem Stichtag beginnenden

Reset-Zeitraum und (vorbehaltlich des Eintritts

eines weiteren Benchmark-Ereignisses) alle

folgenden Zinsanpassungszeiträume dann (x)

dem Neuen Benchmarksatz an dem betreffenden

Zinsfestsetzungstag zuzüglich (y) der

Anpassungsspanne.

(d) _Benchmark-Änderungen. Wenn ein Neuer_

Benchmarksatz und die entsprechende

Anpassungsspanne gemäß diesem § 3(5)

festgelegt werden, und wenn der Unabhängige


(ii) the appointed Independent Adviser has

not determined a New Benchmark Rate,

the Adjustment Spread and/or any

Benchmark Amendments (if required) in

accordance with this § 3(5),

then the Reference Rate applicable to the next

Reset Period shall be the Reference Rate on the

Screen Page on the last day preceding the

relevant Interest Determination Date on which

such Reference Rate was displayed.

If this § 3(5)(b) is to be applied on the Interest

Determination Date for the First Reset Date, the

Reference Rate applicable to the first Reset

Period shall be 1.042 per cent. per annum.

If the fallback rate determined in accordance

with this § 3(5)(b) is to be applied, § 3(5) will be

operated again to determine the Reference Rate

applicable to the next subsequent (and, if

required, further subsequent) Reset Period(s).

(c) _Successor Benchmark Rate or Alternative_

_Benchmark Rate. If the Independent Adviser_

determines in its reasonable discretion that:

(i) there is a Successor Benchmark Rate, then

that Successor Benchmark Rate shall

subsequently be the New Benchmark

Rate; or

(ii) there is no Successor Benchmark Rate but

that there is an Alternative Benchmark

Rate, then that Alternative Benchmark

Rate shall subsequently be the New

Benchmark Rate.

In either case the Reference Rate for the Reset

Period commencing immediately after the

Effective Date and (subject to the occurrence of

a further Benchmark Event) all following Reset

Periods will then be (x) the New Benchmark

Rate on the relevant Interest Determination Date

plus (y) the Adjustment Spread.

(d) _Benchmark Amendments. If any relevant New_

Benchmark Rate and the applicable Adjustment

Spread are determined in accordance with this

§ 3(5), and if the Independent Adviser


-----

Berater feststellt, dass resultierend aus den

vorgenannten Festlegungen Änderungen der

Bedingungen für die Feststellungen des

anwendbaren Reset-Zinssatzes notwendig sind,

um die ordnungsgemäße Anwendung des Neuen

Benchmarksatzes und der entsprechenden

Anpassungsspanne zu gewährleisten (diese

Änderungen, die "Benchmark-Änderungen"),

dann wird der Unabhängige Berater die

Benchmark-Änderungen feststellen.

Diese Benchmark-Änderungen können

insbesondere folgende Regelungen in diesen

Anleihebedingungen erfassen:

(i) den Referenzsatz einschließlich der

"Bildschirmseite" und/oder die Methode

zur Bestimmung des Ausweichsatzes

(sog. fallback rate) für den Referenzsatz

einschließlich des Referenzbankensatzes;

und/oder

(ii) die Definitionen der Begriffe

"Geschäftstag", "Reset-Termin", "Reset
Zeitraum", "Zinsfestsetzungstag",

"Zinsperiode", "Zinstagequotient"

und/oder

"Zinszahlungstag"(einschließlich der

Festlegung, ob der Referenzsatz

vorausschauend vor oder zu Beginn der

betreffenden Zinsperiode oder

zurückblickend vor oder zum Ablauf der

betreffenden Zinsperiode bestimmt wird);

und/oder

(iii) die Geschäftstagekonvention gemäß

§ 6(5).

(e) _Mitteilungen, etc. Die Emittentin wird einen_

Neuen Benchmarksatz, die Anpassungsspanne

und etwaige Benchmark-Änderungen gemäß

diesem § 3(5) bzw. den Ausweichsatz (sog.

_fallback_ _rate)_ gemäß § 3(5)(b) der

Hauptzahlstelle, etwaigen weiteren Zahlstellen,

der Berechnungsstelle sowie gemäß § 13 den

Gläubigern mitteilen, und zwar sobald eine

solche Mitteilung (nach Ansicht der Emittentin)

nach deren Feststellung erforderlich ist,

spätestens jedoch an dem 10. Geschäftstag vor

dem betreffenden Zinsfestsetzungstag. Eine

solche Mitteilung ist unwiderruflich und hat den

Stichtag zu benennen.


determines that, resulting from the

aforementioned determinations, amendments to

the conditions for the determinations of the

applicable Reset Rate of Interest are necessary

to ensure the proper operation of the New

Benchmark Rate and the applicable Adjustment

Spread (such amendments, the "Benchmark

**Amendments"), then the Independent Adviser**

will determine the Benchmark Amendments.

The Benchmark Amendments may include,

without limitation, the following provisions of

these Terms and Conditions:

(i) the Reference Rate including the "Screen

Page" and/or the method for determining

the fallback rate in relation to the

Reference Rate, including the Reference

Bank Rate; and/or

(ii) the definitions of the terms "Business

Day", "Reset Date", "Reset Period",

"Interest Determination Date", "Interest

Period", "Day Count Fraction" and/or

"Interest Payment Date" (including the

determination whether the Reference Rate

will be determined in advance on or prior

to the relevant Interest Period or in arrear

on or prior to the end of the relevant

Interest Period); and/or

(iii) the business day convention in

accordance with § 6(5).

(e) _Notices, etc. The Issuer will notify the Principal_

Paying Agent, any additional paying agents, the

Calculation Agent and, in accordance with § 13,

the Holders of a New Benchmark Rate, the

Adjustment Spread and the Benchmark

Amendments (if any) determined under this

§ 3(5) or the fallback rate in accordance with

§ 3(5)(b), as the case may be, as soon as such

notification is (in the Issuer's view) required

following the determination thereof, but in any

event not later than on the 10[th] Business Day

prior to the relevant Interest Determination

Date. Any such notice shall be irrevocable and

shall specify the Effective Date.


-----

Der Neue Benchmarksatz, die

Anpassungsspanne und etwaige Benchmark
Änderungen bzw. der Ausweichsatz (sog.

_fallback rate), die bzw. der jeweils in der_

Mitteilung benannt werden, sind (sofern nicht

ein offensichtlicher Irrtum vorliegt) für die

Emittentin, die Hauptzahlstelle, etwaige weitere

Zahlstellen, die Berechnungsstelle und die

Gläubiger bindend. Die Anleihebedingungen

gelten ab dem Stichtag als durch den Neuen

Benchmarksatz, die Anpassungsspanne und die

etwaigen Benchmark-Änderungen geändert.

An oder vor dem Tag dieser Mitteilung hat die

Emittentin der Zahlstelle und der

Berechnungsstelle eine durch zwei

Unterschriftsberechtigte der Emittentin

unterzeichnete Bescheinigung zu überlassen, die

(i) bestätigt, dass ein Benchmark-Ereignis

eingetreten ist;

(ii) den nach Maßgabe der Bestimmungen

dieses § 3(5) festgestellten Neuen

Benchmarksatz benennt;

(iii) die entsprechende Anpassungsspanne und

etwaige Benchmark-Änderungen

benennt, die jeweils nach Maßgabe der

Bestimmungen dieses § 3(5) festgestellt

wurden; und


The New Benchmark Rate, the Adjustment

Spread and the Benchmark Amendments (if

any) or the fallback rate, as the case may be, each

as specified in the notice, shall (in the absence

of manifest error) be binding on the Issuer, the

Principal Paying Agent, any additional paying

agents, the Calculation Agent and the Holders.

The Terms and Conditions shall be deemed to

have been amended by the New Benchmark

Rate, the Adjustment Spread and any

Benchmark Amendments with effect from the

Effective Date.

On or prior to the date of such notice, the Issuer

shall deliver to the Paying Agent and the

Calculation Agent a certificate signed by two

authorized signatories of the Issuer:

(i) confirming that a Benchmark Event has

occurred;

(ii) specifying the relevant New Benchmark

Rate determined in accordance with the

provisions of this § 3(5);

(iii) specifying the applicable Adjustment

Spread and the Benchmark Amendments

(if any), each determined in accordance

with the provisions of this § 3(5); and


(iv) den Stichtag benennt; und (iv) specifying the Effective Date; and


(v) bestätigt, dass die etwaigen Benchmark
Änderungen notwendig sind, um die

ordnungsgemäße Anwendung des Neuen

Benchmarksatzes und der entsprechenden

Anpassungsspanne zu gewährleisten.


(v) confirming that the Benchmark

Amendments, if any, are necessary to

ensure the proper operation of the New

Benchmark Rate and the applicable

Adjustment Spread.


(f) _Definitionen. Zur Verwendung in diesem § 3(5):_ (f) _Definitions. As used in this § 3(5):_


Die "Anpassungsspanne", die positiv, negativ

oder gleich Null sein kann, wird in Basispunkten

ausgedrückt und bezeichnet entweder (x) die

Spanne oder (y) das Ergebnis der Anwendung

der Formel oder Methode zur Berechnung der

Spanne, die

(i) im Fall eines Nachfolge
Benchmarksatzes formell im

Zusammenhang mit der Ersetzung des

Ursprünglichen Benchmarksatzes durch

den Nachfolge-Benchmarksatz von dem


The "Adjustment Spread", which may be

positive, negative or zero, will be expressed in

basis points and means either (x) the spread, or

(y) the result of the operation of the formula or

methodology for calculating the spread, which

(i) in the case of a Successor Benchmark

Rate, is formally recommended in relation

to the replacement of the Original

Benchmark Rate with the Successor


-----

Nominierungsgremium empfohlen wird;

oder

(ii) (sofern keine Empfehlung gemäß

Ziffer (i) abgegeben wurde oder im Fall

eines Alternativ-Benchmarksatzes)

üblicherweise an den internationalen

Anleihekapitalmärkten auf den Neuen

Benchmarksatz angewendet wird, um

einen industrieweit akzeptierten Ersatz
Benchmarksatz für den Ursprünglichen

Benchmarksatz zu erzeugen, wobei

sämtliche Feststellungen durch den

Unabhängigen Berater nach billigem

Ermessen vorgenommen werden; oder

(iii) (sofern der Unabhängige Berater nach

billigem Ermessen feststellt, dass keine

solche Spanne üblicherweise angewendet

wird, und dass das Folgende für die

Schuldverschreibungen angemessen ist)

als industrieweiter Standard für Over-the
Counter Derivatetransaktionen, die sich

auf den Ursprünglichen Benchmarksatz

beziehen, anerkannt oder bestätigt ist,

wenn der Ursprüngliche Benchmarksatz

durch den Neuen Benchmarksatz ersetzt

worden ist, wobei sämtliche

Feststellungen durch den Unabhängigen

Berater nach billigem Ermessen

vorgenommen werden.

"Alternativ-Benchmarksatz" bezeichnet eine

alternative Benchmark oder einen alternativen

Bildschirmsatz, die bzw. der üblicherweise an

den internationalen Anleihekapitalmärkten

(oder, hilfsweise, an den internationalen

Swapmärkten) zur Bestimmung eines Mid
Swap-Satzes mit 5-jähriger Laufzeit in Euro

angewendet wird, wobei sämtliche

Feststellungen durch den Unabhängigen Berater

vorgenommen werden.


Benchmark Rate by any Relevant

Nominating Body; or

(ii) (if no recommendation pursuant to

clause (i) has been made, or in the case of

an Alternative Benchmark Rate) is

customarily applied to the New

Benchmark Rate in the international debt

capital markets to produce an industry
accepted replacement benchmark rate for

the Original Benchmark Rate, provided

that all determinations will be made by the

Independent Adviser in its reasonable

discretion; or

(iii) (if the Independent Adviser in its

reasonable discretion determines that no

such spread is customarily applied and

that the following would be appropriate

for the Notes) is recognized or

acknowledged as being the industry

standard for over-the-counter derivative

transactions which reference the Original

Benchmark Rate, where the Original

Benchmark Rate has been replaced by the

New Benchmark Rate, provided that all

determinations will be made by the

Independent Adviser in its reasonable

discretion.

"Alternative Benchmark Rate" means an

alternative benchmark or an alternative screen

rate which is customarily applied in the

international debt capital markets (or,

alternatively, the international swap markets) for

the purpose of determining a mid swap rate with

a 5-year maturity in Euro, provided that all

determinations will be made by the Independent

Adviser.


Ein "Benchmark-Ereignis" tritt ein, wenn: A "Benchmark Event" occurs if:


(i) eine öffentliche Erklärung oder eine

Veröffentlichung von Informationen

durch die für den Administrator des

Ursprünglichen Benchmarksatzes

zuständige Aufsichtsbehörde oder in

deren Namen vorgenommen wird, aus der

hervorgeht, dass dieser Administrator die


(i) a public statement or publication of

information by or on behalf of the

regulatory supervisor of the Original

Benchmark Rate administrator is made,

stating that said administrator has ceased

or will cease to provide the Original

Benchmark Rate permanently or


-----

Bereitstellung des Ursprünglichen

Benchmarksatzes dauerhaft oder auf

unbestimmte Zeit eingestellt hat oder

einstellen wird, es sei denn, es gibt einen

Nachfolgeadministrator, der den

Ursprünglichen Benchmarksatz weiterhin

bereitstellt; oder

(ii) eine öffentliche Erklärung oder eine

Veröffentlichung von Informationen

durch den Administrator des

Ursprünglichen Benchmarksatzes oder in

dessen Namen vorgenommen wird, die

besagt, dass der Administrator die

Bereitstellung des Ursprünglichen

Benchmarksatzes dauerhaft oder auf

unbestimmte Zeit eingestellt hat oder

einstellen wird, es sei denn, es gibt einen

Nachfolgeadministrator, der den

Ursprünglichen Benchmarksatz weiterhin

bereitstellt; oder

(iii) eine öffentliche Erklärung der

Aufsichtsbehörde des Administrators des

Ursprünglichen Benchmarksatzes

veröffentlicht wird, wonach der

Ursprüngliche Benchmarksatz ihrer

Ansicht nach nicht mehr repräsentativ für

den zugrunde liegenden Markt, den er zu

messen vorgibt, ist oder sein wird, und

keine von der Aufsichtsbehörde des

Administrators des Ursprünglichen

Benchmarksatzes geforderten

Maßnahmen zur Behebung einer solchen

Situation ergriffen worden sind oder zu

erwarten sind; oder

(iv) die Verwendung des Ursprünglichen

Benchmarksatzes aus irgendeinem Grund

nach einem Gesetz oder einer

Verordnung, die in Bezug auf die

Zahlstellen, die Berechnungsstelle, die

Emittentin oder jeden Dritten anwendbar

sind, rechtswidrig geworden ist; oder

(v) der Ursprüngliche Benchmarksatz ohne

vorherige offizielle Ankündigung durch

die zuständige Behörde oder den

Administrator dauerhaft nicht mehr

veröffentlicht wird; oder


indefinitely, unless there is a successor

administrator that will continue to provide

the Original Benchmark Rate; or

(ii) a public statement or publication of

information by or on behalf of the Original

Benchmark Rate administrator is made,

stating that said administrator has ceased

or will cease to provide the Original

Benchmark Rate permanently or

indefinitely, unless there is a successor

administrator that will continue to provide

the Original Benchmark Rate; or

(iii) a public statement by the regulatory

supervisor of the Original Benchmark

Rate administrator is made that, in its

view, the Original Benchmark Rate is no

longer, or will no longer be, representative

of the underlying market it purports to

measure and no action to remediate such a

situation is taken or expected to be taken

as required by the supervisor of the

Original Benchmark Rate administrator;

or

(iv) it has become, for any reason, unlawful

under any law or regulation applicable to

any Paying Agent, the Calculation Agent,

the Issuer or any other party to use the

Original Benchmark Rate; or

(v) the Original Benchmark Rate is

permanently no longer published without

a previous official announcement by the

competent authority or the administrator;

or


-----

(vi) die Methode für die Feststellung des

Ursprünglichen Benchmarksatzes (oder

einer Teilkomponente davon) ändert sich

wesentlich gegenüber der Methode, die

der Administrator des Ursprünglichen

Benchmarksatzes bei Verzinsungsbeginn

anwendet.

"Nachfolge-Benchmarksatz" bezeichnet einen

Nachfolger oder Ersatz des Ursprünglichen

Benchmarksatzes, der formell durch das

Nominierungsgremium empfohlen wurde.

"Neuer **Benchmarksatz"** bezeichnet den

jeweils gemäß diesem § 3(5) bestimmten

Nachfolge-Benchmarksatz bzw. Alternativ
Benchmarksatz.

"Nominierungsgremium" bezeichnet in Bezug

auf die Ersetzung des Ursprünglichen

Benchmarksatzes:

(i) die Zentralbank für die Währung, in der

die Benchmark oder der Bildschirmsatz

dargestellt wird oder eine Zentralbank

oder andere Aufsichtsbehörde, die für die

Aufsicht des Administrators der

Benchmark oder des Bildschirmsatzes

zuständig ist; oder

(ii) jede Arbeitsgruppe oder jeden Ausschuss

gefördert durch, geführt oder mitgeführt

von oder gebildet von (1) der Zentralbank

für die Währung in der die Benchmark

oder der Bildschirmsatz dargestellt wird,

(2) einer Zentralbank oder anderen

Aufsichtsbehörde, die für die Aufsicht des

Administrators der Benchmark oder des

Bildschirmsatzes zuständig ist, (3) einer

Gruppe der zuvor genannten

Zentralbanken oder anderer

Aufsichtsbehörden oder (4) dem

Finanzstabilitätsrat (Financial Stability

_Board) oder Teilen davon._

"Unabhängiger Berater" bezeichnet ein von

der Emittentin ernanntes unabhängiges

Finanzinstitut mit internationalem Ansehen oder

einen anderen unabhängigen Finanzberater mit

Erfahrung in den internationalen


(vi) the methodology for the determination of

the Original Benchmark Rate (or any

component part thereof) is materially

altered compared to the methodology as

used by the administrator of the Original

Benchmark Rate at the Interest

Commencement Date.

"Successor **Benchmark** **Rate"** means a

successor to or replacement of the Original

Benchmark Rate which is formally

recommended by any Relevant Nominating

Body.

"New Benchmark Rate" means the Successor

Benchmark Rate or, as the case may be, the

Alternative Benchmark Rate determined in

accordance with this § 3(5).

"Relevant Nominating Body" means, in respect

of the replacement of the Original Benchmark

Rate:

(i) the central bank for the currency to which

the benchmark or screen rate (as

applicable) relates, or any central bank or

other supervisory authority which is

responsible for supervising the

administrator of the benchmark or screen

rate (as applicable); or

(ii) any working group or committee

sponsored by, chaired or co-chaired by or

constituted at the request of (1) the central

bank for the currency to which the

benchmark or screen rate (as applicable)

relates, (2) any central bank or other

supervisory authority which is responsible

for supervising the administrator of the

benchmark or screen rate (as applicable),

(3) a group of the aforementioned central

banks or other supervisory authorities or

(4) the Financial Stability Board or any

part thereof.

"Independent Adviser" means an independent

financial institution of international repute or

other independent financial adviser experienced

in the international debt capital markets, in each

case appointed by the Issuer, and which may be

the Calculation Agent.


-----

Anleihekapitalmärkten, und der die

Berechnungsstelle sein kann.

(g) Der Stichtag für die Anwendung des Neuen

Benchmarksatzes, der Anpassungsspanne und

der etwaigen Benchmark-Änderungen gemäß

diesem § 3(5) (der "Stichtag") ist der

Zinsfestsetzungstag, der auf den frühesten der

folgenden Tage fällt oder diesem nachfolgt:

(i) den Tag, an dem die Veröffentlichung des

Ursprünglichen Benchmarksatzes

eingestellt wird, an dem der

Ursprüngliche Benchmarksatz eingestellt

wird bzw. ab dem der Ursprüngliche

Benchmarksatz nicht mehr repräsentativ

ist oder sein wird, wenn das Benchmark
Ereignis aufgrund der Ziffern (i), (ii) oder

(iii) der Definition des Begriffs

"Benchmark-Ereignis" eingetreten ist;

oder

(ii) den Tag, ab dem der Ursprüngliche

Benchmarksatz nicht mehr verwendet

werden darf, wenn das Benchmark
Ereignis aufgrund der Ziffer (iv) der

Definition des Begriffs "Benchmark
Ereignis" eingetreten ist; oder

(iii) den Tag des Eintritts des Benchmark
Ereignisses, wenn das Benchmark
Ereignis aufgrund der Ziffern (v) oder (vi)

der Definition des Begriffs "Benchmark
Ereignis" eingetreten ist

(h) Eine Anpassung des Ursprünglichen

Benchmarksatzes im Falle eines Benchmark
Ereignisses darf nur insoweit durchgeführt

werden, als dass durch diese Anpassung kein

Verlust der Eigenkapitalanrechnung oder keine

Verkürzung der Eigenkapitalanrechnung

eintritt.

(i) Wenn ein Benchmark-Ereignis in Bezug auf

einen Neuen Benchmarksatz eintritt, gilt dieser

§ 3(5) entsprechend für die Ersetzung des Neuen

Benchmarksatzes durch einen neuen Nachfolge
Benchmarksatz bzw. Alternativ
Benchmarksatz. In diesem Fall gilt jede

Bezugnahme in diesem § 3 auf den Begriff

Ursprünglicher Benchmarksatz als Bezugnahme


(g) The effective date for the application of the New

Benchmark Rate, the Adjustment Spread and the

Benchmark Amendments (if any) determined

under this § 3(5) (the "Effective Date") will be

the Interest Determination Date falling on or

after the earliest of the following dates:

(i) if the Benchmark Event has occurred as a

result of clauses (i), (ii) or (iii) of the

definition of the term "Benchmark Event",

the date of cessation of publication of the

Original Benchmark Rate, the date of the

discontinuation of the Original

Benchmark Rate or the date as from which

the Original Benchmark Rate is no longer,

or will no longer be, representative, as the

case may be; or

(ii) if the Benchmark Event has occurred as a

result of clause (iv) of the definition of the

term "Benchmark Event", the date from

which the prohibition applies; or

(iii) if the Benchmark Event has occurred as a

result of clauses (v) or (vi) of the

definition of the term "Benchmark Event",

the date of the occurrence of the

Benchmark Event.

(h) Any adjustment to the Original Benchmark Rate

in case of a Benchmark Event will be made only

to the extent that no Loss in Equity Credit or

Shortening in Equity Credit would occur as a

result of such adjustment.

(i) If a Benchmark Event occurs in relation to any

New Benchmark Rate, § 3(5) shall apply mutatis

_mutandis to the replacement of such New_

Benchmark Rate by any new Successor

Benchmark Rate or Alternative Benchmark

Rate, as the case may be. In this case, all

references in this § 3 to the term Original

Benchmark Rate shall be deemed to be a


-----

auf den zuletzt verwendeten Neuen

Benchmarksatz.

(j) In diesem § 3(5) schließt jede Bezugnahme auf

den Begriff Ursprünglicher Benchmarksatz

gegebenenfalls auch eine Bezugnahme auf eine

etwaige Teilkomponente des Ursprünglichen

Benchmarksatzes ein, wenn in Bezug auf diese

Teilkomponente ein Benchmark-Ereignis

eingetreten ist.

(6) Die Zinsen für einen beliebigen Zeitraum werden auf

der Grundlage des Zinstagequotienten berechnet.

"Zinstagequotient" bezeichnet bei der Berechnung

des Zinsbetrages für eine Schuldverschreibung für

einen beliebigen Zeitraum (der

"Zinsberechnungszeitraum"):

(a) wenn der Zinsberechnungszeitraum der

Feststellungsperiode entspricht, in die er fällt,

oder kürzer als diese ist, die Anzahl von Tagen

in dem Zinsberechnungszeitraum dividiert

durch die Anzahl von Tagen in der betreffenden

Feststellungsperiode; und

(b) wenn der Zinsberechnungszeitraum länger als

eine Feststellungsperiode ist, die Summe aus

(i) der Anzahl der Tage in dem betreffenden

Zinsberechnungszeitraum, die in die

Feststellungsperiode fallen, in der der

Zinsberechnungszeitraum beginnt,

dividiert durch die Anzahl der Tage in der

betreffenden Feststellungsperiode; und

(ii) die Anzahl der Tage in dem betreffenden

Zinsberechnungszeitraum, die in die

nachfolgende Feststellungsperiode fallen,

dividiert durch die Anzahl der Tage in der

betreffenden Feststellungsperiode.


reference to the New Benchmark Rate last

applied.

(j) Any reference in this § 3(5) to the term Original

Benchmark Rate shall be deemed to include a

reference to any component part thereof, as

applicable, if a Benchmark Event has occurred

in respect of that component part.

(6) Interest for any period of time will be calculated on the

basis of the Day Count Fraction.

"Day Count Fraction" means, in respect of the

calculation of an amount of interest on any Note for

any period of time (the "Calculation Period"):

(a) if the Calculation Period is equal to or shorter

than the Determination Period in which it falls,

the number of days in the Calculation Period

divided by the number of days in such

Determination Period; and

(b) if the Calculation Period is longer than one

Determination Period, the sum of:

(i) the number of days in such Calculation

Period falling in the Determination Period

in which the Calculation Period begins

divided by the number of days in such

Determination Period; and

(ii) the number of days in such Calculation

Period falling in the next Determination

Period divided by the number of days in

such Determination Period.


Dabei gilt Folgendes: Where:


"Feststellungsperiode" bezeichnet jede Periode

ab einem Feststellungstermin (einschließlich),

der in ein beliebiges Jahr fällt, bis zum nächsten

Feststellungstermin (ausschließlich).

"Feststellungstermin" bezeichnet jeden

25. September.

(7) _Zinslaufende._ Die Verzinsung der

Schuldverschreibungen endet mit Beginn des Tages,

an dem ihr Nennbetrag zur Rückzahlung fällig wird.


"Determination Period" means each period

from and including a Determination Date in any

year to but excluding the next Determination

Date.

"Determination **Date"** means each

25 September.

(7) _Cessation of interest accrual. The Notes will cease to_

bear interest from the beginning of the day their

principal amount is due for repayment. If the Issuer


-----

Sollte die Emittentin eine Zahlung von Kapital auf die

Schuldverschreibungen bei Fälligkeit nicht leisten,

endet die Verzinsung der Schuldverschreibungen mit

Beginn des Tages der tatsächlichen Zahlung. Der in

einem solchen Fall jeweils anzuwendende Zinssatz

wird gemäß diesem § 3 bestimmt.

**§ 4**

**FÄLLIGKEIT VON ZINSZAHLUNGEN; AUFSCHUB**

**VON ZINSZAHLUNGEN; ZAHLUNG**

**AUFGESCHOBENER ZINSZAHLUNGEN**

(1) _Fälligkeit_ _von_ _Zinszahlungen;_ _wahlweiser_

_Zinsaufschub. Zinsen, die während einer Zinsperiode_

auflaufen, werden an dem betreffenden

Zinszahlungstag fällig, sofern sich die Emittentin nicht

durch eine Bekanntmachung an die Gläubiger gemäß

§ 13 innerhalb einer Frist von nicht weniger als 10

Geschäftstagen vor dem betreffenden Zinszahlungstag

dazu entscheidet, die betreffende Zinszahlung

(insgesamt, jedoch nicht teilweise) auszusetzen.

Wenn sich die Emittentin an einem Zinszahlungstag

zur Nichtzahlung aufgelaufener Zinsen entscheidet,

dann ist sie nicht verpflichtet, an dem betreffenden

Zinszahlungstag Zinsen zu zahlen. Diese sind

Aufgeschobene Zinszahlungen (wie nachstehend

definiert). Eine Nichtzahlung von Zinsen aus diesem

Grunde begründet keinen Verzug der Emittentin und

keine anderweitige Verletzung ihrer Verpflichtungen

aufgrund der Schuldverschreibungen oder für sonstige

Zwecke.

Nach Maßgabe dieses § 4(1) nicht fällig gewordene

Zinsen sind aufgeschobene Zinszahlungen

("Aufgeschobene Zinszahlungen").


fails to make any payment of principal under the Notes

when due, the Notes will cease to bear interest from the

beginning of the day on which such payment is made.

In such case the applicable rate of interest will be

determined pursuant to this § 3.

**§ 4**

**DUE DATE FOR INTEREST PAYMENTS,**

**DEFERRAL OF INTEREST PAYMENTS, PAYMENT**

**OF ARREARS OF INTEREST**

(1) _Due Date for Interest Payments; Optional Interest_

_Deferral. Interest which accrues during an Interest_

Period will be due and payable (fällig) on the relevant

Interest Payment Date, unless the Issuer elects, by

giving notice to the Holders not less than 10 Business

Days prior to the relevant Interest Payment Date in

accordance with § 13, to defer the relevant payment of

interest (in whole but not in part).

If the Issuer elects not to pay accrued interest on an

Interest Payment Date, then it will not have any

obligation to pay such interest on such Interest

Payment Date and will constitute Arrears of Interest

(as defined below). Any such non-payment of interest

will not constitute a default of the Issuer or any other

breach of its obligations under the Notes or for any

other purpose.

Interest not due and payable in accordance with this

§ 4(1) will constitute arrears of interest ("Arrears of

**Interest").**


Aufgeschobene Zinszahlungen werden nicht verzinst. Arrears of Interest will not bear interest.


(2) _Freiwillige_ _Zahlung_ _von_ _Aufgeschobenen_

_Zinszahlungen._ Die Emittentin ist berechtigt,

ausstehende Aufgeschobene Zinszahlungen jederzeit

insgesamt, jedoch nicht teilweise, nach

Bekanntmachung an die Gläubiger unter Einhaltung

einer Frist von nicht weniger als 10 Geschäftstagen vor

einer solchen freiwilligen Zinszahlung zu zahlen,

wobei eine solche Bekanntmachung (i) den Betrag an

Aufgeschobenen Zinszahlungen, der gezahlt werden

soll, und (ii) den für diese Zahlung festgelegten Termin

enthalten muss.


(2) _Optional Settlement of Arrears of Interest. The Issuer_

will be entitled to pay outstanding Arrears of Interest

in whole but not in part at any time by giving notice to

the Holders not less than 10 Business Days before such

voluntary payment and specifying (i) the amount of

Arrears of Interest to be paid and (ii) the date fixed for

such payment.


-----

(3) _Pflicht_ _zur_ _Zahlung_ _von_ _Aufgeschobenen_

_Zinszahlungen._ Die Emittentin ist verpflichtet,

Aufgeschobene Zinszahlungen insgesamt und nicht

nur teilweise am nächsten Pflichtnachzahlungstag zu

zahlen.

"Pflichtnachzahlungstag" bezeichnet den frühesten

der folgenden Tage:

(i) den Tag, der fünf Geschäftstage nach dem Tag

liegt, an dem ein Obligatorisches

Nachzahlungsereignis eingetreten ist;

(ii) den Tag, an dem die Emittentin Zinsen auf die

Schuldverschreibungen zahlt;

(iii) den Tag, an dem die Emittentin oder eine

Tochtergesellschaft eine Dividende, sonstige

Ausschüttung oder sonstige Zahlung auf eine

Gleichrangige Verbindlichkeit leistet;

(iv) den Tag, an dem die Emittentin oder eine

Tochtergesellschaft eine Gleichrangige

Verbindlichkeit oder eine Schuldverschreibung

zurückzahlt, zurückkauft oder anderweitig

erwirbt (jeweils direkt oder indirekt);

(v) den Tag der Rückzahlung der

Schuldverschreibungen gemäß diesen

Anleihebedingungen; und

(vi) den Tag, an dem eine Entscheidung hinsichtlich

der Auseinandersetzung, Liquidation oder

Auflösung der Emittentin ergeht (sofern dies

nicht für die Zwecke oder als Folge eines

Zusammenschlusses, einer Umstrukturierung

oder Sanierung geschieht, bei dem bzw. bei der

die Emittentin noch zahlungsfähig ist und bei

dem bzw. bei der die fortführende Gesellschaft

im Wesentlichen alle Vermögenswerte und

Verpflichtungen der Emittentin übernimmt),


(3) _Mandatory Payment of Arrears of Interest. The Issuer_

must pay Arrears of Interest (in whole but not in part)

on the next Mandatory Settlement Date.

"Mandatory Settlement Date" means the earliest of:

(i) the date falling five Business Days after the date

on which a Compulsory Settlement Event has

occurred;

(ii) the date on which the Issuer pays interest on the

Notes;

(iii) the date on which the Issuer or any Subsidiary

pays any dividend, other distribution or other

payment in respect of any Parity Obligation;

(iv) the date on which the Issuer or any Subsidiary

redeems, repurchases or otherwise acquires (in

each case directly or indirectly) any Parity

Obligations or any Notes;

(v) the date of redemption of the Notes in

accordance with these Terms and Conditions;

and

(vi) the date on which an order is made for the

winding up, liquidation or dissolution of the

Issuer (other than for the purposes of or pursuant

to an amalgamation, reorganization or

restructuring whilst solvent, where the

continuing entity assumes substantially all of the

assets and obligations of the Issuer),


mit der Maßgabe, dass provided that


(x) in den vorgenannten Fällen (iii) und (iv) kein

Pflichtnachzahlungstag vorliegt, wenn die

Emittentin oder die betreffende

Tochtergesellschaft nach Maßgabe der

Anleihebedingungen der betreffenden

Gleichrangigen Verbindlichkeit zu der Zahlung,

zu der Rückzahlung, zu dem Rückkauf oder zu

dem anderweitigen Erwerb verpflichtet ist;

(y) in dem vorgenannten Fall (iv) kein

Pflichtnachzahlungstag vorliegt, wenn die


(x) in the cases (iii) and (iv) above no Mandatory

Settlement Date occurs if the Issuer or the

relevant Subsidiary is obliged under the terms

and conditions of such Parity Obligation to make

such payment, such redemption, such

repurchase or such other acquisition;

(y) in the case (iv) above no Mandatory Settlement

Date occurs if the Issuer or the relevant


-----

Emittentin oder die betreffende

Tochtergesellschaft (jeweils direkt oder

indirekt) Gleichrangige Verbindlichkeiten oder

Schuldverschreibungen (insgesamt oder

teilweise) nach einem öffentlichen

Rückkaufangebot oder öffentlichen

Umtauschangebot mit einer unter dem

Nennwert liegenden Gegenleistung je

Gleichrangiger Verbindlichkeit bzw. je

Schuldverschreibung zurückkauft oder

anderweitig erwirbt; und

(z) in den vorgenannten Fällen (iii) und (iv) kein

Pflichtnachzahlungstag vorliegt, wenn die

betreffenden Zahlungen auf oder in Bezug auf

Gleichrangige Wertpapiere Konzerninterne

Zahlungen sind.

Ein "Obligatorisches **Nachzahlungsereignis"**

bezeichnet vorbehaltlich des nachstehenden Satzes 2

jedes der folgenden Ereignisse:

(i) die ordentliche Hauptversammlung der

Emittentin beschließt, eine Dividende, sonstige

Ausschüttung oder sonstige Zahlung auf eine

Aktie einer beliebigen Gattung der Emittentin zu

leisten (mit Ausnahme einer Dividende,

Ausschüttung oder Zahlung in Form von

Stammaktien der Emittentin);

(ii) die Emittentin oder eine Tochtergesellschaft

zahlt eine Dividende, sonstige Ausschüttung

oder sonstige Zahlung auf eine Nachrangige

Verbindlichkeit (mit Ausnahme einer

Dividende, Ausschüttung oder Zahlung in Form

von Stammaktien der Emittentin); oder

(iii) die Emittentin oder eine Tochtergesellschaft

(jeweils direkt oder indirekt) zahlt oder kauft

eine Nachrangige Verbindlichkeit zurück oder

erwirbt sie anderweitig.

In den vorgenannten Fällen (ii) und (iii) tritt jedoch

kein Obligatorisches Nachzahlungsereignis ein, wenn

(x) die Emittentin oder die betreffende

Tochtergesellschaft nach Maßgabe der

Anleihebedingungen der betreffenden

Nachrangigen Verbindlichkeit zu der Zahlung,

zu der Rückzahlung, zu dem Rückkauf oder zu

dem anderweitigen Erwerb verpflichtet ist;

(y) die Emittentin oder die betreffende

Tochtergesellschaft Aktien einer beliebigen


Subsidiary repurchases or otherwise acquires (in

each case directly or indirectly) any Parity

Obligations or any Notes in whole or in part in a

public tender offer or public exchange offer at a

consideration per Parity Obligation or Note

below its par value; and

(z) in the cases (iii) and (iv) above no Mandatory

Settlement Date occurs if the relevant payments

on, or in respect of, any Parity Securities are

Intra-Group Payments.

"Compulsory Settlement Event" means any of the

following events, subject to the proviso in sentence 2

below:

(i) the ordinary general meeting of shareholders

(ordentliche Hauptversammlung) of the Issuer

resolves on the payment of any dividend, other

distribution or other payment on any share of

any class of the Issuer (other than a dividend,

distribution or payment which is made in the

form of ordinary shares of the Issuer);

(ii) the Issuer or any Subsidiary pays any dividend,

other distribution or other payment in respect of

any Junior Obligation (other than a dividend,

distribution or payment which is made in the

form of ordinary shares of the Issuer); or

(iii) the Issuer or any Subsidiary redeems,

repurchases or otherwise acquires (in each case

directly or indirectly) any Junior Obligation.

The cases (ii) and (iii) above are subject to the proviso

that no Compulsory Settlement Event occurs if

(x) the Issuer or the relevant Subsidiary is obliged

under the terms and conditions of such Junior

Obligation to make such payment, such

redemption, such repurchase or such other

acquisition;

(y) the Issuer or the relevant Subsidiary repurchases

or otherwise acquires (in each case directly or


-----

Gattung der Emittentin oder eine Nachrangige

Verbindlichkeit nach Maßgabe eines

bestehenden oder zukünftigen Aktienoptions
oder Aktienbeteiligungsprogramms oder

ähnlichen Programms für Mitglieder des

Vorstands oder des Aufsichtsrats (oder, im Falle

verbundener Unternehmen, ähnlicher Gremien)

oder Mitarbeiter der Emittentin oder mit ihr

verbundener Unternehmen (jeweils direkt oder

indirekt) zurückkauft oder anderweitig erwirbt;

oder

(z) die betreffenden Zahlungen auf oder in Bezug

auf Nachrangige Verbindlichkeiten

Konzerninterne Zahlungen sind.

"Konzerninterne Zahlungen" sind Zahlungen, die

ausschließlich von einer Tochtergesellschaft an die

Emittentin und/oder von einer Tochtergesellschaft an

andere Tochtergesellschaften erfolgen.

**§ 5**

**RÜCKZAHLUNG**

(1) _Rückzahlung bei Endfälligkeit. Soweit nicht vorzeitig_

zurückgezahlt oder angekauft und entwertet, werden

die Schuldverschreibungen am 25. März 2082 (der

"Endfälligkeitstag") zu ihrer festgelegten Stückelung

zuzüglich Aufgeschobener Zinszahlungen

zurückgezahlt.


indirectly) any share of any class of the Issuer or

any Junior Obligation pursuant to the

obligations of the Issuer under any existing or

future stock option or stock ownership

programme or similar programme for any

members of the board of management or

supervisory board (or, in the case of affiliates,

comparable boards) or employees of the Issuer

or any of its affiliates; or

(z) the relevant payments on, or in respect of, any

Junior Obligation are Intra-Group Payments.

"Intra-Group Payments" means payments made by a

Subsidiary to the Issuer and/or by one Subsidiary to

another.

**§ 5**

**REDEMPTION**

(1) _Redemption at Maturity. Unless redeemed or_

purchased and cancelled earlier, the Notes will be

redeemed on 25 March 2082 (the "Maturity Date") at

their Specified Denomination plus any Arrears of

Interest.


(2) _Vorzeitige Rückzahlung nach Wahl der Emittentin._ (2) _Early Redemption at the Option of the Issuer._


(a) Die Emittentin kann die Schuldverschreibungen

(insgesamt, jedoch nicht teilweise) mit Wirkung

(i) zu jedem Tag während des Zeitraums ab dem

25. Juni 2030 (der "Erste **Optionale**

**Rückzahlungstag") bis zum Ersten Reset-**

Termin (jeweils einschließlich) und (ii) zu

jedem danach folgenden Zinszahlungstag nach

unwiderruflicher Kündigungsmitteilung an die

Gläubiger gemäß § 13 unter Einhaltung einer

Frist von mindestens 10 und nicht mehr als 40

Geschäftstagen kündigen.

(b) Eine solche Kündigungsmitteilung verpflichtet

die Emittentin, jede ausstehende

Schuldverschreibung an dem in der

Bekanntmachung festgelegten Rückzahlungstag

zu ihrer festgelegten Stückelung zuzüglich bis

dem in der Bekanntmachung festgelegten

Rückzahlungstag (ausschließlich) aufgelaufener


(a) The Issuer may call and redeem the Notes (in

whole but not in part) with effect (i) as of any

day during the period from and including

25 June 2030 (the "First Optional Redemption

**Date") to and including the First Reset Date and**

(ii) on any Interest Payment Date thereafter upon

giving not less than 10 nor more than 40

Business Days' irrevocable notice of redemption

to the Holders in accordance with § 13.

(b) Such notice of redemption shall oblige the Issuer

to redeem each outstanding Note on the

redemption date specified in the notice at their

Specified Denomination plus interest accrued to

but excluding the redemption date specified in

the notice and any outstanding Arrears of

Interest.


-----

Zinsen sowie Aufgeschobener Zinszahlungen

zurückzuzahlen.

(3) _Andere_ _vorzeitige_ _Rückzahlungsereignisse._ Die

Emittentin ist berechtigt, durch Bekanntmachung

gemäß § 13 unter Einhaltung einer Frist von nicht

weniger als 10 und nicht mehr als 60 Tagen, die

Schuldverschreibungen (insgesamt und nicht nur

teilweise) jederzeit zu kündigen, falls eines der

folgenden vorzeitigen Rückzahlungsereignisse ein
getreten ist. Im Falle einer solchen Kündigung ist die

Emittentin verpflichtet, jede ausstehende

Schuldverschreibung an dem in der Bekanntmachung

festgelegten Rückzahlungstag zu ihrem Vorzeitigen

Rückzahlungsbetrag zuzüglich bis zu dem in der

Bekanntmachung festgelegten Rückzahlungstag

(ausschließlich) aufgelaufener Zinsen sowie

Aufgeschobener Zinszahlungen zurückzuzahlen. Die

Bekanntmachung hat die zugrundeliegenden

Tatsachen des Rechts der Emittentin auf vorzeitige

Rückzahlung und den Rückzahlungstag anzugeben.


(3) _Other Early Redemption Events. The Issuer may, upon_

giving not less than 10 nor more than 60 days' notice

pursuant to § 13, call the Notes for redemption (in

whole but not in part) at any time, if any of the early

redemption events as set forth below has occurred. In

this case the Issuer shall redeem each outstanding Note

on the redemption date specified in the notice at its

Early Redemption Amount plus interest accrued to but

excluding the redemption date specified in the notice

and any Arrears of Interest. The notice shall set forth

the underlying facts of the Issuer's right to early

redemption and specify the redemption date.


(a) Ein "Ratingereignis" tritt ein, wenn entweder: (a) A "Rating Event" shall occur if either:


(i) eine Ratingagentur eine Veränderung in

der Methodologie für Hybridkapital oder

der Interpretation dieser Methodologie

veröffentlicht, wodurch entweder (x) die

Schuldverschreibungen nicht mehr länger

in derselben oder einer höheren

Eigenkapitalanrechnung (oder eine

vergleichbare Beschreibung, die von der

Ratingagentur in Zukunft genutzt wird,

um zu beschreiben in wieweit die

Bedingungen eines Instruments die

vorrangigen Verbindlichkeiten der

Emittentin unterstützen) (die

"Eigenkapitalanrechnung") wie an dem

Tag der Begebung der

Schuldverschreibungen einzuordnen sind

oder, wenn keine Eigenkapitalanrechnung

am Tag der Begebung der

Schuldverschreibungen von der

Ratingagentur bestimmt wurde, an dem

Tag, an dem erstmals die

Eigenkapitalanrechnung von der

Ratingagentur bestimmt wird (ein

"Verlust **der**

**Eigenkapitalanrechnung")** (dies gilt

auch für den Fall, dass die

Schuldverschreibungen nach deren Tag


(i) any Rating Agency publishes a change in

hybrid capital methodology or the

interpretation thereof, as a result of which

change, either, (x) the Notes would no

longer be eligible for the same or a higher

category of "equity credit" or such similar

nomenclature as may be used by that

Rating Agency from time to time to

describe the degree to which the terms of

an instrument are supportive of the

Issuer's senior obligations (the "equity

**credit"), attributed to the Notes at the date**

of issue of the Notes, or if "equity credit"

is not assigned on the date of issue of the

Notes by such Rating Agency, at the date

when the equity credit is assigned for the

first time by such Rating Agency (a "Loss

**in Equity Credit") (this also applies if the**

Notes have been partially or fully re
financed since the date of issue of the

Notes (or the date when the equity credit

is assigned for the first time by such

Rating Agency, as the case may be) and a

Loss in Equity Credit would have also

been occurred as a result of such change

had the Notes not been re-financed), or

(y) the period of time the Notes are


-----

der Begebung (bzw. dem Tag, an dem

erstmals die Eigenkapitalanrechnung von

der Ratingagentur bestimmt wird)

teilweise oder insgesamt refinanziert

wurden und der Verlust der

Eigenkapitalanrechnung aufgrund der

Veränderung auch eingetreten wäre, wenn

die Refinanzierung nicht zuvor erfolgt

wäre), oder (y) der Zeitraum, für die die

Schuldverschreibungen in derselben oder

einer höheren Eigenkapitalanrechnung

wie an dem Tag der Begebung der

Schuldverschreibungen (bzw. dem Tag,

an dem erstmals die

Eigenkapitalanrechnung von der

Ratingagentur bestimmt wird)

einzuordnen sind, verkürzt wird (eine

"Verkürzung **der**

**Eigenkapitalanrechnung"), oder**

(ii) die Emittentin eine schriftliche

Bestätigung von einer Ratingagentur

erhalten und diese an die Hauptzahlstelle

in Kopie weitergegeben hat, oder die

Ratingagentur eine Veröffentlichung

veranlasst hat, welche besagt, dass

aufgrund einer Änderung der

Methodologie für Hybridkapital oder der

Interpretation dieser Methodologie, ein

Verlust der Eigenkapitalanrechnung oder

eine Verkürzung der

Eigenkapitalanrechnung erfolgt ist,

und die Emittentin die Gläubiger über das

Ratingereignis gemäß § 13 informiert hat bevor

die Mitteilung der Rückzahlung (wie oben

beschrieben) bekanntgemacht wurde.

"Ratingagentur" bezeichnet jeweils Moody's,

S&P und Fitch, wobei "Moody's" die Moody's

Investors Service Ltd oder eine ihrer

Nachfolgegesellschaften bezeichnet, "S&P" die

S&P Global Ratings Europe Limited bezeichnet

und "Fitch" die Fitch Ratings Limited oder eine

ihrer Nachfolgegesellschaften bezeichnet, oder

eine andere durch die Emittentin bezeichnete

Ratingagentur mit gleichwertiger internationaler

Anerkennung sowie jeweils ihre Tochter- oder

Nachfolgegesellschaften.

(b) Ein "Steuerereignis" tritt ein, wenn die

Emittentin ein Gutachten einer international


eligible for the same or a higher category

of equity credit attributed to the Notes at

the date of issue of the Notes (or the date

when the equity credit is assigned for the

first time by such Rating Agency, as the

case may be) is being shortened (a

"Shortening in Equity Credit"), or

(ii) the Issuer has received, and has provided

the Principal Paying Agent with a copy of,

a written confirmation from any Rating

Agency or an official publication by such

Rating Agency that due to a change in

hybrid capital methodology or the

interpretation thereof, a Loss in Equity

Credit or a Shortening in Equity Credit

occurred,

and the Issuer has given notice to the Holders in

accordance with § 13 of such Rating Event prior

to giving the notice of redemption referred to

above.

"Rating Agency" means each of Moody's, S&P

and Fitch, where "Moody's" means Moody's

Investors Service Ltd or any of its successors,

"S&P" means S&P Global Ratings Europe

Limited and "Fitch" means Fitch Ratings

Limited or any of its successors, or any other

rating agency of equivalent international

standing specified from time to time by the

Issuer and, in each case their respective

subsidiaries or successors.

(b) A "Tax Deductibility Event" shall occur if an

opinion of a recognized law firm of international


-----

anerkannten Rechtsanwaltskanzlei erhalten hat,

aus dem hervorgeht, dass nach dem

Zinslaufbeginn als Folge einer Änderung von

deutschem Recht oder dessen offizieller

Auslegung oder Anwendung die steuerliche

Behandlung dergestalt geändert wurde, dass der

Zinsaufwand der Emittentin in Bezug auf die

Schuldverschreibungen für Zwecke der

Körperschaftsteuer nicht mehr vollständig

abzugsfähig ist, und die Emittentin dieses Risiko

nicht durch das Ergreifen zumutbarer

Maßnahmen vermeiden kann. Klarstellend sei

erwähnt, dass als eine Änderung auch eine

offizielle Auslegung oder Anwendung gilt, die

zum ersten Mal öffentlich bekannt geworden ist.

(c) Ein "Gross-up-Ereignis" tritt ein, wenn die

Emittentin als Folge einer Änderung von

deutschen Gesetzen oder veröffentlichten

Vorschriften nach dem Zinslaufbeginn

verpflichtet ist, sämtliche gemäß § 8 zahlbaren

zusätzlichen Beträge zu zahlen, allerdings nur

soweit die Emittentin die Zahlungsverpflichtung

nicht durch das Ergreifen zumutbarer

Maßnahmen vermeiden kann, die sie nach Treu

und Glauben für angemessen hält.

(d) Der "Vorzeitige **Rückzahlungsbetrag"**

bezeichnet (i) im Falle eines Ratingereignisses

oder eines Steuerereignisses, an dem der

maßgebliche für die Rückzahlung festgelegte

Tag vor dem Ersten Optionalen

Rückzahlungstag fällt, 101% der festgelegten

Stückelung, und (ii) im Falle eines

Ratingereignisses oder eines Steuerereignisses,

an dem der maßgebliche für die Rückzahlung

festgelegte Tag auf den oder nach dem Ersten

Optionalen Rückzahlungstag fällt und im Falle

eines Gross-up-Ereignisses, 100% der

festgelegten Stückelung.

(4) _Vorzeitige_ _Rückzahlung bei geringem ausstehendem_

_Gesamtnennbetrag._ Die Emittentin ist berechtigt,

durch Bekanntmachung gemäß § 13 unter Einhaltung

einer Frist von nicht weniger als 10 und nicht mehr als

60 Tagen, die Schuldverschreibungen (insgesamt und

nicht nur teilweise) jederzeit zu kündigen, falls

mindestens 75 % des ursprünglich begebenen

Gesamtnennbetrages der Schuldverschreibungen

(einschließlich Schuldverschreibungen, die gemäß

§ 12(1) zusätzlich begeben worden sind)


standing has been delivered to the Issuer, stating

that by reason of a change in German law or

regulation, or any change in the official

application or interpretation of such law, after

the Interest Commencement Date, the tax

regime is modified and such modification results

in the interest expense of the Issuer in respect of

the Notes being no longer fully deductible for

corporate income tax purposes, and such risk

cannot be avoided by the Issuer taking

reasonable measures available to it. For the

avoidance of doubt, a change shall also be

deemed to be an official interpretation or

application that has become publicly known for

the first time.

(c) A "Gross-up Event" shall occur if, by reason of

any change in German law or published

regulations becoming effective after the Interest

Commencement Date, the Issuer would have to

pay any additional amounts which may be

payable under § 8, provided that the payment

obligation cannot be avoided by the Issuer

taking such reasonable measures it (acting in

good faith) deems appropriate.

(d) The "Early Redemption Amount" shall be (i)

in case of a Rating Event or a Tax Deductibility

Event where the relevant date fixed for

redemption falls prior to the First Optional

Redemption Date, equal to 101 per cent. of the

Specified Denomination, and (ii) in the case of a

Rating Event or a Tax Deductibility Event where

the relevant date fixed for redemption falls on or

after the First Optional Redemption Date or in

case of a Gross-Up Event, equal to 100 per cent.

of the Specified Denomination.

(4) _Early Redemption in Case of Minimum Outstanding_

_Aggregate Principal Amount. The Issuer may, upon_

giving not less than 10 nor more than 60 days' notice

pursuant to § 13, call the Notes for redemption (in

whole but not in part) at any time if at least 75 per cent.

of the originally issued aggregate principal amount of

the Notes (including any Notes additionally issued in

accordance with § 12(1)) have been redeemed or

purchased and cancelled. In this case the Issuer shall

redeem each outstanding Note on the redemption date


-----

zurückgezahlt oder erworben und eingezogen worden

sind. Im Falle einer solchen Kündigung ist die

Emittentin verpflichtet, jede ausstehende

Schuldverschreibung an dem in der Bekanntmachung

festgelegten Rückzahlungstag zu ihrer festgelegten

Stückelung zuzüglich bis zu dem in der

Bekanntmachung festgelegten Rückzahlungstag

(ausschließlich) aufgelaufener Zinsen sowie

Aufgeschobener Zinszahlungen zurückzuzahlen.

**§ 6**

**ZAHLUNGEN**

(1) (a) _Zahlungen auf Kapital. Zahlungen auf Kapital in_

Bezug auf die Schuldverschreibungen erfolgen

nach Maßgabe von § 6(2) an das Clearing

System oder gegebenenfalls dessen Order zur

Gutschrift auf den Konten der jeweiligen

Kontoinhaber des Clearing Systems.

(b) _Zahlung von Zinsen. Die Zahlung von Zinsen_

auf Schuldverschreibungen erfolgt nach

Maßgabe von § 6(2) an das Clearing System

oder gegebenenfalls dessen Order zur Gutschrift

auf den Konten der jeweiligen Kontoinhaber des

Clearing Systems.

Die Zahlung von Zinsen auf Schuldverschreibungen,

die durch die vorläufige Globalurkunde verbrieft sind,

erfolgt nach Maßgabe von § 6(2) an das Clearing

System oder gegebenenfalls dessen Order zur

Gutschrift auf den Konten der jeweiligen

Kontoinhaber des Clearing Systems, und zwar nach

ordnungsgemäßer Bescheinigung gemäß § 1(3)(b).

(2) _Zahlungsweise. Vorbehaltlich geltender steuerlicher_

und sonstiger gesetzlicher Regelungen und

Vorschriften erfolgen zu leistende Zahlungen auf die

Schuldverschreibungen in der festgelegten Währung.

(3) _Vereinigte Staaten. Für die Zwecke des § 1(3) und_

§ 6(1) bezeichnet "Vereinigte **Staaten"** die

Vereinigten Staaten von Amerika (einschließlich deren

Bundesstaaten und des District of Columbia) sowie

deren Territorien (einschließlich Puerto Rico, der U.S.

Virgin Islands, Guam, American Samoa, Wake Island

und Northern Mariana Islands).

(4) _Erfüllung._ Die Emittentin wird durch Leistung der

Zahlung an das Clearing System oder dessen Order

von ihrer Zahlungspflicht befreit.


specified in the notice at its Specified Denomination

plus interest accrued to but excluding the redemption

date specified in the notice and any Arrears of Interest.

**§ 6**

**PAYMENTS**

(1) (a) _Payment of Principal. Payment of principal in_

respect of Notes shall be made, subject to § 6(2),

to the Clearing System or (if applicable) to its

order for credit to the accounts of the relevant

account holders of the Clearing System.

(b) _Payment of Interest. Payment of interest on_

Notes shall be made, subject to § 6(2), to the

Clearing System or (if applicable) to its order for

credit to the relevant account holders of the

Clearing System.

Payment of interest on Notes represented by the

Temporary Global Note shall be made, subject to

§ 6(2), to the Clearing System or (if applicable) to its

order for credit to the relevant account holders of the

Clearing System, upon due certification as provided in

§ 1(3)(b).

(2) _Manner of Payment. Subject to applicable fiscal and_

other laws and regulations, payments of amounts due

in respect of the Notes shall be made in the Specified

Currency.

(3) _United States. For purposes of § 1(3) and § 6(1),_

"United States" means the United States of America

(including the States thereof and the District of

Columbia) and its possessions (including Puerto Rico,

the U.S. Virgin Islands, Guam, American Samoa,

Wake Island and Northern Mariana Islands).

(4) _Discharge. The Issuer shall be discharged by payment_

to, or to the order of, the Clearing System.


-----

(5) _Zahltag._ Fällt der Fälligkeitstag einer Zahlung in

Bezug auf eine Schuldverschreibung auf einen Tag,

der kein Geschäftstag ist, dann hat der Gläubiger

keinen Anspruch auf Zahlung vor dem nächsten

Geschäftstag. Der Gläubiger ist nicht berechtigt,

weitere Zinsen oder sonstige Zahlungen aufgrund

dieser Verspätung zu verlangen.

(6) _Bezugnahmen auf Kapital und Zinsen. Bezugnahmen_

in diesen Anleihebedingungen auf einen Kapitalbetrag

der Schuldverschreibungen schließen, soweit

anwendbar, die folgenden Beträge ein: die festgelegte

Stückelung der Schuldverschreibungen, den

Vorzeitigen Rückzahlungsbetrag sowie sonstige auf

oder in Bezug auf die Schuldverschreibungen

zahlbaren Beträge. Bezugnahmen in diesen

Anleihebedingungen auf Zinsen auf die

Schuldverschreibungen sollen, soweit anwendbar,

sämtliche gemäß § 8 zahlbaren zusätzlichen Beträge

einschließen.

(7) _Hinterlegung von Kapital und Zinsen. Die Emittentin_

ist berechtigt, beim Amtsgericht Frankfurt am Main

Zins- oder Kapitalbeträge zu hinterlegen, die von den

Gläubigern nicht innerhalb von zwölf Monaten nach

dem jeweiligen Fälligkeitstag beansprucht worden

sind, auch wenn die Gläubiger sich nicht in

Annahmeverzug befinden. Soweit eine solche

Hinterlegung erfolgt, und auf das Recht der

Rücknahme verzichtet wird, erlöschen die Ansprüche

der Gläubiger gegen die Emittentin.

**§ 7**

**VERWALTUNGSSTELLEN**

(1) _Bestellung;_ _bezeichnete_ _Geschäftsstelle._ Die

anfänglich bestellte Hauptzahlstelle und die anfänglich

bestellte Berechnungsstelle und ihre bezeichneten

Geschäftsstellen lauten wie folgt:


(5) _Payment Business Day. If the date for payment of any_

amount in respect of any Note is not a Business Day

then the Holder shall not be entitled to payment until

the next day that is a Business Day and shall not be

entitled to further interest or other payment in respect

of such delay.

(6) _References to Principal and Interest. Reference in_

these Terms and Conditions to principal in respect of

the Notes shall be deemed to include, as applicable: the

Specified Denomination of the Notes, the Early

Redemption Amount and any other amounts which

may be payable under or in respect of the Notes.

Reference in these Terms and Conditions to interest in

respect of the Notes shall be deemed to include, as

applicable, any additional amounts which may be

payable under § 8.

(7) _Deposit of Principal and Interest. The Issuer may_

deposit with the _Amtsgericht in Frankfurt am Main_

principal or interest not claimed by Holders within

twelve months after the relevant due date, even though

such Holders may not be in default of acceptance of

payment. If and to the extent that the deposit is effected

and the right of withdrawal is waived, the respective

claims of such Holders against the Issuer shall cease.

**§ 7**

**AGENTS**

(1) _Appointment; Specified Offices. The initial Principal_

Paying Agent and the initial Calculation Agent and

their respective initial specified offices are:


Hauptzahlstelle: Principal Paying Agent:


**Deutsche Bank Aktiengesellschaft**

Taunusanlage 12

60325 Frankfurt am Main

Deutschland


**Deutsche Bank Aktiengesellschaft**

Taunusanlage 12

60325 Frankfurt am Main

Germany


Berechnungsstelle: Calculation Agent:


**Deutsche Bank Aktiengesellschaft**

Taunusanlage 12

60325 Frankfurt am Main

Deutschland


**Deutsche Bank Aktiengesellschaft**

Taunusanlage 12

60325 Frankfurt am Main

Germany


-----

Die Hauptzahlstelle und die Berechnungsstelle

behalten sich das Recht vor, jederzeit ihre

bezeichneten Geschäftsstellen durch eine andere

bezeichnete Geschäftsstelle in derselben Stadt zu

ersetzen.

(2) _Änderung der Bestellung oder Abberufung. Die_

Emittentin behält sich das Recht vor, jederzeit die

Bestellung der Hauptzahlstelle oder der

Berechnungsstelle zu ändern oder zu beenden und eine

andere Hauptzahlstelle, zusätzliche Zahlstellen oder

eine andere Berechnungsstelle zu bestellen. Die

Emittentin wird zu jedem Zeitpunkt (i) eine

Hauptzahlstelle unterhalten und (ii) eine

Berechnungsstelle unterhalten. Eine Änderung,

Abberufung, Bestellung oder ein sonstiger Wechsel

wird nur wirksam (außer im Insolvenzfall, in dem eine

solche Änderung sofort wirksam wird), sofern die

Gläubiger hierüber gemäß § 13 vorab unter Einhaltung

einer Frist von mindestens 30 und nicht mehr als 45

Tagen informiert wurden.

(3) _Beauftragte der Emittentin. Die Hauptzahlstelle und_

die Berechnungsstelle handeln ausschließlich als

Beauftragte der Emittentin und übernehmen keinerlei

Verpflichtungen gegenüber den Gläubigern und es

wird kein Auftrags- oder Treuhandverhältnis zwischen

ihnen und den Gläubigern begründet.

(4) Wenn die Emittentin gemäß § 3(5) einen

Unabhängigen Berater bestellt, dann ist § 7(3)

entsprechend auf den Unabhängigen Berater

anzuwenden.

**§ 8**

**STEUERN**

Sämtliche auf die Schuldverschreibungen zu zahlenden

Beträge sind an der Quelle ohne Einbehalt oder Abzug von

oder aufgrund von gegenwärtig oder zukünftig bestehenden

Steuern oder sonstigen Abgaben gleich welcher Art zu

leisten, die von oder in der Bundesrepublik Deutschland oder

für deren Rechnung oder von oder für Rechnung einer mit

dem Recht zur Steuererhebung versehenen politischen

Untergliederung oder Behörde der Vorgenannten auferlegt

oder erhoben werden (zusammen "Quellensteuer"), es sei

denn, dieser Einbehalt oder Abzug ist gesetzlich

vorgeschrieben. Wenn die Emittentin gesetzlich zu einem

Einbehalt oder Abzug von Quellensteuern verpflichtet ist,

wird die Emittentin diejenigen zusätzlichen Beträge zahlen,

die erforderlich sind, damit die den Gläubigern zufließenden

Nettobeträge nach diesem Einbehalt oder Abzug jeweils den


The Principal Paying Agent and the Calculation Agent

reserve the right at any time to change their respective

specified offices to some other specified offices in the

same city.

(2) _Variation or Termination of Appointment. The Issuer_

reserves the right at any time to vary or terminate the

appointment of the Principal Paying Agent or the

Calculation Agent and to appoint another Principal

Paying Agent, additional paying agents or another

Calculation Agent. The Issuer shall at all times

maintain (i) a Principal Paying Agent and (ii) a

Calculation Agent. Any variation, termination,

appointment or change shall only take effect (other

than in the case of insolvency, when it shall be of

immediate effect) after not less than 30 nor more than

45 days' prior notice thereof shall have been given to

the Holders in accordance with § 13.

(3) _Agents of the Issuer. The Principal Paying Agent and_

the Calculation Agent act solely as agents of the Issuer

and do not have any obligations towards or relationship

of agency or trust to any Holder.

(4) If the Issuer appoints an Independent Advisor in

accordance with § 3(5), § 7(3) shall apply mutatis

mutandis to the Independent Advisor.

**§ 8**

**TAXATION**

Principal and interest shall be payable without deduction or

withholding for or on account of any present or future taxes,

duties or governmental charges of any nature whatsoever

imposed, levied or collected by or on behalf of Germany or

by or on behalf of any political subdivision or authority

thereof having power to tax (together "Withholding

**Taxes"), unless such deduction or withholding is required by**

law. If the Issuer is required by law to make a deduction or

withholding of Withholding Taxes, the Issuer shall pay such

additional amounts as may be necessary in order that the net

amounts received by the Holders after such deduction or

withholding shall equal the respective amounts of principal

and interest which would have been receivable had no such

deduction or withholding been required. No such additional


-----

Beträgen an Kapital und Zinsen entsprechen, die ohne einen

solchen Abzug oder Einbehalt von den Gläubigern

empfangen worden wären. Die Verpflichtung zur Zahlung

solcher zusätzlicher Beträge besteht jedoch nicht im Hinblick

auf Steuern und Abgaben, die:

(a) anders als durch Einbehalt oder Abzug von Zahlungen

zu entrichten sind, die die Emittentin an den Gläubiger

leistet; oder

(b) von einer als Depotbank oder Inkassobeauftragter des

Gläubigers handelnden Person abgezogen oder

einbehalten werden oder sonst auf andere Weise zu

entrichten sind als dadurch, dass die Emittentin aus den

von ihr zu leistenden Zahlungen von Kapital oder

Zinsen einen Abzug oder Einbehalt vornimmt; oder

(c) von der Hauptzahlstelle oder einer zusätzlich bestellten

Zahlstelle abgezogen oder einbehalten werden, wenn

eine andere Zahlstelle die Zahlung ohne einen solchen

Abzug oder Einbehalt hätte leisten können; oder

(d) aufgrund (i) einer Richtlinie oder Verordnung der

Europäischen Union betreffend die Besteuerung von

Zinserträgen oder (ii) einer zwischenstaatlichen

Vereinbarung über deren Besteuerung, an der die

Bundesrepublik Deutschland oder die Europäische

Union beteiligt ist/sind, oder (iii) einer gesetzlichen

Vorschrift, die diese Richtlinie, Verordnung oder

Vereinbarung umsetzt oder befolgt, abzuziehen oder

einzubehalten sind; oder

(e) aufgrund einer Rechtsänderung zu zahlen sind, welche

später als 30 Tage nach Fälligkeit der betreffenden

Zahlung von Kapital oder Zinsen oder, wenn dies

später erfolgt, ordnungsgemäßer Bereitstellung aller

fälligen Beträge wirksam wird; oder

(f) wegen einer gegenwärtigen oder früheren persönlichen

oder geschäftlichen Beziehung des Gläubigers zu der

Bundesrepublik Deutschland oder weil der Gläubiger

in der Bundesrepublik Deutschland wohnhaft ist bzw.

für Zwecke der Besteuerung so behandelt wird oder

weil der Gläubiger gewünscht hat, so behandelt zu

werden oder weil der Gläubiger einen dauerhaften

Wohnsitz in der Bundesrepublik Deutschland (oder so

behandelt wird) oder in einem anderen Mitgliedstaat

der Europäischen Union hat zu zahlen sind. Dies gilt

jedoch nicht allein deshalb, weil Zahlungen auf die

Schuldverschreibungen aus Quellen in der

Bundesrepublik Deutschland stammen (oder für


amounts shall, however, be payable on account of any taxes,

duties or governmental charges which:

(a) are payable otherwise than by withholding or

deduction from payments made by the Issuer to the

Holder, or

(b) are deducted or withheld by any person acting as

custodian bank or collecting agent on behalf of a

Holder, or otherwise payable in any manner which

does not constitute a deduction or withholding by the

Issuer from payments of principal or interest made by

it; or

(c) are deducted or withheld by the Principal Paying Agent

or an additional paying agent from a payment if the

payment could have been made by another paying

agent without such deduction or withholding; or

(d) are deducted or withheld pursuant to (i) any European

Union Directive or Regulation concerning the taxation

of savings, or (ii) any international treaty or

understanding relating to such taxation and to which

Germany or the European Union is a party/are parties

or (iii) any provision of law implementing, or

complying with, or introduced to conform with, such

Directive, Regulation, treaty or understanding; or

(e) are payable by reason of a change in law that becomes

effective more than 30 days after the relevant payment

becomes due, or is duly provided for, whichever occurs

later; or

(f) are payable by reason of the Holder having, or having

had, some personal or business connection with

Germany or being a (deemed) resident of Germany or

is treated for tax purposes as a resident of Germany or

has elected to be taxed as a resident of Germany or the

Holder having a (deemed) permanent establishment in

Germany or another member state of the European

Union and not merely by reason of the fact that

payments in respect of the Notes are, or for purposes

of taxation are deemed to be, derived from sources in,

or are secured in, Germany.


-----

Zwecke der Besteuerung so behandelt werden) oder

dort besichert sind.

Ungeachtet sonstiger hierin enthaltener Bestimmungen, darf

die Emittentin Beträge, die gemäß einer beschriebenen

Vereinbarung in Section 1471 (b) des U.S. Revenue Code

von 1986 (der "Code") erforderlich sind oder die anderweitig

aufgrund der Sections 1471 bis 1474 des Codes (oder jeder

geänderten oder Nachfolgeregelung), der Regelungen oder

Verträge darunter, der offiziellen Auslegungen davon oder

jeglicher rechtsausführender und zwischenstaatlicher

Zusammenarbeit dazu beruhen, einbehalten oder abziehen

("FATCA Quellensteuer"). Die Emittentin ist aufgrund

einer durch die Emittentin, die Hauptzahlstelle, eine

zusätzlich bestellte Zahlstelle oder eine andere Partei

abgezogenen oder einbehaltenen FATCA Quellensteuer

nicht zur Zahlung zusätzlicher Beträge oder anderweitig zur

Entschädigung der Gläubiger verpflichtet.

**§ 9**

**VORLEGUNGSFRIST**

Die in § 801 Absatz 1 Satz 1 BGB bestimmte

Vorlegungsfrist wird für Ansprüche aus den

Schuldverschreibungen auf zehn Jahre verkürzt.

**§ 10**

**ERSETZUNG**

(1) _Ersetzung. Die Emittentin ist jederzeit berechtigt,_

sofern sie sich nicht mit einer Zahlung von Kapital

oder Zinsen auf die Schuldverschreibungen in Verzug

befindet, ohne Zustimmung der Gläubiger jede andere

Gesellschaft, deren stimmberechtigte Anteile zu mehr

als 90% direkt oder indirekt von der Emittentin

gehalten werden, an Stelle der Emittentin als

Hauptschuldnerin (die "Nachfolgeschuldnerin") für

alle Verpflichtungen aus und im Zusammenhang mit

dieser Emission einzusetzen, vorausgesetzt, dass:

(a) die Nachfolgeschuldnerin alle Verpflichtungen

der Emittentin in Bezug auf die

Schuldverschreibungen übernimmt;

(b) die Nachfolgeschuldnerin alle erforderlichen

Genehmigungen erhalten hat und berechtigt ist,

an die Hauptzahlstelle die zur Erfüllung der

Zahlungsverpflichtungen aus den

Schuldverschreibungen zahlbaren Beträge in

Euro zu zahlen, ohne verpflichtet zu sein,

jeweils in dem Land, in dem die

Nachfolgeschuldnerin ihren Sitz oder Steuersitz


Notwithstanding any other provisions contained herein, the

Issuer shall be permitted to withhold or deduct any amounts

required pursuant to an agreement described in Section 1471

(b) of the U.S. Internal Revenue Code of 1986 (the "Code")

or otherwise imposed pursuant to Sections 1471 through

1474 of the Code (or any amended or successor provisions),

any regulations or agreements thereunder, official

interpretations thereof, or any law implementing and

intergovernmental approach thereto ("FATCA

**withholding"). The Issuer will have no obligation to pay**

additional amounts or otherwise indemnify any Holder for

any such FATCA withholding deducted or withheld by the

Issuer, the Principal Paying Agent, an additional paying

agent or any other party.

**§ 9**

**PRESENTATION PERIOD**

The presentation period provided in § 801 paragraph 1,

sentence 1 BGB (German Civil Code) is reduced to ten years

for claims under the Notes.

**§ 10**

**SUBSTITUTION**

(1) _Substitution._ The Issuer may, without the consent of

the Holders, if no payment of principal of or interest

on any of the Notes is in default, at any time substitute

for the Issuer any other company more than 90 percent

of the voting share or other equity interests of which

are directly or indirectly owned by the Issuer as

principal debtor in respect of all obligations arising

from or in connection with the Notes (the "Substitute

**Debtor") provided that:**

(a) the Substitute Debtor assumes all obligations of

the Issuer in respect of the Notes;

(b) the Substitute Debtor has obtained all necessary

authorizations and may transfer to the Principal

Paying Agent in Euro and without being

obligated to deduct or withhold any taxes or

other duties of whatever nature levied by the

country in which the Substitute Debtor has its

domicile or tax residence, all amounts required


-----

hat, erhobene Steuern oder andere Abgaben

jeder Art abzuziehen oder einzubehalten;

(c) die Nachfolgeschuldnerin sich verpflichtet hat,

jeden Gläubiger hinsichtlich solcher

Quellensteuern, Abgaben oder behördlichen

Lasten freizustellen, die einem Gläubiger

bezüglich der Ersetzung auferlegt werden;

(d) die Emittentin unwiderruflich und unbedingt

gegenüber den Gläubigern die Zahlung aller von

der Nachfolgeschuldnerin auf die

Schuldverschreibungen zahlbaren Beträge auf

nachrangiger Basis garantiert; und

(e) der Hauptzahlstelle jeweils ein Rechtsgutachten

bezüglich der betroffenen Rechtsordnungen von

anerkannten Rechtsanwälten vorgelegt werden,

die bestätigen, dass die Bestimmungen in den

vorstehenden Unterabsätzen (a), (b), (c) und (d)

erfüllt wurden.

(2) _Bekanntmachung. Jede Ersetzung ist gemäß § 13_

bekanntzumachen.

(3) _Änderung von Bezugnahmen. Im Fall einer Ersetzung_

gilt jede Bezugnahme in diesen Anleihebedingungen

auf die Emittentin ab dem Zeitpunkt der Ersetzung als

Bezugnahme auf die Nachfolgeschuldnerin und jede

Bezugnahme auf das Land, in dem die Emittentin ihren

Sitz oder Steuersitz hat, gilt ab diesem Zeitpunkt als

Bezugnahme auf das Land, in dem die

Nachfolgeschuldnerin ihren Sitz oder Steuersitz hat.

Außerdem gilt im Falle der Ersetzung in § 8 und

§ 5(3)(b) und (c) eine alternative Bezugnahme auf die

Bundesrepublik Deutschland als aufgenommen

zusätzlich zu der Bezugnahme nach Maßgabe des

vorstehenden Satzes auf das Land, in dem die

Nachfolgeschuldnerin ihren Sitz oder Steuersitz hat.

Klarstellend sei erwähnt, dass dies nur gilt, soweit sich

nicht aus Sinn und Zweck der jeweiligen Bedingung

ergibt, dass die Bezugnahme entweder weiterhin nur

auf die Bayer AG erfolgen soll (also insbesondere im

Hinblick auf Ziffer (i) der Definition des Begriffs

Obligatorisches Nachzahlungsereignis und das

Ratingereignis), oder dass die Bezugnahme auf die

Nachfolgeschuldnerin und gleichzeitig auch auf die

Bayer AG, im Hinblick auf deren Verpflichtungen aus

der Garantie gemäß § 10(1)(d), erfolgen soll (Gross
up-Ereignis, Steuerereignis und § 8).


for the fulfilment of the payment obligations

arising under the Notes;

(c) the Substitute Debtor has agreed to indemnify

and hold harmless each Holder against any

withholding tax, duty, assessment or

governmental charge imposed on such Holder in

respect of such substitution;

(d) the Issuer irrevocably and unconditionally

guarantees on a subordinated basis in favour of

each Holder the payment of all sums payable by

the Substitute Debtor in respect of the Notes;

and

(e) there shall have been delivered to the Principal

Paying Agent an opinion or opinions of lawyers

of recognized standing to the effect that

subparagraphs (a), (b), (c) and (d) above have

been satisfied.

(2) _Notice. Notice of any such substitution shall be_

published in accordance with § 13.

(3) _Change of References._ In the event of any such

substitution, any reference in these Terms and

Conditions to the Issuer shall from then on be deemed

to refer to the Substitute Debtor and any reference to

the country in which the Issuer is domiciled or resident

for taxation purposes shall from then on be deemed to

refer to the country of domicile or residence for

taxation purposes of the Substitute Debtor.

Furthermore, in the event of such substitution, in § 8

and § 5(3)(b) and (c) an alternative reference to

Germany shall be deemed to have been included in

addition to the reference according to the preceding

sentence to the country of domicile or residence for

taxation purposes of the Substitute Debtor.

For the avoidance of doubt this will apply only to the

extent that the meaning and purpose of the relevant

condition requires that the relevant reference will

continue to be a reference only to Bayer AG (i.e. in

particular in relation to clause (i) of the definition of

the term Compulsory Settlement Event and the Rating

Event), or that the reference will be to the Substitute

Debtor and Bayer AG, in relation to Bayer AG's

obligations under the guarantee pursuant to § 10(1)(d),

at the same time (Gross-up Event, Tax Deductibility

Event and § 8).


-----

Die Emittentin ist berechtigt, die Globalurkunde und

die Anleihebedingungen ohne Zustimmung der

Gläubiger anzupassen, soweit dies erforderlich ist, um

die Wirkungen der Ersetzung nachzuvollziehen.

Entsprechend angepasste Globalurkunden oder

Anleihebedingungen werden bei dem oder für das

Clearing System hinterlegt.

**§ 11**

**ÄNDERUNG DER ANLEIHEBEDINGUNGEN,**

**GEMEINSAMER VERTRETER**

(1) _Änderung der Anleihebedingungen. Die Emittentin_

kann mit Zustimmung der Gläubiger entsprechend den

Bestimmungen des Gesetzes über Schuldverschrei
bungen aus Gesamtemissionen (Schuldverschrei
bungsgesetz – "SchVG") die Anleihebedingungen

hinsichtlich eines nach dem SchVG zugelassenen

Gegenstands ändern. Die Gläubiger entscheiden über

ihre Zustimmung durch einen Beschluss mit der in

§ 11(2) bestimmten Mehrheit. Die

Mehrheitsbeschlüsse der Gläubiger sind für alle

Gläubiger gleichermaßen verbindlich. Ein

Mehrheitsbeschluss der Gläubiger, der nicht gleiche

Bedingungen für alle Gläubiger vorsieht, ist

unwirksam, es sei denn, die benachteiligten Gläubiger

stimmen ihrer Benachteiligung ausdrücklich zu.

(2) _Mehrheitserfordernisse. Die Gläubiger entscheiden_

mit einer Mehrheit von 75 % der an der Abstimmung

teilnehmenden Stimmrechte. Beschlüsse, durch

welche der wesentliche Inhalt der Anleihebedingungen

nicht geändert wird, und die keinen Gegenstand des § 5

Absatz 3 Nr. 1 bis Nr. 8 und (soweit § 10 dieser

Anleihebedingungen keine andere Regelung vorsieht)

Nr. 9 des SchVG betreffen, bedürfen zu ihrer

Wirksamkeit einer einfachen Mehrheit der an der

Abstimmung teilnehmenden Stimmrechte.

(3) _Abstimmung ohne Versammlung. Alle Abstimmungen_

werden, vorbehaltlich des nächsten Satzes,

ausschließlich im Wege der Abstimmung ohne

Versammlung durchgeführt. Eine

Gläubigerversammlung und eine Übernahme der

Kosten für eine solche Versammlung durch die

Emittentin finden ausschließlich im Fall des § 18

Absatz 4 Satz 2 SchVG statt. Die Gegenstände und

Vorschläge zur Beschlussfassung sowie nähere

Angaben zu den Abstimmungsmodalitäten werden den

Gläubigern mit der Aufforderung zur Stimmabgabe

bekannt gemacht. Die Ausübung der Stimmrechte ist


The Issuer is authorized to adapt the global note and

the Terms and Conditions without the consent of the

Holders to the extent necessary to reflect the changes

resulting from the substitution. Appropriately adjusted

global notes or Terms and Conditions will be deposited

with or on behalf of the Clearing System.

**§ 11**

**AMENDMENT OF THE TERMS AND CONDITIONS,**

**HOLDERS' REPRESENTATIVE**

(1) _Amendment of the Terms and Conditions. In_

accordance with the Act on Debt Securities of 2009

(Gesetz _über_ _Schuldverschreibungen_ _aus_

_Gesamtemissionen_ _(Schuldverschreibungsgesetz_ –

"SchVG")) the Issuer may, with the consent of the

Holders, amend the Terms and Conditions with regard

to matters permitted by the SchVG. The Holders'

consent to such amendments is given by resolution

with the majority specified in § 11(2). Majority

resolutions shall be binding on all Holders.

Resolutions which do not provide for identical

conditions for all Holders are void, unless Holders who

are disadvantaged have expressly consented to their

being treated disadvantageously.

(2) _Majority. Resolutions shall be passed by a majority of_

not less than 75 per cent. of the votes cast. Resolutions

relating to amendments of the Terms and Conditions

which are not material and which do not relate to the

matters listed in § 5(3) No. 1 – 8 and (if § 10 of these

Terms and Conditions does not provide otherwise) No.

9 of the SchVG require a simple majority of the votes

cast.

(3) _Vote without a meeting. All votes will be taken, subject_

to the next sentence, exclusively by vote taken without

a meeting. A meeting of Holders and the assumption

of the fees by the Issuer for such a meeting will only

take place in the circumstances of § 18(4) sentence 2

of the SchVG. The subject matter of the vote as well as

the proposed resolutions and further information on

voting procedures shall be notified to the Holders

together with the request for voting. The exercise of

voting rights is subject to the Holders' registration. The

registration must be received at the address stated in

the request for voting no later than the third day


-----

von einer vorherigen Anmeldung der Gläubiger

abhängig. Die Anmeldung muss unter der in der

Aufforderung zur Stimmabgabe mitgeteilten Adresse

spätestens am dritten Tag vor Beginn des

Abstimmungszeitraums zugehen. Mit der Anmeldung

müssen die Gläubiger ihre Berechtigung zur

Teilnahme an der Abstimmung durch einen in

Textform erstellten besonderen Nachweis der

Depotbank gemäß § 14(3)(i)(a) und (b) und durch

Vorlage eines Sperrvermerks der Depotbank, aus dem

hervorgeht, dass die betreffenden

Schuldverschreibungen ab dem Tag der Absendung

der Anmeldung (einschließlich) bis zum letzten Tag

des Abstimmungszeitraums (einschließlich) nicht

übertragbar sind, nachweisen.

(4) _Zweite Versammlung. Wird für die Abstimmung ohne_

Versammlung gemäß § 11(3) die mangelnde

Beschlussfähigkeit festgestellt, kann der

Abstimmungsleiter eine zweite Versammlung im

Sinne von § 15 Absatz 3 Satz 3 SchVG einberufen. Die

Teilnahme an der zweiten Versammlung und die

Ausübung der Stimmrechte sind von einer vorherigen

Anmeldung der Gläubiger abhängig. Die Anmeldung

muss unter der in der Bekanntmachung der

Einberufung mitgeteilten Adresse spätestens am

dritten Tag vor der zweiten Versammlung zugehen.

Mit der Anmeldung müssen die Gläubiger ihre

Berechtigung zur Teilnahme an der Abstimmung

durch einen in Textform erstellten besonderen

Nachweis der Depotbank gemäß § 14(3)(i)(a) und (b)

und durch Vorlage eines Sperrvermerks der

Depotbank, aus dem hervorgeht, dass die betreffenden

Schuldverschreibungen ab dem Tag der Absendung

der Anmeldung (einschließlich) bis zum angegebenen

Ende der Versammlung (einschließlich) nicht

übertragbar sind, nachweisen.

(5) _Leitung der Abstimmung. Die Abstimmung wird von_

einem von der Emittentin beauftragten Notar oder,

falls der Gemeinsame Vertreter (wie in § 11(7)

definiert) zur Abstimmung aufgefordert hat, vom

Gemeinsamen Vertreter geleitet.

(6) _Stimmrecht. An Abstimmungen der Gläubiger nimmt_

jeder Gläubiger nach Maßgabe des Nennwerts oder des

rechnerischen Anteils seiner Berechtigung an den

ausstehenden Schuldverschreibungen teil.

(7) _Gemeinsamer Vertreter. Die Gläubiger können durch_

Mehrheitsbeschluss zur Wahrnehmung ihrer Rechte

einen gemeinsamen Vertreter für alle Gläubiger


preceding the beginning of the voting period. As part

of the registration, Holders must demonstrate their

eligibility to participate in the vote by means of a

special confirmation of the Custodian in accordance

with § 14(3)(i)(a) and (b) hereof in text form and by

submission of a blocking instruction by the Custodian

stating that the relevant Notes are not transferable from

and including the day such registration has been sent

until and including the day the voting period ends.

(4) _Second Meeting. If it is ascertained that no quorum_

exists for the vote without a meeting pursuant to

§ 11(3), the scrutineer (Abstimmungsleiter) may

convene a second meeting within the meaning of

section 15 paragraph 3 sentence 3 of the SchVG.

Attendance at the second meeting and exercise of

voting rights is subject to the Holders' registration. The

registration must be received at the address stated in

the convening notice no later than the third day

preceding the second meeting. As part of the

registration, Holders must demonstrate their eligibility

to participate in the vote by means of a special

confirmation of the Custodian in accordance with

§ 14(3)(i)(a) and (b) hereof in text form and by

submission of a blocking instruction by the Custodian

stating that the relevant Notes are not transferable from

and including the day such registration has been sent

until and including the stated end of the meeting.

(5) _Chair of the vote. The vote will be chaired by a notary_

appointed by the Issuer or, if the Holders'

Representative (as defined in § 11(7) below) has

convened the vote, by the Holders' Representative.

(6) _Voting rights. Each Holder participating in any vote_

shall cast votes in accordance with the nominal amount

or the notional share of its entitlement to the

outstanding Notes.

(7) _Holders' Representative. The Holders may by majority_

resolution appoint a common representative (the

"Holders' Representative") to exercise the Holders'


-----

bestellen (der "Gemeinsame Vertreter"). Der

Gemeinsame Vertreter hat die Aufgaben und

Befugnisse, welche ihm durch Gesetz oder von den

Gläubigern durch Mehrheitsbeschluss eingeräumt

wurden. Er hat die Weisungen der Gläubiger zu

befolgen. Soweit er zur Geltendmachung von Rechten

der Gläubiger ermächtigt ist, sind die einzelnen

Gläubiger zur selbständigen Geltendmachung dieser

Rechte nicht befugt, es sei denn, der

Mehrheitsbeschluss sieht dies ausdrücklich vor. Über

seine Tätigkeit hat der Gemeinsame Vertreter den

Gläubigern zu berichten. Für die Abberufung und die

sonstigen Rechte und Pflichten des Gemeinsamen

Vertreters gelten die Vorschriften des SchVG.

(8) _Garantie. Im Fall einer Schuldnerersetzung gemäß_

§ 10 gilt dieser § 11 entsprechend für Änderungen der

Garantie gemäß § 10(1)(d), und Änderungen der

Anleihebedingungen und der Garantie sind nur mit

Zustimmung der Nachfolgeschuldnerin und der Bayer

Aktiengesellschaft als Garantin zulässig.

**§ 12**

**BEGEBUNG WEITERER**

**SCHULDVERSCHREIBUNGEN,**

**ANKAUF UND ENTWERTUNG**

(1) _Begebung_ _weiterer_ _Schuldverschreibungen._ Die

Emittentin ist jederzeit berechtigt, ohne Zustimmung

der Gläubiger weitere Schuldverschreibungen mit den

gleichen Bedingungen (gegebenenfalls mit Ausnahme

des Tages der Begebung, des Zinslaufbeginns

und/oder des Ausgabepreises) in der Weise zu

begeben, dass sie mit den Schuldverschreibungen eine

einheitliche Emission bilden.

(2) _Ankauf. Die Emittentin ist berechtigt, jederzeit_

Schuldverschreibungen im Markt oder anderweitig zu

jedem beliebigen Preis zu kaufen. Die von der

Emittentin erworbenen Schuldverschreibungen

können nach Wahl der Emittentin von ihr gehalten,

weiterverkauft oder bei der Hauptzahlstelle zwecks

Entwertung eingereicht werden. Sofern diese Käufe

durch öffentliches Rückkaufangebot erfolgen, muss

dieses Angebot allen Gläubigern gleichermaßen

gemacht werden.

(3) _Entwertung. Sämtliche vollständig zurückgezahlten_

Schuldverschreibungen sind unverzüglich zu

entwerten und können nicht wiederbegeben oder

wiederverkauft werden.


rights on behalf of each Holder. The Holders'

Representative shall have the duties and powers

provided by law or granted by majority resolution of

the Holders. The Holders' Representative shall comply

with the instructions of the Holders. To the extent that

the Holders' Representative has been authorized to

assert certain rights of the Holders, the Holders shall

not be entitled to assert such rights themselves, unless

explicitly provided for in the relevant majority

resolution. The Holders' Representative shall provide

reports to the Holders on its activities. The regulations

of the SchVG apply with regard to the recall and the

other rights and obligations of the Holders'

Representative.

(8) _Guarantee._ In the event of a substitution pursuant to

§ 10, this § 11 shall apply _mutatis mutandis for any_

amendment of the guarantee pursuant to § 10(1)(d),

and the Terms and Conditions and such guarantee may

only be amended with the consent of the Substitute

Debtor and Bayer Aktiengesellschaft as guarantor.

**§ 12**

**FURTHER ISSUES, PURCHASES AND**

**CANCELLATION**

(1) _Further Issues._ The Issuer may from time to time,

without the consent of the Holders, issue further Notes

having the same terms and conditions as the Notes in

all respects (or in all respects except for the issue date,

interest commencement date and/or issue price) so as

to form a single issue with the Notes.

(2) _Purchases. The Issuer may at any time purchase Notes_

in the open market or otherwise and at any price. Notes

purchased by the Issuer may, at the option of the Issuer,

be held, resold or surrendered to the Principal Paying

Agent for cancellation. If purchases are made by public

tender, tenders for such Notes must be made available

to all Holders of such Notes alike.

(3) _Cancellation._ All Notes redeemed in full shall be

cancelled forthwith and may not be reissued or resold.


-----

**§ 13**

**MITTEILUNGEN**

(1) _Bekanntmachung. Alle die Schuldverschreibungen_

betreffenden Mitteilungen werden im Bundesanzeiger

veröffentlicht und erfolgen zusätzlich durch

elektronische Publikation auf der Website der

Luxemburger Börse (www.bourse.lu). Jede Mitteilung

gilt am dritten Tag nach dem Tag der Veröffentlichung

als wirksam erfolgt.

(2) _Mitteilungen an das Clearing System._ Solange

Schuldverschreibungen an der Offiziellen Liste der

Luxemburger Börse notiert sind, findet Absatz 1

Anwendung. Soweit die Regeln der Luxemburger

Börse dies sonst zulassen, kann die Emittentin eine

Veröffentlichung nach Absatz 1 durch eine Mitteilung

an das Clearing System zur Weiterleitung an die

Gläubiger ersetzen; jede derartige Mitteilung gilt am

siebten Tag nach dem Tag der Mitteilung an das

Clearing System als den Gläubigern mitgeteilt.

**§ 14**

**ANWENDBARES RECHT,**

**GERICHTSSTAND UND GERICHTLICHE**

**GELTENDMACHUNG**

(1) _Anwendbares_ _Recht._ Form und Inhalt der

Schuldverschreibungen sowie Pflichten der Emittentin

und Rechte der Gläubiger bestimmen sich in jeder

Hinsicht nach deutschem Recht.

(2) _Gerichtsstand._ Vorbehaltlich eines zwingend

vorgeschriebenen Gerichtsstands für bestimmte

Verfahren nach dem SchVG ist nicht ausschließlich

zuständig für sämtliche im Zusammenhang mit den

Schuldverschreibungen entstehenden Klagen oder

sonstige Verfahren ("Rechtsstreitigkeiten") das

Landgericht Frankfurt am Main.

(3) _Gerichtliche Geltendmachung. Jeder Gläubiger von_

Schuldverschreibungen ist berechtigt, in jedem

Rechtsstreit gegen die Emittentin oder in jedem

Rechtsstreit, in dem der Gläubiger und die Emittentin

Partei sind, seine Rechte aus diesen

Schuldverschreibungen im eigenen Namen auf der

folgenden Grundlage wahrzunehmen oder geltend zu

machen: (i) er bringt eine Bescheinigung der

Depotbank bei, bei der er für die

Schuldverschreibungen ein Wertpapierdepot unterhält,

welche (a) den vollständigen Namen und die


**§ 13**

**NOTICES**

(1) _Publication. All notices concerning the Notes shall be_

published in the Federal Gazette (Bundesanzeiger) and

in addition will be made by means of electronic

publication on the internet website of the Luxembourg

Stock Exchange (www.bourse.lu). Any notice so given

will be deemed to have been validly given on the third

day following the date of such publication.

(2) _Notification to Clearing System. So long as any Notes_

are listed on the Official List of the Luxembourg Stock

Exchange, subparagraph (1) shall apply. If the Rules of

the Luxembourg Stock Exchange otherwise so permit,

the Issuer may deliver the relevant notice to the

Clearing System for communication by the Clearing

System to the Holders, in lieu of publication as set

forth in subparagraph (1) above; any such notice shall

be deemed to have been validly given on the seventh

day after the day on which the said notice was given to

the Clearing System.

**§ 14**

**APPLICABLE LAW, PLACE OF JURISDICTION**

**AND ENFORCEMENT**

(1) _Applicable Law._ The Notes, as to form and content,

and all obligations of the Issuer and rights of the

Holders shall be governed by German law.

(2) _Submission to Jurisdiction. Subject to any mandatory_

jurisdiction for specific proceedings under the SchVG,

the District Court (Landgericht) in Frankfurt am Main

shall have non-exclusive jurisdiction for any action or

other legal proceedings ("Proceedings") arising out of

or in connection with the Notes.

(3) _Enforcement._ Any Holder of Notes may in any

proceeding against the Issuer, or to which such Holder

and the Issuer are parties, protect and enforce in its

own name its rights arising under such Notes on the

basis of (i) a statement issued by the Custodian (as

defined below) with whom such Holder maintains a

securities account in respect of the Notes (a) stating the

full name and address of the Holder, (b) specifying the

aggregate principal amount of Notes credited to such

securities account on the date of such statement and (c)

confirming that the Custodian has given written notice


-----

vollständige Adresse des Gläubigers enthält, (b) den

Gesamtnennbetrag der Schuldverschreibungen

bezeichnet, die unter dem Datum der Bestätigung auf

dem Wertpapierdepot verbucht sind und (c) bestätigt,

dass die Depotbank gegenüber dem Clearing System

eine schriftliche Erklärung abgegeben hat, die die

vorstehend unter (a) und (b) bezeichneten

Informationen enthält; und (ii) er legt eine Kopie der

die betreffenden Schuldverschreibungen

verbriefenden Globalurkunde vor, deren

Übereinstimmung mit dem Original eine

vertretungsberechtigte Person des Clearing Systems

oder des Verwahrers des Clearing Systems bestätigt

hat, ohne dass eine Vorlage der Originalbelege oder

der die Schuldverschreibungen verbriefenden

Globalurkunde in einem solchen Verfahren

erforderlich wäre. Für die Zwecke des Vorstehenden

bezeichnet "Depotbank" jede Bank oder ein sonstiges

anerkanntes Finanzinstitut, die bzw. das berechtigt ist,

das Wertpapierverwahrungsgeschäft zu betreiben und

bei der/dem der Gläubiger ein Wertpapierdepot für die

Schuldverschreibungen unterhält, einschließlich des

Clearing Systems. Unbeschadet des Vorstehenden

kann jeder Gläubiger seine Rechte aus den

Schuldverschreibungen auch auf jede andere Weise

schützen oder geltend machen, die im Land des

Rechtsstreits prozessual zulässig ist.

**§ 15**

**SPRACHE**

Diese Anleihebedingungen sind in deutscher Sprache

abgefasst. Eine Übersetzung in die englische Sprache ist

beigefügt. Der deutsche Text ist bindend und maßgeblich.

Die Übersetzung in die englische Sprache ist unverbindlich.


to the Clearing System containing the information

pursuant to (a) and (b); and (ii) a copy of the Note in

global form certified as being a true copy by a duly

authorized officer of the Clearing System or a

depository of the Clearing System, without the need

for production in such proceedings of the actual

records or the global note representing the Notes. For

purposes of the foregoing, "Custodian" means any

bank or other financial institution of recognized

standing authorized to engage in securities custody

business with which the Holder maintains a securities

account in respect of the Notes and includes the

Clearing System. Each Holder may, without prejudice

to the foregoing, protect and enforce its rights under

these Notes also in any other way which is admitted in

the country of the Proceedings.

**§ 15**

**LANGUAGE**

These Terms and Conditions are written in the German

language and provided with an English language translation.

The German text shall be controlling and binding. The

English language translation is provided for convenience

only.


-----

**Restrictions regarding the Redemption and Repurchase of the NC8.5 Notes**

The following paragraphs in italics do not form part of the Terms and Conditions of the NC8.5 Notes.

_The Issuer intends (without thereby assuming a legal or contractual obligation) at any time that it will redeem or repurchase the_
_NC8.5 Notes only to the extent that the aggregate principal amount of NC8.5 Notes to be redeemed or repurchased does not exceed_
_such part of the net proceeds received by the Issuer or any Subsidiary of the Issuer on or prior to the date of such redemption or_
_repurchase from the sale or issuance by the Issuer or such Subsidiary to third parties of NC8.5 Notes which are assigned by S&P, at_
_the time of sale or issuance, an aggregate "equity credit" (or such similar nomenclature used by S&P from time to time) that is equal_
_to or greater than the "equity credit" assigned to the NC8.5 Notes to be redeemed or repurchased at the time of their issuance (but_
_taking into account any changes in hybrid capital methodology or another relevant methodology or the interpretation thereof since the_
_issuance of the NC8.5 Notes)._

_The following exceptions apply as to the Issuer's replacement intention. The NC8.5 Notes are not required to be replaced:_

_(i)_ _if the rating assigned by S&P to the Issuer is the same as or higher than the long-term corporate credit rating assigned to the_
_Issuer on the date when the most recent additional hybrid security was issued (excluding refinancings without net new issuance)_
_and the Issuer is comfortable that such rating would not fall below this level as a result of such redemption or repurchase, or_

_(ii)_ _in the case of repurchase or redemption of the NC8.5 Notes taken together with other repurchases or redemptions of hybrid_
_securities of the Issuer (as the case may be) which are less than (x) 10 per cent. of the aggregate principal amount of the Issuer's_
_outstanding hybrid securities in any period of 12 consecutive months or (y) 25 per cent. of the aggregate principal amount of_
_the Issuer's outstanding hybrid securities in any period of 10 consecutive years provided that in each case such repurchase or_
_redemption has no materially negative effect on the Issuer's credit profile, or_

_(iii) if the NC8.5 Notes are redeemed: (i) pursuant to a Rating Event, a Tax Deductibility Event, a Gross-Up Event, or (ii) in case of_

_a Minimum Outstanding Aggregate Principal Amount, or_

_(iv)_ _if the NC8.5 Notes are not assigned any category (not even minimal, except where minimal results due to effective remaining_
_maturity) of "equity credit" (or such similar nomenclature then used by S&P at the time of such redemption or repurchase), or_

_(v)_ _if such redemption or repurchase occurs on or after 25 September 2050._

_The replacement intention of the Issuer, including during the period of five years following the Interest Commencement Date, shall not_
_apply for repurchases of NC8.5 Notes with an aggregate amount up to the S&P Excess Amount. "S&P Excess Amount" means the_
_aggregate principal amount of outstanding hybrid capital of the Issuer exceeding the maximum aggregate principal amount of hybrid_
_capital for which S&P under its then prevailing methodology would recognize equity credit from time to time based on the Issuer's_
_adjusted total capitalization._


-----

### USE OF PROCEEDS

#### The net proceeds from the issue and sale of the Notes will amount to approximately EUR 1,284,927,000. 

 The Issuer intends to use the net proceeds for general corporate purposes including the refinancing of the existing EUR 1,300,000,000 Subordinated Resettable Fixed Rate Notes due 2075 callable 2 October 2022.


-----

### DESCRIPTION OF THE ISSUER AND THE BAYER GROUP 

#### General Information on Bayer AG

 Incorporation, Corporate Seat, History

 Bayer AG was established on 19 December 1951 under the name "Farbenfabriken Bayer Aktiengesellschaft". It was registered under German law in the commercial register at the local court of Opladen (today the local court of Cologne) under the number HRB 1122 (today, at the local court of Cologne, under the number HRB 48248). Its legal name was changed to "Bayer Aktiengesellschaft" by resolution of the Meeting of the Stockholders on 14 June 1972. The Issuer operates under the commercial name "Bayer".

 Bayer AG operates under the laws of the Federal Republic of Germany. 

 The registered office of Bayer AG is at Kaiser-Wilhelm-Allee 1, 51373 Leverkusen, Germany, telephone number: +49 214 30 48334. 

 The official website of Bayer AG can be found at: https://www.bayer.com/. The information on the website does not form part of this Prospectus unless that information is incorporated by reference into this Prospectus.

 The legal entity identifier (LEI) of Bayer AG is 549300J4U55H3WP1XT59

 Corporate Objectives

 According to its Articles of Incorporation (paragraph 2), the object of Bayer AG is manufacturing, marketing and other industrial activities or the provision of services in the fields of health care and agriculture. The Issuer may also perform these activities in the fields of polymers and chemicals.

 Financial Year

 Bayer AG's financial year is the calendar year.

 Auditors

 The independent auditor of Bayer AG is Deloitte GmbH Wirtschaftsprüfungsgesellschaft, Rosenheimer Platz 4, 81669 Munich, Germany ("Deloitte"), member of Wirtschaftsprüferkammer Berlin. Deloitte has audited the German version of the consolidated financial statements of Bayer AG as of and for the fiscal years ended 31 December 2021 and 2020 and has issued an unqualified auditor's report in each case.

 Organizational Structure

 As the parent company of the Bayer Group, Bayer AG – represented by its Board of Management – performs the principal management functions for the entire Bayer Group. This mainly comprises the Group's strategic alignment, resource allocation, and the management of financial affairs and managerial staff, along with the management of the Group-wide operational business of the Crop Science, Pharmaceuticals and Consumer Health divisions. The supporting functions (enabling functions) support the operational business.

 As of 31 December 2021, the Bayer Group comprised 374 consolidated companies in 83 countries.

 Share Capital and Major Shareholders

 Under Bayer AG's Articles of Incorporation, each of Bayer AG's shares represents one vote. Major shareholders do not have different voting rights. As of 31 December 2021, there were 982,420,000 shares outstanding.

 The shares in Bayer AG are listed on the regulated market of the Frankfurt Stock Exchange and the subsegment of the regulated market with further post-admission duties (Prime Standard). The shares in Bayer AG are a component of the DAX, the index of the 40 largest listed German companies in terms of order book volume and market capitalization.

 Bayer AG has not been notified by any shareholder that it is holding 10 per cent. or more of the share capital in the Issuer.


-----

#### Ratings

 The following ratings have been assigned to Bayer:

 Agency Long-Term Rating Short-Term Rating Outlook

 Moody's Deutschland GmbH
 ("Moody's") Baa2 P2 negative

 S&P Global Ratings Europe
 Limited ("S&P") BBB A2 stable

 Fitch Ratings Ireland Limited
 ("Fitch") BBB+ F2 stable

 Business Overview

 Principal activities of the Bayer Group

 Bayer is a life science company, active in the fields of health care and nutrition. The Issuer believes that its products support efforts to overcome challenges presented by a growing and aging global population. Guided by its purpose "Science for a better life", the Bayer Group aims to deliver breakthrough innovations in health care and agriculture. The Issuer aims to contribute to a world in which diseases are not only treated but effectively prevented or cured, in which people can take better care of their own health needs, and in which enough agriculture products are produced while respecting our planet’s natural resources. In the assessment of the Issuer growth and sustainability must go hand in hand. The Bayer Group endeavors to make its vision “Health for all, hunger for none” a reality. Bayer’s strategy aims to operationalize its vision, by achieving long-term profitable growth and by making a positive contribution to society and the environment.

 Principal Markets and Group Strategic Priorities

 Bayer's subsidiaries and affiliates around the world are grouped into four regions: 

 • Europe / Middle East / Africa 

 • North America

 • Asia / Pacific

 • Latin America

 The Group's total sales in fiscal year 2021 based on customer location, were as follows: 31.0 per cent. in Europe / Middle East / Africa; 33.9 per cent. in North America; 20.1 per cent. in the Asia/Pacific region; and 15.0 per cent. in the Latin America region. 

 The Group's strategic priorities are:

 • We develop innovative products and solutions 

 • We drive the operational performance of our business

 • Sustainability is an integral part of our business strategy, operations and compensation system

 • As a global leader in health and nutrition, we continue to develop our business

 Divisions

 The management structure of the Bayer Group comprises three divisions, which are also our reporting segments:


-----

#### • Crop Science

 • Pharmaceuticals 

 • Consumer Health 

 The enabling functions serve as Group-wide competence centers and provide business support services.

 Crop Science

 In the assessment of the Issuer, Crop Science is the world’s leading agriculture enterprise, with businesses in crop protection, seeds and traits, and digital farming. We offer a broad portfolio of high-value seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions and extensive customer service for sustainable agriculture. We market these products primarily via wholesalers and retailers or directly to farmers. In addition, we market pest and weed control products and services to professional users outside the agriculture industry. Most of our crop protection products are manufactured at the division’s own production sites. Numerous decentralized formulation and filling sites enable Bayer Group to respond quickly to the needs of local markets. The breeding, propagation, production and / or processing of seeds, including seed dressing, take place at locations close to our customers, either at our own facilities or under contract.

 Pharmaceuticals

 Pharmaceuticals concentrates on prescription products, especially for cardiology and women’s health care, and on specialty therapeutics focused on the areas of oncology, hematology, ophthalmology and, in the medium term, cell and gene therapy. We have established a strategic unit for cell and gene therapy spanning the entire value creation chain – from research and development to marketing and patients. The division also comprises the radiology business, which markets diagnostic imaging equipment and digital solutions together with the necessary contrast agents. Our portfolio includes a range of key products that are among the world’s leading pharmaceuticals for their indications. The prescription products of our Pharmaceuticals Division are primarily distributed through wholesalers, pharmacies and hospitals.

 Consumer Health

 In the assessment of the Issuer, Consumer Health is a leading supplier of nonprescription (OTC = over-the-counter) medicines, nutritional supplements, medicated skincare products and other self-care solutions in the categories of pain, cardiovascular risk prevention, dermatology, digestive health, allergy, and cough & cold. The products are generally sold by pharmacies and pharmacy chains, supermarkets, online retailers and other large and small retailers.

 Material Contracts

 Syndicated Credit Facility

 Bayer AG and its U.S. subsidiary Bayer Corporation are party to a EUR 4.5 billion syndicated facility agreement. The facility is available until December 2025 and is, as of the date of this Prospectus, undrawn. The participating banks are entitled to terminate the credit facility in the event of a change of control at Bayer and demand repayment of any loans that may have been granted under this facility up to that time. 

 Financing Arrangements related to Monsanto Acquisition

 A syndicated credit facility in the original amount of US$ 56.9 billion was granted to Bayer US Finance II LLC and Bayer AG in September 2016 to finance the acquisition of Monsanto (the "Monsanto Credit Facility"). Pursuant to the agreement, the Monsanto Credit Facility was reduced in 2016 by the US$ 4.2 billion net proceeds from the issuance of mandatory convertible notes, to US$ 52.7 billion, and in June 2017 by the US$ 1.2 billion net proceeds from the issuance of an exchangeable bond, to US$ 51.5 billion.

 The mandatory convertible notes were issued by Bayer Capital Corporation B.V., guaranteed by Bayer AG and matured in November 2019.


-----

#### The exchangeable bond was issued by Bayer AG and matured in June 2020. It was fully redeemed in cash.

 The Monsanto Credit Facility was drawn in June 2018 to finance the acquisition of Monsanto. The resulting loan was fully repaid in January 2021.

 The Monsanto Credit Facility and the loan were reduced in 2018 through the proceeds from capital increases, a further reduction of Bayer's interest in Covestro AG, a series of divestments to fulfill antitrust requirements, a bond with a nominal volume of EUR 5 billion issued by Bayer Capital Corporation B.V. and guaranteed by Bayer AG, and a US$ 15 billion bond in 144A / Reg S format issued by Bayer US Finance II LLC and guaranteed by Bayer AG. As of 31 December 2021, US$ 12.5 billion out of the US$ 15 billion bond and the full amount of the EUR 5 billion bond were outstanding.

 Moreover, bonds with a nominal volume of US$ 6.9 billion were taken over from Monsanto as part of the acquisition. Thereof, US$ 5.6 billion were outstanding as of 31 December 2021. 

 Other Bonds

 In addition to the aforementioned bonds relating to the Monsanto acquisition, bonds with an aggregate nominal amount of EUR 0.6 billion, issued by Bayer in the years 2014 to 2017 under its Debt Issuance Programme, were outstanding as of 31 December 2021.

 In October 2014, Bayer issued a US$ 7 billion bond in 144A / Reg S format. As of 31 December 2021, the outstanding amount of this bond was US$ 1.8 billion.

 As of 31 December 2021, subordinated bonds with an aggregate nominal amount of EUR 4.55 billion were outstanding. The subordinated bonds were issued by Bayer AG.

 In July 2020, Bayer issued four series of bonds in Reg S format in an aggregate nominal amount of EUR 6 billion for which the full amount was outstanding as of 31 December 2021.

 In January 2021, Bayer issued four additional series of bonds in Reg S format in an aggregate nominal amount of EUR 4 billion for which the full amount was outstanding as of 31 December 2021.

 The majority of the net financial debt is denominated in Euros and a further significant share is in US dollars. The residual amount is in other currencies.

 Bond Maturities

**Nominal volume**

**as of 31 December 2021**

**Hybrid bonds[(1)]**
Hybrid bond 2014 / 2024[(2)] / 2074 EUR 1,500 million

Hybrid bond 2015 / 2022[(2)] / 2075 EUR 1,300 million

Hybrid bond 2019 / 2025[(2)] / 2079 EUR 1,000 million

Hybrid bond 2019 / 2027[(2)] / 2079 EUR 750 million

**USD bonds[(1)(3)]**
Maturity < 1 year USD 250 million

Maturity > 1 year < 5 years USD 9,114 million

Maturity > 5 years USD 10,800 million

**EUR bonds[(1)(3)]**
Maturity < 1 year EUR 1,750 million

Maturity > 1 year < 5 years EUR 4,950 million

Maturity > 5 years EUR 8,800 million

**JPY bonds[(1)]**
Maturity < 1 year JPY 10 billion

Maturity > 1 year < 5 years –

Maturity > 5 years –

(1) The bonds are issued in the functional currency of the issuing entity and mainly have a fixed coupon.
(2) Date of first option to redeem the bond early at par.
(3) Bonds with nominal volumes of USD 1,250 million and EUR 750 million bear variable rates of interest.

|Bond Maturities|Col2|
|---|---|
||Nominal volume as of 31 December 2021|
|Hybrid bonds(1)||
|Hybrid bond 2014 / 2024(2) / 2074|EUR 1,500 million|
|Hybrid bond 2015 / 2022(2) / 2075|EUR 1,300 million|
|Hybrid bond 2019 / 2025(2) / 2079|EUR 1,000 million|
|Hybrid bond 2019 / 2027(2) / 2079|EUR 750 million|
|USD bonds(1)(3)||
|Maturity < 1 year|USD 250 million|
|Maturity > 1 year < 5 years|USD 9,114 million|
|Maturity > 5 years|USD 10,800 million|
|EUR bonds(1)(3)||
|Maturity < 1 year|EUR 1,750 million|
|Maturity > 1 year < 5 years|EUR 4,950 million|
|Maturity > 5 years|EUR 8,800 million|
|JPY bonds(1)||
|Maturity < 1 year|JPY 10 billion|
|Maturity > 1 year < 5 years|–|
|Maturity > 5 years|–|
|||


-----

#### Governmental, Legal, Tax and Arbitration Proceedings

 As a global company with a diverse business portfolio, the Bayer Group is exposed to numerous legal risks, particularly in the areas of product liability, competition and antitrust law, anticorruption, patent disputes, tax assessments and environmental matters. The outcome of any current or future proceedings cannot normally be predicted. It is therefore possible that legal or regulatory judgments or future settlements could give rise to expenses that are not covered, or not fully covered, by insurers’ compensation payments and could significantly affect our sales and earnings. Legal proceedings we currently consider to be material are outlined below. The legal proceedings referred to do not represent an exhaustive list.

 Product-related litigation

 Xarelto™: In the United States, a large number of plaintiffs alleged personal injuries, including cerebral, gastrointestinal or other bleeding and death, from the use of Xarelto™, an oral anticoagulant for the treatment and prevention of blood clots. Plaintiffs claimed, among other things, that Xarelto™ is defective and that Bayer failed to adequately warn its users. In 2019, after prevailing in all six cases that went to trial, Bayer and Janssen Pharmaceuticals reached a global agreement to settle virtually all pending U.S. cases for US$775 million, split equally between the two companies. The Xarelto settlement program is well-established, with fund allocation and dismissal of settled cases continuing to proceed. At this time, there remain only a very small number of opt-out cases. As of 1 February 2022, eleven Canadian lawsuits relating to Xarelto™ seeking class action certification and one individual action had been served upon Bayer. Two of the proposed class actions have been certified. Bayer believes it has meritorious defenses and intends to defend itself vigorously against all claims that are not yet settled.

 Essure™: In the United States, a large number of lawsuits by users of Essure™, a medical device offering permanent birth control with a nonsurgical procedure, had been served upon Bayer. Plaintiffs allege personal injuries from the use of Essure™, including hysterectomy, perforation, pain, bleeding, weight gain, nickel sensitivity, depression and unwanted pregnancy, and seek compensatory and punitive damages. 

 By 1 February 2022, Bayer had reached agreements in principle with plaintiff law firms to resolve approximately 99% of the nearly 40,000 total filed and unfiled U.S. Essure™ claims involving women who allege device-related injuries. The settlements include all of the jurisdictions with significant volumes of Essure™ cases, including the state of California Joint Council Coordinated Proceedings (JCCP) and the Federal District Court for the Eastern District of Pennsylvania (EDPA). Taking into account the payments already made, the remaining provision for settlements amounts to US$0.2 billion as of 31 December 2021. This includes an allowance for outstanding claims, and Bayer is in resolution discussions with counsel for the remaining plaintiffs. At the same time, we continue to support the safety and efficacy of the Essure™ device and are prepared to vigorously defend it in litigation where no amicable resolution can be achieved.

 As of 1 February 2022, two Canadian lawsuits relating to Essure™ seeking class action certification had been served upon Bayer. One of the proposed class actions was certified. Certification in the other class action has been denied; the decision has been appealed by plaintiffs. In addition, approximately 130 single-plaintiff claims have been served on Bayer. Bayer believes it has meritorious defenses and intends to defend itself vigorously.

 Class actions over neonicotinoids in Canada: Proposed class actions against Bayer were filed in Quebec and Ontario (Canada) concerning crop protection products containing the active substances imidacloprid and clothianidin (neonicotinoids). The plaintiffs are honey producers, who have filed a proposed nationwide class action in Ontario and a Quebec-only class action in Quebec. Plaintiffs claim for compensatory damages and punitive damages and allege Bayer and another crop protection company were negligent in the design, development, marketing and sale of neonicotinoid pesticides. The proposed Ontario class action is in a very early procedural phase. In Quebec, a court certified a class proposed by plaintiffs in 2018. Bayer believes it has meritorious defenses and intends to defend itself vigorously.

 Roundup™ (glyphosate): A large number of lawsuits from plaintiffs claiming to have been exposed to glyphosate-based products manufactured by Bayer’s subsidiary Monsanto have been served upon Monsanto in the United States. Glyphosate is the active ingredient contained in a number of Monsanto’s herbicides, including Roundup™-branded products. Plaintiffs allege personal injuries resulting from exposure to those products, including non-Hodgkin lymphoma


-----

#### (NHL) and multiple myeloma, and seek compensatory and punitive damages. Plaintiffs claim, inter alia, that the glyphosate-based herbicide products are defective and that Monsanto knew, or should have known, of the risks allegedly associated with such products and failed to adequately warn its users. Additional lawsuits are anticipated. The majority of plaintiffs have brought actions in state courts in Missouri and California. Cases pending in U.S. federal courts have been consolidated in a multidistrict litigation (MDL) in the Northern District of California for common pre-trial management.

 In 2020, Monsanto reached an agreement in principle with plaintiffs, without admission of liability, to settle most of the current Roundup™ litigation and to put in place a mechanism to resolve potential future claims. As of 1 February 2022, Monsanto had reached settlements and/or was close to settling in a substantial number of claims. As we now have greater visibility regarding the number and quality of claims made, we consider that, of the approximately 138,000 claims in total which have been brought, approximately 107,000 have been settled or are not eligible for various reasons.

 The three adverse verdicts – Johnson, Hardeman and Pilliod – are not covered by the settlement. In August 2021, the California Court of Appeal ruled against Monsanto in the Pilliod appeal. In November 2021, the California Supreme Court denied review of the appeal. Bayer is considering its options with respect to seeking review by the Supreme Court of the United States. The Johnson case was concluded with payment of the US$20.5 million final judgment plus interest in March 2021. In May 2021, the United States Court of Appeals for the 9th Circuit ruled against Monsanto in the Hardeman appeal. Bayer has petitioned the U.S. Supreme Court for review in Hardeman. In December 2021 the Supreme Court invited the U.S. Solicitor General to file a brief in the matter stating the government’s views. In light of the Supreme Court’s solicitation of views from the government, Bayer will not entertain any further settlement discussions with plaintiff lawyers at this point in time.

 Bayer is convinced that the verdicts are not supported by the evidence at trial and the law and therefore intends to pursue the appeals vigorously.

 In October 2021, the jury in another trial, Clark, issued a verdict in Monsanto’s favor. The jury determined that Roundup™ did not cause the plaintiff’s child’s lymphoma. The Clark trial took place in the Superior Court of the State of California for the County of Los Angeles.

 In December 2021, the jury in another trial, Stephens, issued a verdict in Monsanto’s favor. The jury determined that Roundup™ did not cause the plaintiff’s lymphoma. The Stephens trial took place in the Superior Court of the State of California for the County of San Bernardino. 

 The mechanism to resolve potential future claims involved a class settlement agreement between Monsanto and plaintiffs’ counsel. In May 2021, this agreement failed to obtain approval by Judge Chhabria of the U.S. District Court for the Northern District of California. Following the judge’s denial, in May 2021 Bayer announced a series of measures to resolve potential future glyphosate litigation, combining both legal and commercial actions. In July 2021, Bayer provided an update on the progress made and announced additional details. Bayer has developed two scenarios based on a potential ruling by the Supreme Court of the United States in the Hardeman case. If the Supreme Court accepts the petition filed by Bayer in August 2021 for review and rules in favor of Bayer, it would effectively end potential future litigation. The second scenario assumes that the Supreme Court either refuses to hear the Hardeman case or issues a ruling in favor of the plaintiff, in which case Bayer would activate its own claims administration program. Bayer has implemented corresponding accounting measures for this scenario, resulting in a discounted allocation to provisions for litigations of €3.5 billion in the second quarter of 2021 on top of the existing provisions. As of 31 December 2021, Bayer had a provision of US$7.5 billion for the aforementioned settlements to resolve existing and future glyphosate claims.

 Bayer is confident that this provides an effective path to manage and address any risks from potential future Roundup™ litigation, while simultaneously giving Bayer more control going forward. Bayer continues to believe there is no reason for safety concerns in connection with these products.

 As of 1 February 2022, a total of 28 Canadian lawsuits relating to Roundup™ had been served upon Bayer, including 11 seeking class action certification.


-----

#### Bayer believes it has meritorious defenses and intends to defend the safety of glyphosate and our glyphosate-based formulations vigorously.

 Dicamba: In November 2016, Bader Peach Farms filed a lawsuit against Monsanto and BASF in Missouri state court. Subsequently, lawsuits from approximately 250 plaintiffs were filed in both U.S. state and federal courts alleging crop damage claims against Monsanto, primarily for soybeans, and there were approximately six non-soybean lawsuits. The general claims are that off-target movement from the dicamba herbicide and/or the XtendTM system has damaged non- dicamba-tolerant soybean and other crops. The Dicamba Herbicide MDL, which currently includes approximately 30 cases, was formed in U.S. federal court in 2018; it is pending in the Eastern District of Missouri, Southeastern Division. In June 2021, a group of approximately 50 Texas grape vineyard growers filed a lawsuit in Texas state court (Timmons et al.) alleging dicamba damage to their vineyards, and a honeybee farmer (Coy’s Honey Farm) filed a lawsuit in Arkansas federal court alleging damages due to dicamba. Both of those cases were subsequently transferred to the MDL, where a motion to dismiss is currently pending in the Coy’s Honey Farm case, and the Timmons case was remanded back to Texas state court.

 The first dicamba trial was the Bader Farms case which was heard in January 2020. The jury rendered a verdict for plaintiffs in the amount of US$15 million in compensatory damages and US$250 million in punitive damages, jointly and severally against defendants Monsanto and BASF. Monsanto filed post-trial motions resulting in the punitive damages being reduced to US$60 million, thereby reducing the total verdict to US$75 million. We have appealed to the 8th Circuit Court of Appeals. 

 With respect to all of the other dicamba cases except for Bader and a small number of newly filed lawsuits and claims, Monsanto has entered into a mass tort settlement agreement. The settlement will provide for the payment of substantiated claims by soybean growers in crop years 2015-2020 who can demonstrate a yield loss due to the application of dicamba products to an XtendTM crop. That portion of the settlement is capped at US$300 million. The settlement also provides additional funds of up to US$100 million to pay for dicamba damage claims made by growers of other, non-soybean crops, as well as attorneys’ fees, litigation costs, and settlement administra¬tion costs. Claims could be filed until May 2021, and the settlement claims administrator is currently in the process of determining claim eligibility and the amounts to be awarded to eligible claimants. Taking into account the payments already made, the remaining provision for settlements amounts to US$0.3 billion as of 31 December 2021.

 Insurance against statutory product liability claims

 In connection with the above-mentioned product-related litigations, Bayer is insured against statutory product liability claims to the extent customary in the respective industries and has, based on the information currently available, taken corresponding accounting measures. The accounting measures relating to, in particular, Essure™, dicamba and Roundup™ (glyphosate) claims exceed the available insurance coverage.

 Patent disputes

 Bollgard II RR Flex™/Intacta™: In 2019, the Cotton Producers Association of the State of Mato Grosso (AMPA) in Brazil filed a patent invalidity action in federal court seeking to invalidate four of Bayer's patents covering Bollgard II RR Flex™, a cotton technology owned by Bayer. In 2020, the Brazilian patent office, in the court proceedings, acknowledged the validity of all four challenged patents. Two of the patents are also being challenged in administrative nullity proceedings before the Brazilian patent office. One of the patents, the promoter patent, is also at issue in a patent invalidation action filed in Brazilian federal court by the Soybean Growers Association from the State of Mato Grosso (Aprosoja/MT) in 2017 regarding the Intacta™ soybean technology. In addition to the patent invalidity claims, both lawsuits seek a refund of twice the amount of the paid royalties. Both lawsuits were filed as collective actions and are proceeding before the same federal judge. Bayer's Intacta™ soybean technology is further protected by two other patents, one of which has been challenged in administrative nullity proceedings before the Brazilian patent office by the Soybean Growers Association from the State of Rio Grande do Sul (Aprosoja/RS).

 In addition to the action filed in 2017 regarding the promoter patent, the Soybean Growers Association from the State of Mato Grosso (Aprosoja/MT) is also seeking a correction of the expiration dates of all three patents protecting Bayer's


-----

#### Intacta™ soybean technology in a separate action claiming that two of these patents had already expired and is additionally seeking a corresponding refund of paid royalties and reduction of ongoing royalty payments. In December 2021, the federal court decided to grant the requests by further soybean grower associations and the Cotton Producers Association of the State of Mato Grosso (AMPA) to be admitted as co-plaintiffs to this lawsuit. One of the two patents, the promoter patent, also covers Bollgard II RR Flex™ and is at issue in the disputes with AMPA. Aprosoja/MT argues that the term of the patents had been determined unconstitutionally. In September 2021, a decision by the Brazilian Supreme Court – that the term of patents previously determined to be a minimum of 10 years from the patent being granted is unconstitutional, and that this term shall instead be set at 20 years from the filing of the patent application – became final. This will apply retroactively to certain patents, thereby shortening their term. However, Bayer believes that neither Aprosoja/MT nor other associations are entitled to a refund of paid royalties or to a reduction of ongoing royalty payments.

 Bayer believes it has meritorious defenses in the above patent disputes and intends to defend itself vigorously.

 Further legal proceedings

 Trasylol™/Avelox™: A qui tam complaint relating to marketing practices for Trasylol™ (aprotinin) and Avelox™ (moxifloxacin) filed by a former Bayer employee is pending in the U.S. District Court in New Jersey. The case is proceeding with discovery. The U.S. government has declined to intervene at the present time.

 Baycol™: A qui tam complaint (filed by the same relator as in the Trasylol™/Avelox™ complaint) asserting Bayer fraudulently induced a contract with the Department of Defense is pending in the U.S. District Court in Minnesota. The case is proceeding with discovery.

 BASF arbitration: In 2019, Bayer was served with a request for arbitration by BASF SE. BASF alleges to have indemnification claims under the asset purchase agreements signed in 2017 and 2018 related to the divestment of certain Crop Science businesses to BASF. BASF alleges that particular cost items, including certain personnel costs, had not been appropriately disclosed and allocated to some of the divested businesses. Bayer believes it has meritorious defenses and intends to defend itself vigorously. The amounts claimed by BASF are significant and a decision of the arbitration tribunal will be handed down in the coming months.

 Newark Bay environmental matters: In the United States, governmental and private parties have asserted that Bayer is liable for remediation costs and natural resource damages associated with the Lower Passaic River and/or the Newark Bay Complex in northern New Jersey. Bayer, along with a number of other parties, participated in an EPA-sponsored but non-binding allocation process for the Lower Passaic River remediation before an independent allocator. In 2020, the allocator issued its final report. The allocation assigned a very low share to Bayer, giving confidence that this connection will not result in a material liability. Bayer is a backup indemnitor for certain other liabilities from the Lower Passaic River and / or the Newark Bay Complex, which are being satisfied by an unrelated company. Bayer is currently unable to determine the extent of its potential future liability for this matter.

 Asbestos: In many cases, plaintiffs allege that Bayer and co-defendants employed third parties on their sites in past decades without providing them with sufficient warnings or protection against the known dangers of asbestos. Additionally, a Bayer affiliate in the United States is the legal successor to companies that sold asbestos products until 1976. Union Carbide has agreed to indemnify Bayer for this liability. Similarly, Bayer’s subsidiary Monsanto faces numerous claims based on exposure to asbestos at Monsanto premises without adequate warnings or protection and based on the manufacture and sale of asbestos-containing products. Bayer believes it has meritorious defenses and intends to defend itself vigorously.

 PCBs: Bayer’s subsidiary Monsanto has been named in lawsuits brought by various governmental entities in the United States claiming that Monsanto, Pharmacia and Solutia, collectively as a manufacturer of PCBs, should be responsible for a variety of damages due to PCBs in the environment, including bodies of water, regardless of how PCBs came to be located there. PCBs are chemicals that were widely used for various purposes until the manufacture of PCBs was prohibited by the EPA in the United States in 1979.


-----

#### In 2020, Bayer reached an agreement for a nation-wide class settlement to settle claims of approximately 2,500 municipal government entities across the United States for a total payment, including class benefits and attorney fees, of approximately US$650 million. This settlement assumes a minimum participation rate of 98% of all qualified municipal entities, failing which Monsanto will have the option to cancel the settlement agreement. This agreement will require court approval before it becomes effective. 

 Additionally, in 2020, Bayer reached agreements to settle individual suits brought by the Attorneys General of the States of New Mexico and Washington, as well as the District of Columbia for a total amount of approximately US$170 million. Suits by Ohio and New Hampshire were settled in 2021, for a total amount of approximately US$105 million. Individual suits by Attorneys General of the States of Pennsylvania, Oregon, Delaware and Maryland are currently pending. A relatively small number of other states are expected to follow. Bayer will continue its vigorous defense of any case that remains pending.

 Monsanto also faces numerous lawsuits claiming personal injury and/ or property damage due to use of and exposure to PCB products. In July 2021, a jury in King County, Washington, awarded a total amount of US$185 million (compensatory and punitive damages) to three plaintiffs alleging personal injury from allegedly being exposed to PCBs in their workplace, the Sky Valley Education Center. Bayer disagrees with the verdict and has appealed. That case was followed by a second case, which began in November 2021, involving the same school building where the jury awarded approximately US$62 million (compensatory and punitive damages) in total to eight plaintiffs. Bayer disagrees with this second verdict based on many of the same errors seen in the first trial and plans to appeal. The undisputed evidence in these cases does not support the conclusions that plaintiffs were exposed to unsafe levels of PCBs or that any exposure could have possibly caused their claimed injuries. There are approximately 200 plaintiffs in connection with the relevant building. We believe that we also have meritorious defenses in these matters and intend to defend ourselves vigorously.

 Shareholder litigation concerning Monsanto acquisition: In Germany and the United States, investors have filed lawsuits claiming damages suffered due to the drop in the Issuer’s share price. Plaintiffs allege that the company's capital market communication in connection with the acquisition of Monsanto Company was flawed and that the information provided by Bayer on the risks, in particular regarding glyphosate product liability claims in the United States, was insufficient. In Germany, as of 31 December 2021, two claims were filed and served upon Bayer which are still at an early stage. A model case proceeding in accordance with the Capital Markets Model Case Act (Kapitalanleger-Musterverfahrensgesetz) has been requested. Further claims were filed in December 2021 which will be served upon Bayer successively. In the parallel proceeding in the United States, one lawsuit seeking class action certification has been served upon Bayer. In October 2021, the United States District Court for the Northern District of California, San Francisco Division, decided that the lawsuit shall move forward with regard to some of the allegations. Bayer believes it has duly complied with its capital markets law obligations at all times in connection with the acquisition of Monsanto Company and its disclosures concerning glyphosate product liability claims and intends to defend itself vigorously against the claims in all shareholder lawsuits.

 Management and Supervisory Bodies

 In accordance with the German Stock Corporation Act (Aktiengesetz), Bayer AG has both a Board of Management (Vorstand) and a Supervisory Board (Aufsichtsrat). The Board of Management is responsible for the management of Bayer's business; the Supervisory Board supervises the Board of Management and appoints its members. The two boards are separate, and no individual may simultaneously be a member of both boards.

 Board of Management

 The following table shows the current members of Bayer's Management Board, their responsibilities, the date of their initial appointment and their current term of office.


-----

#### Name Area of Responsibility Appointed Term of Office


#### Werner Baumann Chairman of the Board of Management (CEO) and Chief Sustainability Officer

 Sarena Lin Member of the Board of Management,
 Chief Transformation and Talent Officer,
 Labor Director

 Wolfgang Nickl Member of the Board of Management and
 responsible for Finance (Chief Financial
 Officer) and for the region North America

 Stefan Oelrich Member of the Board of Management and
 Head of the Pharmaceuticals Division.
 Also responsible for the region Europe /
 Middle East

 Rodrigo Santos Member of the Board of Management and
 Head of the Crop Science Division. Also responsible for the region Latin America
 and Africa

 Heiko Schipper Member of the Board of Management and
 Head of the Consumer Health Division.
 Also responsible for the region
 Asia/Pacific


#### 1 January 2010 Current term expires 2024 

 1 February 2021 Current term expires 2024

 26 April 2018 Current term expires 2025

 1 November 2018 Current term expires 2025

 1 January 2022 Current term expires 2024

 1 March 2018 Current term expires 2025


#### No member of the Management Board performs any principal activities outside the Group which are significant with respect to Bayer AG or the Bayer Group.

 Supervisory Board

 The following table shows the current members of Bayer's Supervisory Board, their principal occupations, the year in which they were first elected or appointed and memberships they held as of the date of this Prosepctus (unless otherwise indicated) on the supervisory boards of other companies or in comparable domestic and foreign controlling bodies.

 Memberships on other Supervisory
 Position/ Responsibilities/ Boards or in comparable domestic
 Name Education First Elected and foreign Controlling Bodies

 Prof. Dr. Norbert Chairman of the Supervisory Board, 2018 Deutsche Bank Aktiengesellschaft Winkeljohann Independent management consultant Georgsmarienhütte Holding GmbH
 Sievert AG (Chairman)
 Bohnenkamp AG (Chairman)

 Oliver Zühlke Vice Chairman of the Supervisory 2007  Board,
 Chairman of the Bayer Central
 Works Council

 Dr. Paul Achleitner Chairman of the Supervisory Board 2002 Deutsche Bank AG (Chairman)
 of Deutsche Bank AG Henkel AG & Co. KGaA (Shareholders'
 Committee)


-----

#### Memberships on other Supervisory
 Boards or in comparable domestic
 and foreign Controlling Bodies


#### Name

 Dr. rer. nat. Simone Bagel-Trah


#### Chairwoman of the Supervisory
 Board of Henkel AG & Co. KGaA
 and Henkel Management AG and
 Shareholders' Committee of Henkel
 AG & Co. KGaA


#### Position/ Responsibilities/
 Education First Elected


#### 2014 Henkel AG & Co. KGaA (Chairwoman) Henkel Management AG (Chairwoman)
 Heraeus Holding GmbH
 Henkel AG & Co. KGaA (Shareholders'
 Committee, Chairwoman)


#### Horst Baier Independent Consultant 2020 DIAKOVERE gGmbH
 Ecclesia Holding GmbH
 Whitbread PLC (Board of Directors)


#### Dr. Norbert W. Bischofberger


#### President and Chief Executive
 Officer of Kronos Bio, Inc.


#### André van Broich Chairman of the Bayer Group Works
 Council and Chairman of the Works
 Council of the Dormagen site


#### 2017 Kronos Bio, Inc. (Board of Directors)
 Morphic Therapeutic, Inc. 
 (Board of Directors)

 2012 

#### Ertharin Cousin Independent Consultant 2019  Camelot North America
 (Board of Directors)
 Mondelez International, Inc. 
 (Board of Directors)


#### Dr. Thomas Elsner Chairman of the Managerial
 Employees' Committee of Bayer
 AG, Leverkusen, and Chairman of
 the Bayer Group Managerial
 Employees' Committee


#### 2017 

#### Colleen A. Goggins Independent Consultant 2017 The Toronto-Dominion Bank 
 (Board of Directors)
 IQVIA Holdings Inc.
 (Board of Directors)
 SIG Combibloc Services AG 
 (Board of Directors)


#### Robert Gundlach Vice Chairman of the Works Council
 of the Berlin site

 Heike Hausfeld Chairwoman of the Works Council
 of the Leverkusen site

 Reiner Hoffmann Chairman of the German Trade
 Union Confederation

 Dr. Fei-Fei Li Professor in the Computer Science Department at Stanford University
 and Co-Director of Stanford's
 Human-Centered Artificial
 Intelligence Institute


#### 2019 
 2017 
 2006 
 2021 Nimble Robotics, Inc. 
 (Board of Directors)
 Reinvent Technology Partners
 (Board of Directors)
 Twitter Inc. 
 (Board of Directors)


-----

#### Memberships on other Supervisory
 Boards or in comparable domestic
 and foreign Controlling Bodies


#### Name


#### Position/ Responsibilities/
 Education First Elected


#### Frank Löllgen North Rhine District Secretary of the
 German Mining, Chemical and
 Energy Industrial Union

 Petra Reinbold-Knape Trade Union Secretary at the
 German Mining, Chemical and Energy Industrial Union, board
 division 1, overall management

 Andrea Sacher Vice Chairwoman of the Bayer
 Central Works Council and
 Chairwoman of the Works Council
 of the Berlin site


#### 2015 Evonik Industries AG

 2012 Covestro AG
 Covestro Deutschland AG

 2020 
 2012 
 2021 Linde plc
 (Board of Directors)
 PepsiCo Inc.
 (Board of Directors)

 2014 

#### Michael Schmidt- Kießling


#### Chairman of the Works Council of
 the Elberfeld site


#### Alberto Weisser Senior Consultant at Temasek
 International Pte. Ltd.


#### Prof. Dr. med. Dr. h.c. mult. Otmar D. Wiestler


#### President of the Herman von
 Helmholtz Association of German
 Research Centers e.V.


#### The business address of each member of the Board of Management and the Supervisory Board is Bayer Aktiengesellschaft, Kaiser-Wilhelm-Allee 1, 51373 Leverkusen, Germany.

 Conflicts of Interest

 There are no potential conflicts of interest between any duties of the members of the Board of Management or the Supervisory Board toward Bayer and their respective private interests and/or other duties.

 Declaration of Conformity

 With respect to the past, present and future corporate governance practice, the following declaration of the Issuer published in December 2021 refers to the German Corporate Governance Code (the "Code") as amended on 16 December 2019:

 "Pursuant to Section 161 of the German Stock Corporation Act, the Board of Management and Supervisory Board of Bayer AG hereby declare as follows: 

 The company has been in compliance with the recommendations of the Code since issuance of the last annual compliance declaration in December 2020.

 All the recommendations of the Code will be complied with in full in the future."

 No further declaration has been issued since December 2021.


-----

#### Selected Financial Information

 This selected Financial Information has been extracted or derived from the audited consolidated financial statements of the Bayer Group as of and for the year ended 31 December 2021 or from the Issuer's internal or external accounting records. The consolidated financial statements have been prepared according to the International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board (IASB), London, and the interpretations of the IFRS Interpretations Committee, both as endorsed by the EU and in effect at the end of the respective reporting periods and the additional requirements of German commercial law pursuant to Section 315e (1) German Commercial Code (HGB). 

 Where financial information in the following tables is labeled "audited", this means that it has been taken from the audited consolidated financial statements of Bayer AG as of and for the fiscal year ended 31 December 2021 and the comparative figures included in these consolidated financial statements as of and for the fiscal year ended 31 December 2020. The financial information marked as "unaudited" is extracted from the the Group’s accounting records or the internal reporting systems or has been calculated on the basis of figures extracted from the above-mentioned sources.

 Financial year ended 31 December

 2021 2020

 (amounts in EUR million) (audited)

 Net Sales 44,081 41,400

 Net income 1,000 -10,495


#### Net cash provided by (used in) operating activities 


#### 5,089 4,903

 As of 31 December


#### 2020 2021
 (Restated)[(1) ]

 (amounts in EUR million) (audited)

 Total assets 120,241 116,804

 Equity 33,168 30,675

(1) Restated for the finalization of the purchase price allocation adjustments in connection with the purchase of Asklepios BioPharmaceutical Inc.

#### Alternative Performance Measures

 This Prospectus contains non-IFRS measures and ratios which are not required by, or presented in accordance with, IFRS or the accounting standards of any other jurisdiction ("Alternative Performance Measures"). The Alternative Performance Measures may not be comparable to other similarly titled measures of other companies and should be considered together with Bayer Group's IFRS results. The Issuer has provided these Alternative Performance Measures because it believes they provide investors with additional information to assess the operating performance and financial results of Bayer Group's business activities.

 EBIT, EBITDA and EBITDA before special items

 "EBIT" (earnings before interest and taxes) serves to present a company's performance while eliminating the effects of differences among local taxation systems and different financing activities.

 "EBITDA" stands for earnings before interest, taxes, depreciation and impairment losses / loss reversals on property, plant and equipment, impairment losses on goodwill, and amortization and impairment losses / loss reversals on other


-----

#### intangible assets. This performance indicator neutralizes the effects of the financial result along with distortions of operational performance that result from divergent depreciation and amortization methods and the exercise of measurement discretion. EBITDA is EBIT plus the amortization of intangible assets and the depreciation of property, plant and equipment, plus impairment losses and minus impairment loss reversals, recognized in profit or loss during the reporting period.

 "EBITDA before special items" shows the development of the operational business irrespective of the effects of special items, i.e. special effects for the Bayer Group with regard to their nature and magnitude. These may include acquisition costs, divestments, litigations, restructuring, integration costs, impairment losses and impairment loss reversals. In the calculation of EBITDA before special items, special charges are added, and special gains subtracted.

 Financial year ended 31 December

 2021 2020

 (amounts in EUR million) (audited, unless otherwise indicated)

 Income before income taxes 2,046 -17,250

 Financial result -1,307 -1,081

 EBIT 3,353 -16,169


#### Depreciation, amortization and impairment losses / loss reversals 


#### -3,056 -13,259


#### EBITDA [(1) ] 6,409 -2,910

 Special items [(1)] -4,770 -14,371

 EBITDA before special items 11,179 11,461

(1) Unaudited.

#### Free Cash Flow

 "Free Cash Flow" is an alternative performance measure that is based on the cash flow from operating activities under IAS 7. Free Cash Flow illustrates the cash flows available for paying dividends and reducing debt as well as for investing in innovation and acquisitions. It is calculated by subtracting cash outflows for additions to property, plant and equipment ("PPE") and intangible assets from the net cash provided by (used in) operating activities, adding interest and dividends received along with interest received from interest-rate swaps, and deducting interest paid including interest-rate swaps.

 Financial year ended 31 December

 2021 2020

 (amounts in EUR million) (audited unless otherwise indicated)


#### Net cash provided by (used in) operating activities


#### 5,089 4,903


#### Cash outflow for PPE and intangible assets -2,611  -2,418

 Interest and dividends received 137  134

 Interest paid including interest-rate swaps - 1,227  -1,301

 Interest received from interest rate swaps 27 25

 Free Cash Flow [(1)] 1,415  1,343

(1) Unaudited.


-----

#### Net Financial Debt

 "Net Financial Debt" is an important financial management indicator for the Bayer Group and is used both internally and externally in assessing its liquidity, capital structure and financial flexibility.

 As of 31 December

 2020 2021
 (Restated)[(1) ]

 (amounts in EUR million) (audited, unless otherwise indicated)

 Bonds and notes 37,593 36,745

 Liabilities to banks [(2)] 773 3,669

 Lease liabilities 1,165 1,143 

 Liabilities from derivatives [(3)] 69 136

 Other financial liabilities 1,272 77

 Receivables from derivatives [(3)(4)] -114 -141

 Financial debt [(4)] 40,758 41,629

 Cash and cash equivalents -4,564 -4,191

 Current financial assets [(4)(5)] -3,057 -7,393

 Net Financial Debt [(4)] 33,137 30,045

(1) Restated for the finalization of the purchase price allocation adjustments in connection with the purchase of Asklepios BioPharmaceutical Inc.

(2) Including both financial and nonfinancial liabilities.

(3) Including the market values of interest-rate and currency hedges of recorded transactions.

(4) Unaudited.

(5) Including short-term receivables with maturities between 3 and 12 months outstanding from banks and other companies as well as financial
investments in debt and equity instruments that were recorded as current on first-time recognition

#### Leverage Ratio

 The "Leverage Ratio" illustrates the ratio between Bayer Group's indebtedness and its earnings.

 The Leverage Ratio is calculated as follows:

 Net Financial Debt
 plus
 Provisions for pensions and other post-employment benefits
 less
 50% of the outstanding nominal amount of the Group's hybrid bonds

 EBITDA before special items for the relevant period

 As of 31 December 2021, the Leverage Ratio of Bayer was 3.40x (31 December 2020: 3.16x).

 Trend Information and Significant Changes

 There has been no material adverse change in the prospects of the Issuer and Bayer Group since 31 December 2021.

 There has been no significant change in the financial position or in the financial performance of the Issuer and Bayer Group since 31 December 2021.


-----

#### Recent Events

 On 9 March 2022, we signed a definitive agreement with the private equity firm Cinven for the sale of our Environmental Science (ES) Professional business for a purchase price of USD 2.6 billion. The transaction is expected to close in the second half of 2022.

 In February 2022, we decided, as a result of a re-assessment of the benefit-risk-profile of eliapixant, an investigational P2X3 receptor antagonist that was being evaluated for potential indications in endometriosis, refractory chronic cough, overactive bladder and diabetic neuropathic pain, to terminate the development program in all indications.


-----

### TAXATION

#### The following is a general overview of certain tax considerations relating to the purchasing, holding and disposing of Notes. It does not purport to be a complete analysis of all tax considerations relating to the Notes. In particular, this discussion does not consider any specific facts or circumstances that may apply to a particular Noteholder. The discussions that follow for each jurisdiction are based upon the applicable laws in force and their interpretation on the date of this Prospectus. These tax laws and interpretations are subject to change that may occur after such date, even with retroactive effect.

 The information contained in this section is limited to taxation issues and prospective investors should not apply any information set out below to other areas, including (but not limited to) the legality of transactions involving the Notes.

 Prospective Noteholders should consult their own tax advisers as to the particular tax consequences of subscribing, purchasing, holding and disposing the Notes, including the application and effect of any federal, state or local taxes, under the tax laws of Germany, the Grand Duchy of Luxembourg and each country of which they are residents or citizens.

### Germany

#### The following general overview does not consider all aspects of income taxation in Germany that may be relevant to a Noteholder in the light of the Noteholder's particular circumstances and income tax situation. This general overview is based on German tax laws and regulations, all as currently in effect and all subject to change at any time, possibly with retroactive effect. 

 Tax resident Noteholders

 The section "Tax resident Noteholders" refers to persons who are tax residents of Germany (i.e. persons whose residence, habitual abode, statutory seat, or place of effective management is located in Germany).

 Withholding tax on interest payments and capital gains

 Interest payments received by an individual Noteholder will be subject to German withholding tax if the Notes are kept or administrated in a custodial account with a German branch of a German or non-German credit institution (Kreditinstitut) or financial services institution (Finanzdienstleistungsinstitut), a German securities trading company (Wertpapierhandelsunternehmen) or a German securities trading bank (Wertpapierhandelsbank) (each a "Disbursing Agent", auszahlende Stelle). The flat income tax rate is 25% (plus 5.5% solidarity surcharge thereon, the total withholding being 26.375%). An electronic information system for withholding of church tax will apply to individuals subject to church tax in relation to investment income, with the effect that church tax will be collected by the Disbursing Agent by way of withholding unless the investor has filed a blocking notice (Sperrvermerk) with the German Federal Central Tax Office (Bundeszentralamt für Steuern) in which case the investor will be assessed to church tax.

 The same treatment applies to capital gains (i.e. the difference between the proceeds from the disposal, redemption, repayment or assignment after deduction of expenses directly related to the disposal, redemption, repayment or assignment and the cost of acquisition) derived by an individual Noteholder provided the Notes have been held in a custodial account with a Disbursing Agent since the time of their acquisition. If Notes held or administrated in the same custodial account have been acquired at different points in time, the Notes first acquired will be deemed to have been sold first for the purposes of determining the capital gains. Where Notes are acquired and/or sold or redeemed in a currency other than Euro, the sales/redemption price and the acquisition costs have to be converted into Euro on the basis of the foreign exchange rates prevailing on the sale or redemption date and the acquisition date respectively. If interest coupons or interest claims are disposed of separately (i.e. without the Notes), the proceeds from the disposition are subject to withholding tax. The same applies to proceeds from the payment of interest coupons or interest claims if the Notes have been disposed of separately. 

 To the extent the Notes have not been kept in a custodial account with a Disbursing Agent since the time of their acquisition, upon the disposal, redemption, repayment or assignment withholding tax applies at a rate of 26.375%


-----

#### (including solidarity surcharge, plus church tax, if applicable) on 30% of the disposal or redemption proceeds (plus interest accrued on the Notes ("Accrued Interest", Stückzinsen), if any), unless the investor or the previous depository bank was able and allowed to prove evidence for the investor's actual acquisition costs to the Disbursing Agent. 

 In computing any German tax to be withheld, the Disbursing Agent may generally deduct from the basis of the withholding tax negative investment income realized by the individual Noteholders via the Disbursing Agent (e.g. losses from the sale of other securities with the exception of shares). The Disbursing Agent may also deduct Accrued Interest on the Notes or other securities paid separately upon the acquisition of the respective security via the Disbursing Agent. In addition, subject to certain requirements and restrictions the Disbursing Agent may credit foreign withholding taxes levied on investment income in a given year regarding securities held by the individual Noteholder in the custodial account with the Disbursing Agent.

 Individual Noteholders may be entitled to an annual allowance (Sparer-Pauschbetrag) of EUR 801 (EUR 1,602 for jointly assessed individual Noteholders) for all investment income received in a given year. Upon the individual Noteholder filing an exemption certificate (Freistellungsauftrag) with the Disbursing Agent, the Disbursing Agent will take the allowance into account when computing the amount of tax to be withheld. No withholding tax will be deducted if the Noteholder of the Notes has submitted to the Disbursing Agent a certificate of non-assessment
 (Nichtveranlagungsbescheinigung) issued by the competent local tax office.

 If Notes are kept or administrated in a custodial account with a Disbursing Agent, German withholding tax will not apply to gains from the disposal, redemption, repayment or assignment of Notes held by a corporation as Noteholder while ongoing payments, such as interest payments, are subject to withholding tax (irrespective of any deductions of foreign tax and capital losses incurred). With regard to gains from the disposal, repayment or assignment of Notes held by an individual Noteholder, a business partnership or through the permanent establishment of a non-resident taxpayer, the same may apply upon application where the Notes form part of a trade or business. 

 The Issuer is not obliged under German law to withhold any withholding tax (Kapitalertragsteuer) on interest payments and upon the sale or redemption of the Notes.

 Taxation of current income and capital gains

 The personal income tax liability of an individual Noteholder deriving income from capital investments under the Notes is, in principle, settled by the tax withheld. To the extent withholding tax has not been levied, such as in the case of Notes kept in custody abroad or if no Disbursing Agent is involved in the payment process, the individual Noteholder must report his or her income and capital gains derived from the Notes on his or her tax return and then will also be taxed at a rate of 25% (plus solidarity surcharge and church tax thereon, if applicable). If the withholding tax on a disposal, redemption, repayment or assignment has been calculated from 30% of the disposal proceeds (rather than from the actual gain), an individual Noteholder may and, in case the actual gain is higher than 30% of the disposal proceeds, must also apply for an assessment on the basis of his or her actual acquisition costs. Further, an individual Noteholder may request that all investment income of a given year is taxed at his or her lower individual tax rate based upon an assessment to tax with any amounts over withheld being refunded. In each case, the deduction of expenses (other than transaction costs) on an itemized basis is not permitted. 

 Capital losses from the disposal, redemption, repayment or assignment of the Notes held as private assets should generally be tax-recognized irrespective of the holding period of the Notes. The losses may, however, not be used to offset other income like employment or business income but may only be offset against investment income subject to certain limitations. Losses not utilised in one year may be carried forward into subsequent years but may not be carried back into preceding years. 

 Losses from the Notes resulting, inter alia, from a bad debt (Forderungsausfall), i.e., should the Issuer become insolvent, and from a waiver of a receivable (Forderungsverzicht), to the extent the waiver does not qualify as a hidden contribution, can be set off up to €20,000 against other investment income. Such losses exceeding €20,000 can be carried forward and set off up to €20,000 in later tax assessment periods, subject to certain requirements. Any tax deductible losses in accordance with the foregoing will not be considered for withholding tax purposes by the German Disbursing Agent, but


-----

#### need to be claimed by a Noteholder by way of tax assessment. According to the recent act on the reduction of the solidarity surcharge (Gesetz zur Rückführung des Solidaritätszuschlags), the solidarity surcharge shall only be levied for wage tax and income tax purposes from the assessment period 2021 onwards if the individual income tax of the individual investor exceeds the threshold of EUR°16,956 (EUR 33,912 for jointly assessed Noteholders). The solidarity surcharge shall however continue to be applicable for withholding tax, flat tax and corporate income tax purposes. If, in case of flat tax, the income tax burden for an individual investor is lower than the flat tax of 25%, the individual investor can apply for its capital investment income being assessed at its individual progressive rates (see above) in which case solidarity surcharge would be refunded. 

 Where Notes form part of a trade or business the withholding tax, if any, will not settle the personal or corporate income tax liability. Where Notes form part of a trade or business, interest (accrued) must be taken into account as income. The respective Noteholder will have to report income and related (business) expenses in the tax return and the balance will be taxed at the Noteholder's applicable tax rate. Withholding tax levied, if any, will be credited against the personal or corporate income tax of the Noteholder. Where Notes form part of a German trade or business the current income and gains from the disposal, redemption, repayment or assignment of the Notes are in principle also be subject to German trade tax.

 Non-resident Noteholders

 Interest, including Accrued Interest, and capital gains are not subject to German taxation, unless (i) the Notes form part of the business property of a permanent establishment, including a permanent representative, or a fixed base maintained in Germany by the Noteholder or (ii) the income otherwise constitutes German-source income. In cases (i) and (ii) a tax regime similar to that explained above under "Tax resident Noteholders" applies.

 Non-residents of Germany are, in general, exempt from German withholding tax on interest and the solidarity surcharge thereon. However, where the interest is subject to German taxation as set forth in the preceding paragraph and the Notes are held in a custodial account with a Disbursing Agent, withholding tax may be levied under certain circumstances. The withholding tax may be refunded based on an assessment to tax or under an applicable tax treaty.

 Interest, including Accrued Interest, and capital gains are in principle also subject to German taxation, if the Notes are held by a non-resident Noteholder, which is resident in a non-cooperative country or territory within the meaning of the act to prevent tax evasion and unfair tax competition (Steueroasen-Abwehrgesetz). 

 Substitution of the Issuer

 If the Issuer exercises the right to substitute the debtor of the Notes, the substitution might, for German tax purposes, be treated as an exchange of the Notes for new notes issued by the Substitute Debtor and subject to similar taxation rules like the Notes. In particular, such a substitution could result in the recognition of a taxable gain or loss for any Noteholders. 

 Inheritance and gift tax

 The transfer of the Notes to another person by way of gift or inheritance may be subject to German gift or inheritance tax, respectively, if, inter alia,

 (i) the testator, the donor, the heir, the donee or any other acquirer had his residence, habitual abode or, in case of a corporation, association (Personenvereinigung) or estate (Vermögensmasse), has its seat or place of management in Germany at the time of the transfer of property,

 (ii) except as provided under (i), the testator's or donor's Notes belong to business assets attributable to a permanent
 establishment or a permanent representative in Germany.

 Special regulations may apply to certain German expatriates.

 Other taxes

 No stamp, issue, value added, capital transfer or registration taxes or such duties will be payable in Germany in connection with the issuance, delivery or execution as well as the purchase, sale or other disposal of the Notes. However, under


-----

#### certain circumstances entrepreneurs may choose liability to German value added tax with regard to the sale of the Notes to other entrepreneurs which would otherwise be tax exempt. Currently, net assets tax is not levied in Germany.


-----

### SUBSCRIPTION AND SALE OF THE NOTES

#### General

 Pursuant to a subscription agreement dated 23 March 2022 (the "Subscription Agreement") among the Issuer and the Joint Bookrunners, the Issuer has agreed to sell to the Joint Bookrunners, and the Joint Bookrunners have agreed, subject to certain customary closing conditions, to purchase, the Notes on 25 March 2022. The Issuer has furthermore agreed to pay certain fees to the Joint Bookrunners and to reimburse the Joint Bookrunners for certain expenses incurred in connection with the issue of the Notes.

 The Subscription Agreement provides that the Joint Bookrunners under certain circumstances will be entitled to terminate the Subscription Agreement. In such event, no Notes will be delivered to investors. Furthermore, the Issuer has agreed to indemnify the Joint Bookrunners against certain liabilities in connection with the offer and sale of the Notes.

 Certain of the Joint Bookrunners and their respective affiliates may be customers of, borrowers from or creditors of the Bayer AG and its affiliates. Proceeds of the issuance of the Notes may be used to repay a portion or all of the loan financing from such creditors. In addition, certain Joint Bookrunners and their respective affiliates have engaged, and may in the future engage, in investment banking and/or commercial banking transactions with, and may perform services for, Bayer AG and its affiliates in the ordinary course of business. In particular, in the ordinary course of their business activities, the Joint Bookrunners and their respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers. Such investments and securities activities may involve securities and/or instruments of Bayer AG or its affiliates. Certain of the Joint Bookrunners or their respective affiliates that have a lending relationship with Bayer AG routinely hedge their credit exposure to Bayer AG consistent with their customary risk management policies. Typically, such Joint Bookrunners and their respective affiliates would hedge such exposure by entering into transactions which consist of either the purchase of credit default swaps or the creation of short positions in securities, including potentially the Notes issued. Any such positions could adversely affect future trading prices of the Notes. The Joint Bookrunners and their respective affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.

 There are no interests of natural and legal persons involved in the issue, including conflicting ones, that are material to the issue.

 Selling Restrictions 

 General

 Each Joint Bookrunner has acknowledged that other than explicitly mentioned in this Prospectus no action is taken or will be taken by the Issuer in any jurisdiction that would permit a public offering of the Notes, or possession or distribution of any offering material relating to them, in any jurisdiction where action for that purpose is required.

 Each Joint Bookrunner has represented and agreed that it will comply with all applicable laws and regulations in each jurisdiction in which it purchases, offers, sells or delivers Notes or has in its possession or distributes any offering material relating to them.

 Prohibition of Sales to EEA Retail Investors 

 Each Joint Bookrunner has represented, warranted and agreed that it has not offered, sold or otherwise made available and will not offer, sell or otherwise make available any Notes to any retail investor in the European Economic Area. For the purposes of this provision the expression "retail investor" means a person who is one (or more) of the following:

 (i) a retail client as defined in point (11) of Article 4(1) of MiFID II (as amended); or


-----

#### (ii) a customer within the meaning of Directive 2016/97/EU, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II.

 United Kingdom

 Prohibition of Sales to UK Retail Investors 

 Each Joint Bookrunner has represented and agreed that it has not offered, sold or otherwise made available and will not offer, sell or otherwise make available any Notes which are the subject of the offering contemplated by this Prospectus in relation thereto to any retail investor in the United Kingdom. For the purposes of this provision the expression "retail investor" means a person who is one (or more) of the following:

 (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("EUWA"); or

 (ii) a customer within the meaning of the provisions of the FSMA and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA.

 Other regulatory restrictions 

 Each Joint Bookrunner has represented, warranted and agreed that:

 (i) it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the FSMA) received by it in connection with the issue or sale of the Notes in circumstances in which Section 21(1) of the FSMA does not apply to the Issuer, and

 (ii) it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the Notes in, from or otherwise involving the United Kingdom.

 United States of America and its territories

 The Notes have not been and will not be registered under the Securities Act, and may not be offered or sold within the United States or to, or to the account of benefit of, U.S. persons except in transactions exempt from the registration requirements of the Securities Act. Terms used in this paragraph have the meanings given to them by Regulation S.

 The Notes are subject to U.S. tax law requirements and may not be offered, sold or delivered within the United States or its possessions or to a United States person, except in certain transactions permitted by the U.S. tax regulations. Terms used in this paragraph have the meanings given to them by the U.S. Internal Revenue Code of 1986 and regulations thereunder. 

 Each Joint Bookrunner has represented and agreed that except as permitted by the Subscription Agreement, it has not offered, sold or delivered and will not offer, sell or deliver any Notes (i) as part of their distribution and any time or (ii) otherwise until 40 days after the later of the commencement of the offering and the Issue Date, within the United States or to, for the account of benefit of, U.S. persons, and will have sent to each dealer to which it sells the Notes and any related guarantee during the distribution compliance period a confirmation or other notice setting forth the restrictions on offers and sales of the Notes within the United States or to, or for the account or benefit of, U.S. persons. Terms used in this paragraph have the meanings given to them by Regulation S.

 In addition, until 40 days after the commencement of the offering of the Notes, an offer or sale of the Notes within the United States by any dealer (whether or not participating in the offering) may violate the registration requirements of the Securities Act.


-----

#### Singapore

 Each Joint Bookrunner has acknowledged that this Prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, each Joint Bookrunner has represented and agreed that it has not offered or sold any Notes or caused the Notes to be made the subject of an invitation for subscription or purchase and will not offer or sell any Notes or cause the Notes to be made the subject of an invitation for subscription or purchase, and has not circulated or distributed, nor will it circulate or distribute, this Prospectus or any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the Notes, whether directly or indirectly, to any person in Singapore other than (i) to an institutional investor (as defined in Section 4A of the Securities and Futures Act 2001 of Singapore, as modified or amended from time to time (the "SFA")) pursuant to Section 274 of the SFA, (ii) to a relevant person (as defined in Section 275(2) of the SFA) pursuant to Section 275(1) of the SFA, or any person pursuant to Section 275(1A) of the SFA, and in accordance with the conditions specified in Section 275 of the SFA, or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.

 Where Notes are subscribed or purchased under Section 275 of the SFA by a relevant person which is:

 (a) a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or

 (b) a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor,

 securities or securities-based derivatives contracts (each term as defined in Section 2(1) of the SFA) of that corporation or the beneficiaries' rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the Notes pursuant to an offer made under Section 275 of the SFA except:

 (i) to an institutional investor or to a relevant person, or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(i)(B) of the SFA;

 (ii) where no consideration is or will be given for the transfer;

 (iii) where the transfer is by operation of law; 

 (iv) as specified in Section 276(7) of the SFA; or

 (v) as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and Securities- based Derivatives Contracts) Regulations 2018.


-----

### GENERAL INFORMATION

#### 1. Authorisations: The creation and issue of the Notes has been authorised by a resolution of the Board of Management (Vorstand) of the Issuer on 8 February 2022 and by a resolution of the Supervisory Board (Aufsichtsrat) of the Issuer on 25 February 2022.

 2. Expenses of Admission to Trading: The total expenses related to the admission to trading of the Notes are expected to amount to EUR 15,000.

 3. Clearing Systems: Payments and transfers of the Notes will be settled through Euroclear Bank SA/NV, 1 Boulevard du Roi Albert II, B-1210 Brussels, Belgium and Clearstream Banking S.A., 42 Avenue JF Kennedy, L-1855 Luxembourg.

 The NC5.5 Notes have the following securities codes:

 ISIN: XS2451802768  Common Code: 245180276 German Securities Code (WKN): A3MQSV

 The NC8.5 Notes have the following securities codes:

 ISIN: XS2451803063 Common Code: 245180306 German Securities Code (WKN): A3MQSW

 4. Listing and Admission to Trading: Application has been made to the Luxembourg Stock Exchange for each Series of Notes to be admitted to trading on the Luxembourg Stock Exchange's regulated market (which is a regulated market for the purposes of MiFID II) and to be listed on the Official List of the Luxembourg Stock Exchange on or around the Issue Date.

 5. Documents on Display: Electronic versions of the following documents are available on the Issuer's website:

 (a) the articles of association of the Issuer (accessed by using the hyperlink
 "https://www.bayer.com/sites/default/files/articles-of-incorporation-of-bayer-ag-2021.pdf "); and

 (b) the documents incorporated by reference into this Prospectus (accessed by using the hyperlinks set out in the section "Documents Incorporated by Reference" below).

 This Prospectus and any supplement to this Prospectus will be published on the website of the Luxembourg Stock Exchange (www.bourse.lu).

 6. Third Party Information: With respect to any information included herein and specified to be sourced from a third party (i) the Issuer confirms that any such information has been accurately reproduced and as far as the Issuer is aware and is able to ascertain from information available to it from such third party, no facts have been omitted the omission of which would render the reproduced information inaccurate or misleading and (ii) neither the Issuer nor any Joint Bookrunner has independently verified any such information and neither the Issuer nor any Joint Bookrunner accepts any responsibility for the accuracy thereof.

 7. Yield:

 For the Noteholders, the yield of the NC5.5 Notes until the NC5.5 Notes First Reset Date is 4.625 per cent. per annum, calculated on the basis of the issue price of the NC5.5 Notes. 

 For the Noteholders, the yield of the NC8.5 Notes until the NC8.5 Notes First Reset Date is 5.500 per cent. per annum, calculated on the basis of the issue price of the NC8.5 Notes. 

 Such yields are calculated in accordance with the ICMA (International Capital Markets Association) Method. 


-----

#### The yield of the Notes for the periods after their respective first reset dates cannot be determined as of the date of this Prospectus.

 8. Ratings: The Notes are expected to be rated "BB+" by S&P[1], "Ba1" by Moodys[2] and "BBB-" by Fitch[3].

 S&P, Moody’s and Fitch are established in the European Union and are registered under Regulation (EC) No 1060/2009 of the European Parliament and of the Council of 16 September 2009 on credit rating agencies, as amended (the "CRA Regulation")[4].

 Investors in the Notes should be aware that a credit rating is not a recommendation to buy, sell or hold securities and may be revised or withdrawn by the rating agency at any time.

 9. Legal Entity Identifier: The LEI of Bayer AG is 549300J4U55H3WP1XT59.

1 S&P defines BB+ as follows: An obligation rated 'BB' is less vulnerable to nonpayment than other speculative issues.
However, it faces major ongoing uncertainties or exposure to adverse business, financial, or economic conditions which
could lead to the obligor's inadequate capacity to meet its financial commitment on the obligation.The ratings from 'AA' to
'CCC' may be modified by the addition of a plus (+) or minus (-) sign to show relative standing within the major rating
categories

2 Moodys defines Ba1 as follows: Obligations rated Ba are judged to have a speculative element and are subject to substantial
credit risk. Moody's appends numerical modifiers 1, 2, and 3 to each generic rating classification from Aa through Caa. The
modifier 1 indicates that the obligation ranks in the higher end of its generic rating category; the modifier 2 indicates a midrange ranking; and the modifier 3 indicates a ranking in the lower end of that generic rating category.

3 Fitch defines BBB- as follows: BBB’ ratings indicate that expectations of default risk are currently low. The capacity for
payment of financial commitments is considered adequate, but adverse business or economic conditions are more likely to
impair this capacity.

4 The European Securities and Markets Authority publishes on its website (https://www.esma.europa.eu/supervision/creditrating-agencies/risk) a list of credit rating agencies registered in accordance with the CRA Regulation. That list is updated
within five working days following the adoption of a decision under Article 16, 17 or 20 CRA Regulation. The European
Commission shall publish that updated list in the Official Journal of the European Union within 30 days following such update.


-----

### DOCUMENTS INCORPORATED BY REFERENCE

#### The pages specified below of the following documents which have previously been published or are published simultaneously with this Prospectus and which have been filed with the CSSF are incorporated by reference into this Prospectus: (i) the audited Annual Report of Bayer AG for the fiscal year ended 31 December 2021 (the "Audited Annual Report 2021") and (ii) the audited Annual Report of Bayer AG for the fiscal year ended 31 December 2020 (the "Audited Annual Report 2020"), each containing the English language translation of the respective German language consolidated financial statements of the Issuer and of the German language auditor's report (Bestätigungsvermerk) in respect thereof.

 (1) Extracted from: Bayer AG – Audited Annual Report 2021

 Bayer Group Consolidated Income Statements ...............................................  page 131

 Bayer Group Consolidated Statements of Comprehensive Income .................  page 132

 Bayer Group Consolidated Statements of Financial Position ..........................  page 133

 Bayer Group Consolidated Statements of Changes in Equity .........................  page 134

 Bayer Group Consolidated Statements of Cash Flow .....................................  page 135

 Notes to the Consolidated Financial Statements of the Bayer Group .............  pages 136-221

 Independent auditor's report[5] ...........................................................................  pages 223-232

 (2) Extracted from: Bayer AG – Audited Annual Report 2020

 Bayer Group Consolidated Income Statements ...............................................  page 156

 Bayer Group Consolidated Statements of Comprehensive Income .................  page 157

 Bayer Group Consolidated Statements of Financial Position ..........................  page 158

 Bayer Group Consolidated Statements of Changes in Equity .........................  pages 159

 Bayer Group Consolidated Statements of Cash Flow .....................................  page 160

 Notes to the Consolidated Financial Statements of the Bayer Group .............  pages 161-248

 Independent auditor's report[6] ...........................................................................  pages 250-258

 All of these pages shall be deemed to be incorporated by reference into, and to form part of, this Prospectus.

 The non-incorporated parts of such documents, i.e. the pages not listed in the table above, are either not relevant for the investor or covered elsewhere in the Prospectus.

 Copies of documents incorporated by reference in this Prospectus may be obtained (without charge) from the registered office of the Issuer and the website of the Luxembourg Stock Exchange (www.bourse.lu).

 Electronic versions of the documents incorporated by reference are also available on the website of the Issuer (https://www.investor.bayer.com) can be accessed by using the following hyperlinks:

5 The audit opinion refers to the German-language consolidated financial statements and the combined management report of
the Group and the Issuer as a whole and not solely to the respective consolidated financial statements incorporated by
reference.

6 The audit opinion refers to the German-language consolidated financial statements and the combined management report of
the Group and the Issuer as a whole and not solely to the respective consolidated financial statements incorporated by
reference.


-----

#### (1) Bayer AG – Audited Annual Report 2021:

 https://www.bayer.com/sites/default/files/2022-03/Bayer-Annual-Report-2021.pdf

 (2) Bayer AG – Audited Annual Report 2020:

 https://www.bayer.com/sites/default/files/2021-02/Bayer-Annual-Report-2020.pdf


-----

#### Issuer

 Bayer Aktiengesellschaft
 51368 Leverkusen
 Germany

 Principal Paying Agent and Calculation Agent

 Deutsche Bank Aktiengesellschaft 
 Taunusanlage 12
 60325 Frankfurt am Main
 Germany

 Joint Bookrunners


#### Banco Bilbao Vizcaya Argentaria, S.A.
 C/ Sauceda, 28 - Edificio Asia 2nd Floor, 28050
 Madrid
 Spain

 Morgan Stanley Europe SE
 Grosse Gallusstrasse 18
 60312 Frankfurt am Main
 Germany

**Barclays Bank Ireland Plc**

One Molesworth Street

Dublin 2

DO2RF29

Ireland

**Mizuho Securities Europe GmbH**

Taunustor 1

60310 Frankfurt am Main

Germany


#### J.P. Morgan SE
 (TaunusTurm)
 Taunustor 1
 60310 Frankfurt am Main
 Germany

 UniCredit Bank AG
 Arabellastrasse 12
 81925 Munich
 Germany

 Deutsche Bank Aktiengesellschaft
 Mainzer Landstrasse 11-17
 60329 Frankfurt am Main
 Germany

 SMBC Nikko Capital Markets Europe GmbH
 Neue Mainzer Strasse 52-58
 60311 Frankfurt am Main
 Germany


#### Standard Chartered Bank AG
 Taunusanlage 16
 60325 Frankfurt am Main
 Germany

 Auditors to the Issuer

 Deloitte GmbH
 Wirtschaftsprüfungsgesellschaft
 Rosenheimer Platz 4
 81669 München
 Germany

 Legal Advisers

 To the Issuer To the Joint Bookrunners


#### Linklaters LLP
 Taunusanlage 8
 60329 Frankfurt am Main
 Germany


#### Clifford Chance Partnerschaft mbB
 Junghofstrasse 14
 60311 Frankfurt am Main
 Germany


-----

